UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or Section 15(d)
of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): October 11, 2023
L Catterton Asia Acquisition Corp
(Exact
name of registrant as specified in its charter)
| Cayman Islands |
001-40196 |
98-1577355 |
| (State or other jurisdiction of |
(Commission |
(I.R.S. Employer |
| incorporation or organization) |
File Number) |
Identification Number) |
| 8 Marina View, Asia Square Tower 1 |
|
|
| #41-03, Singapore |
|
018960 |
| (Address of principal executive offices) |
|
(Zip Code) |
+65 6672
7600
Registrant’s
telephone number, including area code
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| x | Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of
the Act:
| |
|
Trading |
|
Name of each exchange on |
| Title
of each class |
|
Symbol(s) |
|
which registered |
| Units, each consisting of one Class A Ordinary Share, $0.0001
par value, and one-third of one redeemable warrant |
|
LCAAU |
|
The Nasdaq Stock Market LLC |
| |
|
|
|
|
| Class A Ordinary Shares included as part of the units |
|
LCAA |
|
The Nasdaq Stock Market LLC |
| |
|
|
|
|
| Redeemable warrants included as part of the units, each whole warrant
exercisable for one Class A Ordinary Share at an exercise price of $11.50 |
|
LCAAW |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange
Act of 1934.
Emerging growth company x
If an emerging growth
company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Item 1.01 Entry Into A Material Definitive Agreement.
Amended and Restated Merger Agreement
As
previously disclosed, on January 31, 2023, L Catterton Asia Acquisition Corp, an exempted company limited by shares incorporated
under the laws of the Cayman Islands (“SPAC” or “LCAA”) entered into the Agreement and Plan of
Merger (the “Original Merger Agreement”), with Lotus Technology Inc., an exempted company limited by shares incorporated
under the laws of the Cayman Islands (the “Company” or “Lotus Tech”), Lotus Temp Limited, an exempted
company limited by shares incorporated under the laws of the Cayman Islands and a wholly-owned subsidiary of the Company (“Merger
Sub 1”), and Lotus EV Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands and
a wholly-owned subsidiary of the Company (“Merger Sub 2”), pursuant to which, among other things, (i) Merger
Sub 1 will merge with and into LCAA (the “First Merger”), with LCAA surviving the First Merger as a wholly owned subsidiary
of Lotus Tech (the surviving entity of the First Merger, “Surviving Entity 1”), and (ii) immediately following
the consummation of the First Merger, Surviving Entity 1 will merge with and into Merger Sub 2 (the “Second Merger”,
and together with the First Merger, collectively, the “Mergers”), with Merger Sub 2 surviving the Second Merger as
a wholly owned subsidiary of Lotus Tech (the transactions contemplated by the Original Merger Agreement, including the Mergers, collectively,
the “Business Combination”).
On October 11, 2023, SPAC,
the Company, Merger Sub 1 and Merger Sub 2 entered into the First Amended and Restated Agreement and Plan of Merger (the “Amended
Merger Agreement”), pursuant to which the Original Merger Agreement was amended and restated to provide, among other things,
that the Company shall cause a sponsored American depositary share facility to be established with a reputable depositary bank reasonably
acceptable to SPAC (the “Depositary Bank”) for the purpose of issuing and distributing the American depositary shares
of the Company (the “Company ADSs”), each duly and validly issued against the deposit of one (1) underlying ordinary
share of the Company, par value $0.00001 per share (the “Company Ordinary Share”) deposited with the Depositary Bank
in accordance with the deposit agreement to be entered into between the Company and the Depositary Bank.
Pursuant to the Amended
Merger Agreement, immediately prior to the effective time of the First Merger (the “First Effective Time”), each Class B
ordinary share, par value $0.0001 per share, of SPAC (each, a “SPAC Class B Ordinary Share”) shall be automatically
converted into one Class A ordinary share, par value $0.0001 per share, of SPAC (each, a “SPAC Class A Ordinary Share”,
together with SPAC Class B Ordinary Share, collectively, “SPAC Shares”) (such automatic conversion, the “SPAC
Class B Conversion”) and shall no longer be issued and outstanding and shall be cancelled. In addition, at the First Effective
Time: (i) each of SPAC’s units (“Units”) (each consisting of one SPAC Class A Ordinary Share and one-third
of a SPAC Warrant (as defined below)) issued and outstanding immediately prior to the First Effective Time shall be automatically detached
and the holder thereof shall be deemed to hold one SPAC Class A Ordinary Share and one-third of a SPAC Warrant in accordance with
the terms of the applicable Unit (the “Unit Separation”); provided that no fractional SPAC Warrant shall be issued
in connection with the Unit Separation such that if a holder of such Units would be entitled to receive a fractional SPAC Warrant upon
the Unit Separation, the number of SPAC Warrants to be issued to such holder upon the Unit Separation will be rounded down to the nearest
whole number of SPAC Warrants; (ii) immediately following the Unit Separation, each SPAC Class A Ordinary Share (including
SPAC Class A Ordinary Shares (a) issued in connection with the SPAC Class B Conversion and (b) held as a result of
the Unit Separation) issued and outstanding immediately prior to the First Effective Time (other than treasury shares held by SPAC or
any of its subsidiaries (if applicable), SPAC Shares that are held by SPAC shareholders that validly exercise their redemption rights,
SPAC Shares that are held by SPAC shareholders that exercise and perfect their relevant dissenters’ rights and SPAC Shares that
are held by the Founder Shareholders (as defined below)) shall automatically be cancelled and cease to exist in exchange for the right
to receive one Company ADS; (iii) each SPAC Share issued and outstanding immediately prior to the First Effective Time held
by the Founder Shareholders shall automatically be cancelled and cease to exist in exchange for the right to receive one Company Ordinary
Share; and (iv) each warrant issued by SPAC to acquire SPAC Class A Ordinary Shares (each, a “SPAC Warrant”)
(including the SPAC Warrants held a result of the Unit Separation) outstanding immediately prior to the First Effective Time shall cease
to be a warrant with respect to SPAC Shares and be assumed by the Company and converted into a warrant to purchase one Company Ordinary
Share in the form of Company ADS (each, a “Company Warrant”), subject to substantially the same terms and conditions
as were applicable to SPAC Warrants prior to the First Effective Time.
The foregoing
description of the Amended Merger Agreement does not purport to be complete and is qualified in its entirety by the terms and
conditions of the Amended Merger Agreement, a copy of which is attached hereto as Exhibit 2.1 and is incorporated herein
by reference. The Amended Merger Agreement contains representations, warranties and covenants that the respective parties made to
each other as of the date of such agreement or other specific dates. The assertions embodied in those representations, warranties
and covenants were made for purposes of the contract among the respective parties and are subject to important qualifications and
limitations agreed to by the parties in connection with negotiating the Amended Merger Agreement. The Amended Merger Agreement has
been included to provide investors with information regarding its terms. It is not intended to provide any other factual information
about the parties to the Amended Merger Agreement. In particular, the representations, warranties, covenants and agreements
contained in the Amended Merger Agreement, which were made only for purposes of the Amended Merger Agreement and as of specific
dates, were solely for the benefit of the parties to the Amended Merger Agreement, may be subject to limitations agreed upon by the
contracting parties (including being qualified by confidential disclosures made for the purposes of allocating contractual risk
between the parties to the Amended Merger Agreement instead of establishing these matters as facts) and may be subject to standards
of materiality applicable to the contracting parties that differ from those applicable to investors and reports and documents filed
with the SEC. Investors should not rely on the representations, warranties, covenants and agreements, or any descriptions thereof,
as characterizations of the actual state of facts or condition of any party to the Amended Merger Agreement. In addition, the
representations, warranties, covenants and agreements and other terms of the Amended Merger Agreement may be subject to subsequent
waiver or modification. Moreover, information concerning the subject matter of the representations and warranties and other terms
may change after the date of the Amended Merger Agreement, which subsequent information may or may not be fully reflected in
LCAA’s public disclosures.
Form of Registration Rights Agreement
In connection with the
parties’ entry into the Amended Merger Agreement, the previously agreed form of the registration rights agreement (as amended,
the “Registration Rights Agreement”) attached to the Original Merger Agreement as an exhibit and to be entered into
by SPAC, the Company, the Founder Shareholders and potentially certain shareholders of the Company at the Closing was amended to reflect,
among other things, the issuance of Company ADSs in lieu of Company Ordinary Shares to applicable shareholders of SPAC.
The foregoing description
of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by the terms and conditions of
the Registration Rights Agreement, a copy of which is filed with this Current Report on Form 8-K as Exhibit 10.1 and
the terms of which are incorporated by reference herein.
Form of Assignment, Assumption and
Amendment Agreement
In connection with the parties’ entry
into the Amended Merger Agreement, the previously agreed form of the assignment, assumption and amendment agreement (as amended, the
“Assignment, Assumption and Amendment Agreement”) attached to the
Original Merger Agreement as an exhibit and to be entered into at the Closing was amended, such that, at the Closing, SPAC, the
Company, Continental Stock Transfer & Trust Company (“Continental”)
and Equiniti Trust Company, LLC (“Equiniti”) will enter into the
Assignment, Assumption and Amendment Agreement, pursuant to which, among other things, (i) LCAA will assign to Lotus Tech all
of its rights, interests, and obligations in and under its existing warrant agreement with Continental (the “Warrant
Agreement”), (ii) Equiniti will be engaged to act as the warrant agent for Lotus Tech, (iii) Continental, as
the warrant agent for LCAA, will assign to Equiniti all of its rights, interests, and obligations in and under the Warrant
Agreement, and (iv) the Warrant Agreement will be amended (a) to change all references to Warrants (as such term is
defined therein) to Company Warrants, and all references to Ordinary Shares (as such term is defined therein) underlying such
warrants to Company Ordinary Shares in the form of Company ADSs and (b) to cause each outstanding Company Warrant to represent
the right to receive, from the Closing, one whole Company Ordinary Share in the form of one Company ADS.
The foregoing description
of the Assignment, Assumption and Amendment Agreement does not purport to be complete and is qualified in its entirety by the terms and
conditions of the Assignment, Assumption and Amendment Agreement, a copy of which is filed with this Current Report on Form 8-K
as Exhibit 10.2 and the terms of which are incorporated by reference herein.
Forward-Looking Statements
This current report (the “Current Report”)
contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange
Act, that are based on beliefs and assumptions and on information currently available to Lotus Tech and LCAA. All statements other than
statements of historical fact contained in this Current Report are forward-looking statements. In some cases, you can identify forward-looking
statements by terminology such as “may”, “should”, “expect”, “intend”, “will”,
“estimate”, “anticipate”, “believe”, “predict”, “potential”, “forecast”,
“plan”, “seek”, “future”, “propose” or “continue”, or the negatives of these
terms or variations of them or similar terminology although not all forward-looking statements contain such terminology. Such forward-looking
statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed
or implied by such forward looking statements.
These forward-looking statements are based
upon estimates and assumptions that, while considered reasonable by LCAA and its management, and Lotus Tech and its management, as
the case may be, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations
include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the
termination of definitive agreements with respect to the proposed Business Combination between LCAA, Lotus Tech and the other
parties thereto; (2) the outcome of any legal proceedings that may be instituted against LCAA, the combined company or others
following the announcement of the Business Combination and any definitive agreements with respect thereto; (3) the amount of
redemption requests made by LCAA public shareholders and the inability to complete the Business Combination due to the failure to
obtain approval of the shareholders of LCAA, to obtain financing to complete the Business Combination or to satisfy other conditions
to the Closing; (4) changes to the proposed structure of the Business Combination that may be required or appropriate as a
result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination;
(5) the ability to meet stock exchange listing standards following the consummation of the Business Combination; (6) the
risk that the Business Combination disrupts current plans and operations of the Company as a result of the announcement and
consummation of the Business Combination; (7) the ability to recognize the anticipated benefits of the Business Combination,
which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably,
maintain relationships with customers and suppliers and retain its management and key employees; (8) costs related to the
Business Combination; (9) risks associated with changes in applicable laws or regulations and the Company’s international
operations; (10) the possibility that the Company or the combined company may be adversely affected by other economic,
business, and/or competitive factors; (11) the Company’s estimates of expenses and profitability; (12) the
Company’s ability to maintain agreements or partnerships with its strategic partner Geely and to develop new agreements or
partnerships; (13) the Company’s ability to maintain relationships with its existing suppliers and strategic partners,
and source new suppliers for its critical components, and to complete building out its supply chain, while effectively managing the
risks due to such relationships; (14) the Company’s reliance on its partnerships with vehicle charging networks to
provide charging solutions for its vehicles and its strategic partners for servicing its vehicles and their integrated software;
(15) the Company’s ability to establish its brand and capture additional market share, and the risks associated with
negative press or reputational harm, including from lithium-ion battery cells catching fire or venting smoke;
(16) delays in the design, manufacture, launch and financing of the Company’s vehicles and the Company’s reliance
on a limited number of vehicle models to generate revenues; (17) the Company’s ability to continuously and rapidly
innovate, develop and market new products; (18) risks related to future market adoption of the Company’s offerings;
(19) increases in costs, disruption of supply or shortage of materials, in particular for lithium-ion cells or
semiconductors; (20) the Company’s reliance on its partners to manufacture vehicles at a high volume, some of which have
limited experience in producing electric vehicles, and on the allocation of sufficient production capacity to the Company by its
partners in order for the Company to be able to increase its vehicle production capacities; (21) risks related to the
Company’s distribution model; (22) the effects of competition and the high barriers to entry in the automotive industry,
and the pace and depth of electric vehicle adoption generally on the Company’s future business; (23) changes in
regulatory requirements, governmental incentives and fuel and energy prices; (24) the impact of the
global COVID-19 pandemic on LCAA, the Company, the Company’s post business combination’s projected results of
operations, financial performance or other financial metrics, or on any of the foregoing risks; and (25) other risks and
uncertainties set forth in the section entitled “Risk Factors” and “Cautionary Note Regarding Forward-Looking
Statements” in LCAA’s final prospectus relating to its initial public offering
(File No. 333-253334) declared effective by the SEC on March 10, 2021, and other documents filed, or to be
filed, with the SEC by LCAA or Lotus Tech, including the Registration/Proxy Statement. There may be additional risks that neither
LCAA nor Lotus Tech presently know or that LCAA or Lotus Tech currently believe are immaterial that could also cause actual results
to differ from those contained in the forward-looking statements.
Nothing in this Current Report should be regarded
as a representation by any person that the forward-looking statements set forth herein will be achieved in any specified timeframe, or
at all, or that any of the contemplated results of such forward-looking statements will be achieved in any specified timeframe, or at
all. The forward-looking statements in this Current Report represent the views of LCAA and Lotus Tech as of the date they are made. While
LCAA and Lotus Tech may update these forward-looking statements in the future, LCAA and Lotus Tech specifically disclaim any obligation
to do so, except to the extent required by applicable law. You should not place undue reliance on forward-looking statements.
Additional Information
In connection with the
proposed Business Combination, (i) Lotus Tech is expected to file with the SEC a registration statement on Form F-4 containing
a preliminary proxy statement of LCAA and a preliminary prospectus (the “Registration/Proxy Statement”); and (ii) LCAA
will file a definitive proxy statement relating to the proposed Business Combination (the “Definitive Proxy Statement”)
and will mail the Definitive Proxy Statement and other relevant materials to its shareholders after the Registration/Proxy Statement
is declared effective. The Registration/Proxy Statement will contain important information about the proposed Business Combination and
the other matters to be voted upon at a meeting of LCAA shareholders to be held to approve the proposed Business Combination. This Current
Report does not contain all the information that should be considered concerning the proposed Business Combination and is not intended
to form the basis of any investment decision or any other decision in respect of the Business Combination.
Before
making any voting or other investment decisions, securityholders of LCAA and other interested persons are advised to read, when available,
the Registration/Proxy Statement and the amendments thereto and the Definitive Proxy Statement and other documents filed in connection
with the proposed Business Combination, as these materials will contain important information about LCAA, Lotus Tech and the Business
Combination. When available, the Definitive Proxy Statement and other relevant materials for the proposed Business Combination
will be mailed to shareholders of LCAA as of a record date to be established for voting on the proposed Business Combination. Shareholders
will also be able to obtain copies of the Registration/Proxy Statement, the Definitive Proxy Statement and other documents filed with
the SEC, without charge, once available, at the SEC’s website at www.sec.gov, or by directing a request to: LCAA, 8 Marina View,
Asia Square Tower 1, #41-03, Singapore 018960, attention: Katie Matarazzo.
INVESTMENT IN ANY
SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED
UPON OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE.
Participants in the
Solicitation
LCAA and Lotus Tech,
and certain of their directors and executive officers may be deemed participants in the solicitation of proxies from LCAA’s shareholders
with respect to the proposed Business Combination. A list of the names of those directors and executive officers and a description of
their interests in LCAA is set forth in LCAA’s filings with the SEC (including LCAA’s final prospectus related to its initial
public offering (File No. 333-253334) declared effective by the SEC on March 10, 2021), and are available
free of charge at the SEC’s web site at www.sec.gov, or by directing a request to LCAA, 8 Marina View, Asia Square Tower 1, #41-03,
Singapore 018960, attention: Katie Matarazzo. Additional information regarding the interests of such participants and other persons who
may, under the rules of the SEC, be deemed participants in the solicitation of the shareholders in connection with the proposed
Business Combination will be contained in the Registration/Proxy Statement for the proposed Business Combination when available.
No Offer and Non-Solicitation
This Current Report
is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential
transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of LCAA or Lotus Tech, nor
shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful
prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made
except by means of a prospectus meeting the requirements of the Securities Act.
Item
9.01. Exhibits.
(d) Exhibits.
| No. |
|
Description |
| 2.1* |
|
First Amended and Restated
Agreement and Plan of Merger, dated as of October 11, 2023, by and among Lotus Technology, Inc., L Catterton
Asia Acquisition Corp, Lotus Temp Limited and Lotus EV Limited. |
| 10.1 |
|
Form of Registration
Rights Agreement, by and among Lotus Technology, Inc., L Catterton Asia Acquisition Corp, LCA Acquisition Sponsor, LP and certain
other shareholders of L Catterton Asia Acquisition Corp |
| 10.2 |
|
Form of Assignment,
Assumption and Amendment Agreement, by and among Lotus Technology, Inc., L Catterton Asia Acquisition Corp, Continental
Stock Transfer & Trust Company and Equiniti Trust Company, LLC |
| 104 |
|
Cover Page Interactive Data File (embedded within
the Inline XBRL document) |
* Certain exhibits and
schedules to this Exhibit have been omitted in accordance with Regulation S-K Item 601(b)(2). LCAA hereby undertakes to furnish
supplementally a copy of any omitted schedule to the SEC upon its request; provided, however, that LCAA may request confidential treatment
for any such schedules so furnished.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: October 11, 2023
| |
L CATTERTON ASIA ACQUISITION CORP |
| |
|
|
| |
By: |
/s/ Chinta
Bhagat |
| |
Name: |
Chinta Bhagat |
| |
Title: |
Co-Chief Executive Officer and Chairman |
Exhibit 2.1
Execution Version
FIRST AMENDED AND RESTATED AGREEMENT AND PLAN
OF MERGER
by and among
Lotus Technology Inc.,
Lotus Temp Limited,
Lotus EV Limited,
and
L Catterton Asia Acquisition Corp
dated
as of October 11, 2023
TABLE OF CONTENTS
Page
| Article I |
| |
| |
|
| CERTAIN DEFINITIONS |
| |
| |
|
| Section 1.1. |
Definitions | |
4 |
| Section 1.2. |
Construction | |
23 |
| |
| |
|
| Article II |
| |
| |
|
| TRANSACTIONS; CLOSING |
| |
| |
|
| Section 2.1. |
Pre-Closing Actions | |
25 |
| Section 2.2. |
The Mergers | |
26 |
| Section 2.3. |
Effect of the Mergers on Issued Securities of SPAC, Merger
Sub 1 and Merger Sub 2 | |
28 |
| Section 2.4. |
Closing Deliverables | |
30 |
| Section 2.5. |
Establishment of ADS Facility; Distribution of Merger Consideration | |
31 |
| Section 2.6. |
Further Assurances | |
33 |
| Section 2.7. |
Dissenter’s Rights | |
33 |
| Section 2.8. |
Withholding | |
33 |
| |
| |
|
| Article III |
| |
| |
|
| REPRESENTATIONS AND
WARRANTIES OF THE COMPANY |
| |
| |
|
| Section 3.1. |
Organization, Good Standing and Qualification | |
34 |
| Section 3.2. |
Subsidiaries | |
34 |
| Section 3.3. |
Capitalization of the Company | |
35 |
| Section 3.4. |
Capitalization of Subsidiaries | |
36 |
| Section 3.5. |
Authorization | |
37 |
| Section 3.6. |
Consents; No Conflicts | |
38 |
| Section 3.7. |
Compliance with Laws; Consents; Permits | |
39 |
| Section 3.8. |
Tax Matters | |
41 |
| Section 3.9. |
Financial Statements | |
42 |
| Section 3.10. |
Absence of Changes | |
43 |
| Section 3.11. |
Actions | |
43 |
| Section 3.12. |
Undisclosed Liabilities | |
43 |
| Section 3.13. |
Material Contracts and Commitments | |
43 |
| Section 3.14. |
Title; Properties | |
44 |
| Section 3.15. |
Intellectual Property and Data Protection | |
46 |
| Section 3.16. |
Labor and Employee Matters | |
50 |
| Section 3.17. |
Brokers | |
51 |
| Section 3.18. |
Environmental Matters | |
51 |
| Section 3.19. |
Insurance | |
52 |
| Section 3.20. |
Company Related Parties | |
52 |
| Section 3.21. |
Proxy/Registration Statement | |
52 |
| Section 3.22. |
Company Product | |
52 |
| Section 3.23. |
No Additional Representation or Warranties | |
52 |
| |
| |
|
| Article IV |
| |
| |
|
| REPRESENTATIONS AND
WARRANTIES OF SPAC |
| |
| |
|
| Section 4.1. |
Organization, Good Standing, Corporate Power and Qualification | |
53 |
| Section 4.2. |
Capitalization and Voting Rights | |
53 |
| Section 4.3. |
Corporate Structure; Subsidiaries | |
54 |
| Section 4.4. |
Authorization | |
55 |
| Section 4.5. |
Consents; No Conflicts | |
56 |
| Section 4.6. |
Tax Matters | |
56 |
| Section 4.7. |
Financial Statements | |
57 |
| Section 4.8. |
Absence of Changes | |
58 |
| Section 4.9. |
Actions | |
58 |
| Section 4.10. |
Brokers | |
58 |
| Section 4.11. |
Proxy/Registration Statement | |
58 |
| Section 4.12. |
SEC Filings | |
59 |
| Section 4.13. |
Trust Account | |
59 |
| Section 4.14. |
Investment Company Act; JOBS Act | |
60 |
| Section 4.15. |
Business Activities | |
60 |
| Section 4.16. |
Nasdaq Quotation | |
60 |
| Section 4.17. |
SPAC Related Parties | |
60 |
| Section 4.18. |
No Additional Representations and Warranties | |
60 |
| |
| |
|
| Article V |
| |
| |
|
| COVENANTS OF THE
COMPANY |
| |
| |
|
| Section 5.1. |
Conduct of Business | |
61 |
| Section 5.2. |
Access to Information | |
64 |
| Section 5.3. |
Company Listing | |
64 |
| Section 5.4. |
Acquisition Proposals and Alternative Transactions | |
65 |
| Section 5.5. |
D&O Indemnification and Insurance | |
65 |
| Section 5.6. |
Post-Closing Board of Directors of the Company | |
66 |
| Section 5.7. |
Notice of Developments | |
66 |
| Section 5.8. |
Financials | |
67 |
| Section 5.9. |
No Trading | |
67 |
| Section 5.10. |
Distribution Agreement and Put Option Agreements | |
67 |
| Section 5.11. |
Additional Pre-Closing Actions | |
68 |
| Section 5.12. |
Additional Agreements | |
68 |
| Article VI |
| |
| |
|
| COVENANTS OF SPAC |
| |
| |
|
| Section 6.1. |
Conduct of Business | |
68 |
| Section 6.2. |
Access to Information | |
70 |
| Section 6.3. |
Acquisition Proposals and Alternative Transactions | |
71 |
| Section 6.4. |
Nasdaq Listing | |
71 |
| Section 6.5. |
SPAC Public Filings | |
71 |
| Section 6.6. |
Section 16 Matters | |
71 |
| Section 6.7. |
SPAC Extension | |
71 |
| |
| |
|
| Article VII |
| |
| |
|
| JOINT COVENANTS |
| |
| |
|
| Section 7.1. |
Regulatory Approvals; Other Filings | |
72 |
| Section 7.2. |
Proxy/Registration Statement; SPAC Shareholders' Meeting and
Approvals; Company Shareholders' Approval | |
73 |
| Section 7.3. |
Support of Transaction | |
77 |
| Section 7.4. |
Tax Matters | |
77 |
| Section 7.5. |
Shareholder Litigation | |
78 |
| Section 7.6. |
Pre-Closing Financing and PIPE Financing | |
78 |
| |
| |
|
| Article VIII |
| |
| |
|
| CONDITIONS TO OBLIGATIONS |
| |
| |
|
| Section 8.1. |
Conditions to Obligations of Each Party | |
79 |
| Section 8.2. |
Additional Conditions to Obligations of SPAC | |
80 |
| Section 8.3. |
Additional Conditions to Obligations of the Company, Merger
Sub 1 and Merger Sub 2 | |
80 |
| Section 8.4. |
Frustration of Conditions | |
81 |
| |
| |
|
| Article IX |
| |
| |
|
| TERMINATION/EFFECTIVENESS |
| |
| |
|
| Section 9.1. |
Termination | |
81 |
| Section 9.2. |
Effect of Termination | |
83 |
| |
| |
|
| Article X |
| |
| |
|
| MISCELLANEOUS |
| |
| |
|
| Section 10.1. |
Trust Account Waiver | |
84 |
| Section 10.2. |
Waiver | |
84 |
| Section 10.3. |
Notices | |
84 |
| Section 10.4. |
Assignment | |
85 |
| Section 10.5. |
Rights of Third Parties | |
85 |
| Section 10.6. |
Expenses | |
86 |
| Section 10.7. |
Governing Law | |
86 |
| Section 10.8. |
Consent to Jurisdiction | |
86 |
| Section 10.9. |
Headings; Counterparts | |
87 |
| Section 10.10. |
Disclosure Letters | |
87 |
| Section 10.11. |
Entire Agreement | |
87 |
| Section 10.12. |
Amendments | |
88 |
| Section 10.13. |
Publicity | |
88 |
| Section 10.14. |
Confidentiality | |
88 |
| Section 10.15. |
Severability | |
88 |
| Section 10.16. |
Enforcement | |
89 |
| Section 10.17. |
Non-Recourse | |
89 |
| Section 10.18. |
Non-Survival of Representations, Warranties and Covenants | |
89 |
| Section 10.19. |
Conflicts and Privilege | |
90 |
| Exhibits |
|
| |
|
| Exhibit A |
Sponsor Support Agreement |
| Exhibit B |
Company Support Agreement |
| Exhibit C |
Distribution Agreement |
| Exhibit D-1 |
Put Option Agreement |
| Exhibit D-2 |
Put Option Agreement |
| Exhibit E |
Form of Registration Rights Agreement |
| Exhibit F |
Form of First Plan of Merger |
| Exhibit G |
Form of Second Plan of Merger |
| Exhibit H |
Form of A&R Company Charter |
| Exhibit I |
Form of Assignment, Assumption and Amendment
Agreement |
| Exhibit J |
Form of Lock-Up Agreement |
Schedules
SPAC Disclosure Letter
Company Disclosure Letter
INDEX OF DEFINED TERMS
| A&R
Company Charter | |
2.1(b) |
| Action | |
1.1 |
| Additional
Financial Statements | |
5.8 |
| ADS
Facility | |
2.5(a) |
| ADS
Merger Consideration | |
1.1 |
| Affiliate | |
1.1 |
| Aggregate
Cash Proceeds | |
1.1 |
| Agreement | |
Preamble |
| Anti-Corruption
Laws | |
3.7(d) |
| Anti-Money
Laundering Laws | |
1.1 |
| Assignment,
Assumption and Amendment Agreement | |
Recitals |
| Audited
Financial Statements | |
3.9(a) |
| Authorization
Notice | |
2.2(c)(i) |
| Benefit
Plan | |
1.1 |
| Business | |
1.1 |
| Business
Combination | |
1.1 |
| Business
Combination Deadline | |
6.7 |
| Business
Data | |
1.1 |
| Business
Day | |
1.1 |
| Capital
Restructuring | |
2.1(d) |
| Cayman
Act | |
Recitals |
| Cayman
Registrar | |
1.1 |
| Charging
Business | |
1.1 |
| Closing | |
2.2(a) |
| Closing
Date | |
2.2(a) |
| Code | |
1.1 |
| Company | |
Preamble |
| Company
Acquisition Proposal | |
1.1 |
| Company
ADS | |
1.1 |
| Company
Board | |
Recitals |
| Company
Board Recommendation | |
7.2(c)(ii) |
| Company
Charter | |
1.1 |
| Company
Closing Statement | |
2.4(a)(ii) |
| Company
Contract | |
1.1 |
| Company
Directors | |
5.6 |
| Company
Disclosure Letter | |
Article III |
| Company
Financial Statements | |
3.9(b) |
| Company
IP | |
1.1 |
| Company
Lease | |
3.14(c) |
| Company
Material Adverse Effect | |
1.1 |
| Company
Options | |
1.1 |
| Company
Ordinary Shares | |
1.1 |
| Company
Product | |
1.1 |
| Company
Shareholder | |
1.1 |
| Company
Shareholders’ Approval | |
1.1 |
| Company
Shareholders’ Meeting | |
7.2(c)(i) |
| Company
Shares | |
1.1 |
| Company
Support Agreement | |
Recitals |
| Company
Transaction Expenses | |
1.1 |
| Company
Warrant | |
2.3(d) |
| Company
Warrant Agent | |
Recitals |
| Competing
SPAC | |
1.1 |
| Contemplated
Business | |
1.1 |
| Contemplated
Company Products | |
1.1 |
| Contract | |
1.1 |
| Control | |
1.1 |
| Control
Documents | |
1.1 |
| Controlled | |
1.1 |
| COVID-19 | |
1.1 |
| COVID-19
Measures | |
1.1 |
| Data
Protection Laws | |
1.1 |
| Deposit
Agreement | |
2.5(a) |
| Depositary
Bank | |
2.5(a) |
| Disclosure
Letter | |
1.1 |
| Dissenting
SPAC Shareholders | |
2.7(a) |
| Dissenting
SPAC Shares | |
2.7(a) |
| Distribution
Agreement | |
Recitals |
| DTC | |
1.1 |
| Encumbrance | |
1.1 |
| Enforceability
Exceptions | |
3.5(a) |
| Environmental
Laws | |
1.1 |
| Equity
Pledge Registration | |
3.2(b) |
| Equity
Securities | |
1.1 |
| ERISA | |
1.1 |
| ERISA
Affiliate | |
1.1 |
| ESOP | |
1.1 |
| Event | |
1.1 |
| Exchange
Act | |
1.1 |
| Exercising
Warrantholders | |
2.5(c) |
| Extension
Expenses | |
1.1 |
| Extension
Proposal | |
6.7 |
| Extension
Proxy Statement | |
6.7 |
| Extension
Recommendation | |
6.7 |
| First
Effective Time | |
2.2(a) |
| First
Merger | |
Recitals |
| First
Merger Filing Documents | |
2.2(a) |
| First
Plan of Merger | |
1.1 |
| Form F-6 | |
2.5(a) |
| Founder
Shareholder | |
Recitals |
| Fully-Diluted
Company Shares | |
1.1 |
| GAAP | |
1.1 |
| Government
Official | |
1.1 |
| Governmental
Authority | |
1.1 |
| Governmental
Order | |
1.1 |
| Group | |
1.1 |
| Group
Companies | |
1.1 |
| Group
Company | |
1.1 |
| Indebtedness | |
1.1 |
| Intellectual
Property | |
1.1 |
| Intended
Tax Treatment | |
7.4 |
| Interim
Period | |
5.1 |
| Investment
Company Act | |
1.1 |
| IPO | |
10.1 |
| IT
Systems | |
1.1 |
| K&E | |
10.19 |
| Knowledge
of SPAC | |
1.1 |
| Knowledge
of the Company | |
1.1 |
| Law | |
1.1 |
| Leased
Real Property | |
1.1 |
| LGIL
Seller | |
Recitals |
| Liabilities | |
1.1 |
| Lock-Up
Agreement | |
5.12(a) |
| Management
Accounts | |
3.9(b) |
| Material
Contracts | |
1.1 |
| Material
Permit | |
3.7(i) |
| Merger
Consideration | |
1.1 |
| Merger
Sub 1 | |
Preamble |
| Merger
Sub 2 | |
Preamble |
| Merger
Subs | |
Preamble |
| Mergers | |
Recitals |
| Nasdaq | |
4.16 |
| NDA | |
1.1 |
| Non-Recourse
Parties | |
10.17 |
| Non-Recourse
Party | |
10.17 |
| Open
Source Software | |
1.1 |
| Ordinary
Course | |
1.1 |
| Ordinary
Share Merger Consideration | |
1.1 |
| Ordinary
Shares | |
1.1 |
| Organizational
Documents | |
1.1 |
| Original
Merger Agreement | |
Recitals |
| Owned
IP | |
1.1 |
| Owned
Real Property | |
1.1 |
| Parties | |
Preamble |
| Party | |
Preamble |
| Patents | |
1.1 |
| Permitted
Encumbrances | |
1.1 |
| Person | |
1.1 |
| Personal
Data | |
1.1 |
| PIPE
Financing | |
7.6(b) |
| PIPE
Financing Proceeds | |
1.1 |
| PIPE
Investors | |
7.6(b) |
| PRC | |
1.1 |
| Pre-Closing
Financing | |
7.6(a) |
| Pre-Closing
Financing Agreements | |
7.6(a) |
| Pre-Closing
Financing Investors | |
7.6(a) |
| Pre-Closing
Financing Proceeds | |
1.1 |
| Preferred
Share Conversion | |
2.1(a) |
| Preferred
Shares | |
1.1 |
| Price
per Share | |
1.1 |
| Privacy
Laws | |
1.1 |
| Process | |
1.1 |
| Processed | |
1.1 |
| Processing | |
1.1 |
| Prohibited
Person | |
1.1 |
| Proxy
Statement | |
1.1 |
| Proxy/Registration
Statement | |
7.2(a)(i) |
| Put
Option Agreement | |
Recitals |
| Recapitalization | |
2.1(d) |
| Recapitalization
Factor | |
1.1 |
| Redeeming
SPAC Shares | |
1.1 |
| Re-designation | |
2.1(c) |
| Registered
IP | |
1.1 |
| Registration
Rights Agreement | |
Recitals |
| Regulatory
Approvals | |
7.1(a) |
| Related
Entity | |
1.1 |
| Related
Party | |
1.1 |
| Remaining
Trust Fund Proceeds | |
2.4(b)(iv) |
| Representatives | |
1.1 |
| Required
Governmental Authorizations | |
1.1 |
| Required
Shareholders’ Approval | |
1.1 |
| restraint | |
8.1(e) |
| Sanctioned
Territory | |
1.1 |
| Sanctions | |
1.1 |
| Sarbanes-Oxley
Act | |
1.1 |
| SEC | |
1.1 |
| Second
Effective Time | |
2.2(b) |
| Second
Merger | |
Recitals |
| Second
Merger Filing Documents | |
2.2(b) |
| Second
Plan of Merger | |
1.1 |
| Securities
Act | |
1.1 |
| Security
Incident | |
1.1 |
| Series A
Preferred Shares | |
1.1 |
| Series Pre-A
Preferred Shares | |
(viii) |
| Shareholder
Litigation | |
7.5 |
| Shareholders
Agreement | |
(viii) |
| Social
Insurance | |
1.1 |
| Software | |
1.1 |
| SPAC | |
Preamble |
| SPAC
Acquisition Proposal | |
1.1 |
| SPAC
ADS Recipients | |
2.5(b) |
| SPAC
Board | |
Recitals |
| SPAC
Board Recommendation | |
7.2(b)(ii) |
| SPAC
Change in Recommendation | |
7.2(b)(ii) |
| SPAC
Charter | |
1.1 |
| SPAC
Class A Ordinary Shares | |
1.1 |
| SPAC
Class B Conversion | |
2.3(a) |
| SPAC
Class B Ordinary Shares | |
1.1 |
| SPAC
Closing Statement | |
2.4(a)(i) |
| SPAC
D&O Indemnified Parties | |
5.5(a) |
| SPAC
D&O Insurance | |
5.5(b) |
| SPAC
Disclosure Letter | |
IV |
| SPAC
Financial Statements | |
4.7(a) |
| SPAC
Material Adverse Effect | |
1.1 |
| SPAC
Ordinary Shares | |
1.1 |
| SPAC
Preference Shares | |
1.1 |
| SPAC
Related Party | |
1.1 |
| SPAC
SEC Filings | |
4.12 |
| SPAC
Securities | |
1.1 |
| SPAC
Shareholder | |
1.1 |
| SPAC
Shareholder Extension Approval | |
6.7 |
| SPAC
Shareholder Redemption Amount | |
1.1 |
| SPAC
Shareholder Redemption Right | |
1.1 |
| SPAC
Shareholders’ Approval | |
(viii) |
| SPAC
Shareholders’ Meeting | |
7.2(b)(i) |
| SPAC
Shares | |
1.1 |
| SPAC
Termination Statement | |
9.2(b) |
| SPAC
Transaction Expenses | |
1.1 |
| SPAC
Unit | |
1.1 |
| SPAC
Warrant | |
1.1 |
| SPAC
Warrant Agent | |
Recitals |
| Sponsor | |
Recitals |
| Sponsor
Group | |
10.19 |
| Sponsor
Support Agreement | |
Recitals |
| Subscription
Agreements | |
7.6(b) |
| Subsidiary | |
1.1 |
| Supporting
Company Shareholder | |
Recitals |
| Surviving
Entity 1 | |
Recitals |
| Surviving
Entity 2 | |
Recitals |
| Tax | |
1.1 |
| Tax Returns | |
1.1 |
| Taxes | |
1.1 |
| Terminating Company
Breach | |
9.1(f) |
| Terminating SPAC
Breach | |
9.1(h) |
| Termination Date | |
9.1(i) |
| Top 10 Suppliers | |
1.1 |
| Trade Secrets | |
1.1 |
| Trademarks | |
1.1 |
| Transaction Document | |
1.1 |
| Transaction Documents | |
1.1 |
| Transaction Proposals | |
1.1 |
| Transactions | |
1.1 |
| Trust Account | |
10.1 |
| Trust Agreement | |
4.13 |
| Trustee | |
4.13 |
| U.S. | |
1.1 |
| under common Control
with | |
1.1 |
| Union | |
1.1 |
| Unit Separation | |
2.3(b) |
| Warrant Agreement | |
1.1 |
| Working Capital
Loans | |
1.1 |
| Written Objection | |
2.2(c) |
| Wuhan Lotus E-Commerce | |
1.1 |
| Wuhan Lotus Technology | |
1.1 |
FIRST AMENDED AND RESTATED AGREEMENT AND PLAN
OF MERGER
This
First Amended and Restated Agreement and Plan of Merger, dated as of October 11, 2023 (this “Agreement”), is made
and entered into by and among (i) Lotus Technology Inc., an exempted company limited by shares incorporated under the laws of the
Cayman Islands (the “Company”), (ii) Lotus Temp Limited, an exempted company limited by shares incorporated under
the laws of the Cayman Islands and a direct wholly owned Subsidiary of the Company (“Merger Sub 1”), (iii) Lotus
EV Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned Subsidiary
of the Company (“Merger Sub 2”, and together with Merger Sub 1, the “Merger Subs”), and (iv) L
Catterton Asia Acquisition Corp, an exempted company limited by shares incorporated under the laws of the Cayman Islands (“SPAC”).
Each of the Company, Merger Sub 1, Merger Sub 2 and SPAC are individually referred to herein as a “Party” and, collectively,
as the “Parties.”
RECITALS
WHEREAS,
SPAC is a blank check company and was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase,
reorganization or similar business combination with one or more businesses;
WHEREAS,
each of the Merger Subs is a newly incorporated Cayman Islands exempted company limited by shares, wholly owned by the Company, and was
formed for the purpose of effectuating the Mergers (as defined below);
WHEREAS,
immediately following the Capital Restructuring (as defined below), upon the terms and subject to the conditions set forth in this Agreement
and in accordance with the applicable provisions of the Companies Act (As Revised) of the Cayman Islands (the “Cayman Act”),
at the Closing (as defined below), Merger Sub 1 will merge with and into SPAC (the “First Merger”), with SPAC being
the surviving company (as defined in the Cayman Act) and becoming a wholly owned Subsidiary of the Company (SPAC is hereinafter referred
to for the periods from and after the First Effective Time as “Surviving Entity 1”);
WHEREAS,
immediately following the consummation of the First Merger, upon the terms and subject to the conditions set forth in this Agreement
and in accordance with the applicable provisions of the Cayman Act, Surviving Entity 1 will merge with and into Merger Sub 2 (the “Second
Merger” and together with the First Merger, collectively, the “Mergers”), with Merger Sub 2 being the surviving
company (as defined in the Cayman Act) and remaining a wholly owned Subsidiary of the Company (Merger Sub 2 is hereinafter referred to
for the periods from and after the Second Effective Time as the “Surviving Entity 2”);
WHEREAS,
the Parties entered into that certain Agreement and Plan of Merger, dated as of January 31, 2023 (the “Original Merger
Agreement”), and desire to amend and restate the Original Merger Agreement to provide that, among other things, each applicable
SPAC Shareholder immediately prior to the First Effective Time shall receive Company ADSs in lieu of Company Ordinary Shares in the Mergers;
WHEREAS,
the Company has received, concurrently with the execution and delivery of the Original Merger Agreement, a Sponsor Support Agreement
in the form attached hereto as Exhibit A (the “Sponsor Support Agreement”) signed by the Company, SPAC,
LCA Acquisition Sponsor, LP, a Cayman Islands exempted limited partnership (“Sponsor”), and certain other Persons
identified therein (collectively with Sponsor, the “Founder Shareholders” and each, a “Founder Shareholder”),
pursuant to which, among other things, and subject to the terms and conditions set forth therein, each Founder Shareholder agrees (a) to
vote all SPAC Shares held by such Founder Shareholder in favor of (i) the Transactions and (ii) the other Transaction Proposals,
(b) to waive the anti-dilution rights of the SPAC Class B Ordinary Shares under the SPAC Charter, (c) to appear at the
SPAC Shareholders’ Meeting in person or by proxy for purposes of counting towards a quorum, (d) to vote all SPAC Shares held
by such Founder Shareholder against any proposals that would or would be reasonably likely to in any material respect impede the Transactions
or any other Transaction Proposal, (e) not to redeem any SPAC Shares held by such Founder Shareholder, (f) not to amend that
certain letter agreement between SPAC, Sponsor and certain other parties thereto, dated as of March 10, 2021, (g) not to transfer
any SPAC Securities held by such Founder Shareholder, subject to certain exceptions, (h) to unconditionally and irrevocably waive
the dissenters’ rights pursuant to the Cayman Act in respect to all SPAC Shares held by such Founder Shareholder with respect to
the First Merger, to the extent applicable, and (i) not to transfer Company Ordinary Shares, Company Warrants, or Company Ordinary
Shares received upon the exercise of any Company Warrants, if any, held by the Founder Shareholders during the period after the Closing
as set forth therein, subject to certain exceptions, and Sponsor agrees to subject certain SPAC Class B Ordinary Shares held by
it to certain forfeiture and earn-out mechanism;
WHEREAS,
SPAC has received concurrently with the execution and delivery of the Original Merger Agreement, a Shareholder Support Agreement and
Deed in the form attached hereto as Exhibit B (the “Company Support Agreement”) signed by the Company,
SPAC and certain applicable Company Shareholders (each such Company Shareholder, a “Supporting Company Shareholder”),
pursuant to which, among other things, and subject to the terms and conditions set forth therein, each Supporting Company Shareholder
agrees (a) to vote all the Company Shares held by such Supporting Company Shareholder in favor of the Transactions, (b) to
appear at the Company Shareholders’ Meeting, or at any adjournment thereof, in person or by proxy for purposes of counting towards
a quorum, (c) to vote all Company Shares held by such Supporting Company Shareholder against any proposals that would or would be
reasonably likely to in any material respect impede the Transactions, (d) not to transfer any Company Shares held by such Supporting
Company Shareholder, subject to certain exceptions, and (e) for the period after the Closing specified therein, not to transfer
the Company Ordinary Shares held by such Supporting Company Shareholder, if any, subject to certain exceptions;
WHEREAS,
concurrently with the execution and delivery of the Original Merger Agreement, Lotus Technology Innovation Limited, an indirectly wholly
owned Subsidiary of the Company, has entered into a Distribution Agreement with Lotus Cars Limited in the form attached hereto as Exhibit C
(the “Distribution Agreement”), pursuant to which Lotus Technology Innovation Limited will distribute vehicles,
parts and certain tools purchased from Lotus Car Limited for sale and provide after sales service;
WHEREAS,
concurrently with the execution and delivery of the Original Merger Agreement, each of Geely International (Hong Kong) Limited and Etika
Automotive Sdn Bhd (each, an “LGIL Seller”) has respectively entered into a Put Option Agreement with the Company,
Lotus Advance Technologies Sdn Bhd, a private limited company incorporated under the laws of Malaysia and Lotus Group International Limited,
a private company limited by shares incorporated in England and Wales, in the form attached hereto as Exhibit D-1 and Exhibit D-2
(each, a “Put Option Agreement”), pursuant to which, each LGIL Seller has the right to require the Company to
purchase from such LGIL Seller all of the issued and outstanding equity interests held by it in Lotus Advance Technologies Sdn Bhd (or
such other holding company determined pursuant to the terms therein), on the terms and subject to the conditions set forth therein;
WHEREAS,
at the Closing, the Company, Sponsor, SPAC and certain Company Shareholders shall enter into a registration rights agreement in substantially
the form attached hereto as Exhibit E (the “Registration Rights Agreement”);
WHEREAS,
at the Closing, the Company, SPAC, Continental Stock Transfer & Trust Company (the “SPAC Warrant Agent”)
and Equiniti Trust Company, LLC (the “Company Warrant Agent”) shall enter into an assignment, assumption and amendment
agreement in substantially the form attached hereto as Exhibit I (the “Assignment, Assumption and Amendment Agreement”)
pursuant to which, among other things, (i) SPAC will assign to the Company all of its rights, interests, and obligations in and
under the Warrant Agreement, (ii) the Company Warrant Agent will be engaged to act as the warrant agent for the Company, (iii) the
SPAC Warrant Agent, as the warrant agent for SPAC, will assign to the Company Warrant Agent all of its rights, interests, and obligations
in and under the Warrant Agreement, and (iv) the Warrant Agreement will be amended (a) to change all references to Warrants
(as such term is defined therein) to Company Warrants, and all references to Ordinary Shares (as such term is defined therein) underlying
such warrants to Company Ordinary Shares in the form of Company ADSs and (b) to cause each outstanding Company Warrant to represent
the right to receive, from the Closing, one whole Company Ordinary Share in the form of one Company ADS;
WHEREAS,
the board of directors of SPAC (the “SPAC Board”) has unanimously (a) determined that (x) it is fair to,
advisable and in the best interests of SPAC to enter into this Agreement and to consummate the Mergers and the other Transactions, and
(y) the Transactions constitute a “Business Combination” as such term is defined in the SPAC Charter, (b) (i) approved
and declared advisable this Agreement and the execution, delivery and performance hereof, the Mergers and the other Transactions, and
(ii) approved and declared advisable the First Plan of Merger, the Second Plan of Merger, the Sponsor Support Agreement, the Assignment,
Assumption and Amendment Agreement, the Company Support Agreement, the Registration Rights Agreement, each other Transaction Document
to which SPAC is a party and the execution, delivery and performance thereof, (c) resolved to recommend the adoption of this Agreement
and the First Plan of Merger by the SPAC Shareholders, and (d) directed that this Agreement and the First Plan of Merger be submitted
to the SPAC Shareholders for their approval at the SPAC Shareholders’ Meeting;
WHEREAS,
(a) the sole director of Merger Sub 1 has (i) determined that it is desirable and in the best interests of Merger Sub 1 to
enter into this Agreement and to consummate the First Merger and the other Transactions, (ii) approved and declared desirable this
Agreement and the First Plan of Merger and the execution, delivery and performance of this Agreement and the First Plan of Merger and
the consummation of the Transactions and (b) the Company, in its capacity as the sole shareholder of Merger Sub 1, has approved
the First Plan of Merger by a written resolution;
WHEREAS,
(a) the sole director of Merger Sub 2 has (i) determined that it is desirable and in the best interests of Merger Sub 2 to
enter into this Agreement and to consummate the Second Merger and the other Transactions, (ii) approved and declared desirable this
Agreement and the Second Plan of Merger and the execution, delivery and performance of this Agreement and the Second Plan of Merger and
the consummation of the Transactions and (b) the Company, in its capacity as the sole shareholder of Merger Sub 2, has approved
the Second Plan of Merger by a written resolution;
WHEREAS,
the board of directors of the Company (the “Company Board”) has (a) determined that this Agreement and the other
Transaction Documents to which the Company is a party and the consummation of the Transactions would be in the best interests of the
Company, (b) authorized and approved the execution, delivery and performance by the Company of this Agreement and the other Transaction
Documents to which the Company is a party and the consummation of the Transactions; and
NOW,
THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth
in this Agreement and intending to be legally bound hereby, the Company, Merger Sub 1, Merger Sub 2 and SPAC agree to amend and restate
the Original Merger Agreement as follows:
Article I
CERTAIN
DEFINITIONS
Section 1.1. Definitions.
As used herein, the following terms shall have the following meanings:
“Action”
means any charge, claim, action, complaint, petition, prosecution, investigation, appeal, suit, litigation, arbitration or other
similar proceeding initiated or conducted by a mediator, arbitrator or Governmental Authority, whether administrative, civil, regulatory
or criminal, and whether at law or in equity, or otherwise under any applicable Law;
“ADS
Merger Consideration means the right to receive such number of Company ADSs by applicable SPAC Shareholders pursuant to Section 2.3(c);
“Affiliate”
means, with respect to any Person, any other Person which, directly or indirectly, Controls, is Controlled by or is under common
Control with such Person. In the case of a Person which is a fund or which is directly or indirectly Controlled by a fund, the term “Affiliate”
also includes (a) any of the general partners of such fund, (b) the fund manager managing such fund, any other person which,
directly or indirectly, Controls such fund or such fund manager, or any other funds managed by such fund manager and (c) trusts
(excluding the Trust Account for all purposes other than for the sole purpose of the release of the proceeds of the Trust Account in
accordance with this Agreement and the Trust Agreement) Controlled by or for the benefit of any Person referred to in (a) or (b);
“Aggregate
Cash Proceeds” means, without duplication, an amount equal to (a) all amounts in the Trust Account immediately
prior to the Closing (after deducting the SPAC Shareholder Redemption Amount) plus (b) the PIPE Financing Proceeds plus
(c) the Pre-Closing Financing Proceeds; provided that, notwithstanding anything to the contrary in the foregoing, “Aggregate
Cash Proceeds” shall not include any PIPE Financing Proceeds or any Pre-Closing Financing Proceeds in connection with the exercise,
exchange or conversion of the Equity Securities listed on Section 1.1(a) of the Company Disclosure Letter;
“Anti-Money Laundering
Laws” means all financial recordkeeping and reporting requirements and all money laundering related Laws and any related or
similar Law issued, administered or enforced by any Governmental Authority and applicable to the Group Companies.
“Benefit
Plan” means any “employee benefit plan” (as such term is defined in Section 3(3) of ERISA, whether
or not subject to ERISA) and compensation or benefit plan, program, policy, practice, Contract or other arrangement, including any compensation,
severance, termination pay, deferred compensation, retirement, profit sharing, incentive, bonus, health, welfare, performance awards,
equity or equity-based compensation (including stock option, equity purchase, equity ownership and restricted stock unit), disability,
death benefit, life insurance, fringe benefits, indemnification, retention or stay-bonus, transaction or change-in control agreement,
or other compensation or benefits, whether written, unwritten or otherwise, that is sponsored, maintained, contributed to or required
to be contributed to by the Company or its ERISA Affiliates for the benefit of any current or former employee, director or officer or
individual contractor of the Company and its Subsidiaries, in each case other than any statutory benefit plan mandated by Law;
“Business”
means the businesses of (i) designing, developing, testing, certifying, marketing, selling, distributing and delivering battery
electric vehicles (“BEVs”) and their hardware and software components, (ii) maintaining, sustaining and supporting,
and providing other aftermarket services for, BEVs, including parts distribution and other logistics, maintenance, repair and overhaul
services, modifications and training, and (iii) any combination of any aspects of any of the foregoing clauses (i) and (ii),
in each case as currently conducted by the Company and its Subsidiaries;
“Business
Combination” has the meaning given in the SPAC Charter;
“Business
Data” means confidential or proprietary data, databases, data compilations and data collections (including customer
databases), and technical, business and other information and data, including Personal Data to the extent collected, used, stored,
shared, distributed, transferred, disclosed, destroyed, disposed of or otherwise Processed by or on behalf of the Company or any of its
Subsidiaries;
“Business
Day” means a day on which commercial banks are open for business in New York, U.S., the Cayman Islands and the
PRC, except a Saturday, Sunday or public holiday (gazetted or ungazetted and whether scheduled or unscheduled);
“Cayman Registrar”
means the Registrar of Companies of the Cayman Islands;
“Code”
means the United States Internal Revenue Code of 1986, as amended;
“Company
Acquisition Proposal” means (a) any, direct or indirect, acquisition by any third party, in one transaction or
a series of transactions, of the Company or of more than 10% of the consolidated total assets, Equity Securities or businesses of the
Company and its Controlled Affiliates taken as a whole (whether by merger, consolidation, scheme of arrangement, business combination,
reorganization, recapitalization, purchase or issuance of Equity Securities, purchase of assets, tender offer or otherwise) other than
the Transactions; (b) any direct or indirect acquisition by any third party, in one transaction or a series of transactions, of
voting Equity Securities representing more than 10%, by voting power, of (x) the Company (whether by merger, consolidation, recapitalization,
purchase or issuance of Equity Securities, tender offer or otherwise) or (y) the Company’s Controlled Affiliates which comprise
more than 10% of the consolidated total assets, revenues or earning power of the Company and its Controlled Affiliates taken as a whole,
other than the Transactions, (c) any direct or indirect acquisition by any third party, in one transaction or a series of transactions,
of more than 10% of the consolidated total assets, revenues or earning power of the Company and its Controlled Affiliates, taken as a
whole, other than by SPAC or its Affiliates or pursuant to the Transactions or (d) the issuance by the Company of more than 10%
of its voting Equity Securities as consideration for the assets or securities of a third party (whether an entity, business or otherwise),
except in any such case as permitted under Section 5.1(c) or Section 5.1(d);
“Company ADS”
means an American depositary share of the Company duly and validly issued against the deposit of one (1) underlying Company Ordinary
Share deposited with the Depositary Bank in accordance with the Deposit Agreement;
“Company
Charter” means the Fifth Amended and Restated Memorandum and Articles of Association of the Company, adopted pursuant
to a special resolution passed on September 20, 2022 and effective on October 11, 2022;
“Company
Contract” means any Contract to which a Group Company is a party or by which a Group Company is bound and for which
performance of substantive obligations is ongoing;
“Company IP”
means, collectively: (a) all Owned IP, and (b) all other Intellectual Property to the extent licensed, used or held for use,
to or by the Company or any of its Subsidiaries, or in the conduct of the Business;
“Company
Material Adverse Effect” means any Event that has had, or would reasonably be expected to have, individually or in the
aggregate, a material adverse effect on (i) the business, assets and liabilities, results of operations or financial condition of
the Company and its Subsidiaries, taken as a whole or (ii) the ability of the Company, any of its Subsidiaries or either Merger
Sub to consummate the Transactions; provided, however, that in no event would any of the following, alone or in combination,
be deemed to constitute, or be taken into account in determining whether there has been or will be, a “Company Material Adverse
Effect”: (a) any change in applicable Laws or GAAP or any interpretation thereof following the date of this Agreement, (b) any
change in interest rates or economic, political, business or financial market conditions generally, (c) the taking or refraining
from taking of any action expressly required to be taken or refrained from being taken under this Agreement or the Original Merger Agreement,
(d) any natural disaster (including hurricanes, storms, tornados, flooding, earthquakes, volcanic eruptions or similar occurrences),
epidemic or pandemic (including any COVID-19 Measures or any change in such COVID-19 Measures or interpretations following the date of
this Agreement), acts of nature or change in climate, (e) any acts of terrorism or war, the outbreak or escalation of hostilities,
geopolitical conditions, local, national or international political conditions, riots or insurrections, (f) any failure in and of
itself of the Company and any of its Subsidiaries to meet any projections or forecasts, provided, however, that the exception
in this clause (f) shall not prevent or otherwise affect a determination that any Event underlying such failure has resulted
in or contributed to a Company Material Adverse Effect except to the extent such Event is within the scope of any other exception within
this definition, (g) any Events generally applicable to the industries or markets in which the Company or any of its Subsidiaries
operate, (h) any action taken by SPAC, or taken at the written request of SPAC, or (i) the announcement of this Agreement or
the Original Merger Agreement or the consummation of the Transactions; provided, however, that in the case of each of clauses (b),
(d), (e) and (g), any such Event to the extent it disproportionately affects the Company or any of its Subsidiaries relative to
other similarly situated participants in the industries and geographies in which such Persons operate shall not be excluded from the
determination of whether there has been, or would reasonably be expected to be, a Company Material Adverse Effect, but only to the extent
of the incremental disproportionate effect on the Company and its Subsidiaries, taken as a whole, relative to such similarly situated
participants;
“Company
Options” means all outstanding options exercisable to purchase Company Shares pursuant to the ESOP or otherwise, as
adjusted to give effect to the Recapitalization;
“Company
Ordinary Shares” means ordinary shares of the Company, par value $0.00001 per share, as further described in the A&R
Company Charter;
“Company Product”
means each of the products and services that have been marketed, distributed, licensed, sold, offered, or otherwise provided or made
available, in each case, by the Company or any of its Subsidiaries, including all versions of any of the foregoing;
“Company
Shareholder” means any holder of any issued and outstanding Ordinary Shares, Preferred Shares or Company Ordinary Shares,
as applicable, as of any determination time prior to the First Effective Time;
“Company Shareholders’
Approval” means (i) (x) the adoption of the A&R Company Charter, (y) the Preferred Share Conversion and
(z) Re-designation, in each case, by the Company Shareholders by a special resolution passed by the affirmative vote of the holders
of at least two-thirds (2/3) of the issued and outstanding Company Shares, voting together as a single class, which, being entitled to
do so, attend and vote in person or by proxy at a general meeting of the Company at which a quorum is present and of which notice specifying
the intention to propose the resolution as a special resolution has been duly given, or by unanimous written resolutions approved by
all of the Company Shareholders entitled to vote at a general meeting of the Company, pursuant to the terms and subject to the conditions
of the Company Charter and applicable Law, (ii) the approval of the Recapitalization by the Company Shareholders by an ordinary
resolution passed by the affirmative vote of the holders of a simple majority of the issued and outstanding Company Shares which, being
entitled to do so, attend and vote in person or by proxy at a general meeting of the Company at which a quorum is present and of which
notice specifying the intention to propose the resolution as an ordinary resolution has been duly given, or by unanimous written resolutions
approved by all of the Company Shareholders entitled to vote at a general meeting of the Company, pursuant to the terms and subject to
the conditions of the Company Charter and applicable Law ((i) and (ii) are collectively referred to as the “Required
Shareholders’ Approval”), and (iii) the approval of the adoption of the A&R Company Charter by written consent
of Geely and Etika (each as defined in the Shareholders Agreement);
“Company
Shares” means, collectively, the Ordinary Shares and the Preferred Shares;
“Company
Transaction Expenses” means any fees and expenses payable by the Company or any of its Subsidiaries or Affiliates (whether
or not billed or accrued for) as a result of or in connection with the negotiation, documentation and consummation of the Transactions,
including (a) all fees, costs, expenses, brokerage fees, commissions, finders’ fees and disbursements of financial advisors,
investment banks, data room administrators, attorneys, accountants and other advisors and service providers, including the Depositary
Bank, consultants and public relations firms, and (b) any and all filing fees payable by the Company or any of its Subsidiaries
or Affiliates to the Governmental Authorities in connection with the Transactions, except that the Company shall only be responsible
for fifty percent (50%) of the fees, costs and expenses incurred in connection with (x) any filing, submission or application for
the Governmental Order pertaining to the anti-trust Laws applicable to the Transactions and (y) the preparation, filing and mailing
of the Proxy/Registration Statement in connection with the Transactions;
“Competing
SPAC” means any publicly traded special purpose acquisition company other than SPAC;
“Contemplated Business”
means the businesses listed on Section 1.1(b) of the Company Disclosure Letter, as planned to be conducted by the Company
or any of its Subsidiaries as of the date hereof (including designing, developing, manufacturing, testing, certifying, marketing, selling,
leasing, distribution and delivering BEV charging equipment, including charging poles (the “Charging Business”));
“Contemplated Company
Products” means, with respect to the Contemplated Business, (i) products and services associated with vehicle types 133,
134 and 135, and (ii) any products and services that have been or are being developed and are scheduled for release within the twelve
(12) months after the Closing, by the Company or any of its Subsidiaries; in each case, including all versions of any of the foregoing;
“Contract”
means any legally binding written, oral or other agreement, contract, subcontract, lease, instrument, note, option, warranty,
purchase order, license, sublicense, mortgage, guarantee, purchase order, insurance policy or commitment or undertaking of any nature
that has any outstanding rights or obligations;
“Control”
in relation to any Person means (a) the direct or indirect ownership of, or ability to direct the casting of, more than fifty
percent (50%) of the total voting rights conferred by all the shares then in issue and conferring the right to vote at all general
meetings of such Person; (b) the ability to appoint or remove a majority of the directors of the board or equivalent governing body
of such Person; (c) the right to control the votes at a meeting of the board of directors (or equivalent governing body) of such
Person; or (d) the ability to direct or cause the direction of the management and policies of such Person whether by Contract or
otherwise, and “Controlled” and “under common Control with” shall be construed accordingly;
“Control Documents”
means the agreements entered into from time to time that provide to Wuhan Lotus Technology exclusive contractual control over Wuhan Lotus
E-Commerce and its Subsidiaries and allow the Company to consolidate one hundred percent (100%) of the financial statements of Wuhan
Lotus E-Commerce and its Subsidiaries with those of the Company for financial reporting purpose under GAAP, including the following contracts
and documents (each as amended, supplemented, restated or replaced from time to time) collectively: (i) an Exclusive Consultancy
and Service Agreement (《独家咨询和服务协议》) entered into by and
between Wuhan Lotus Technology and Wuhan Lotus E-Commerce as of March 8, 2022; (ii) an Exclusive Call Option Agreement
(《独家购买权协议》) entered into by and among Wuhan Lotus Technology, Wuhan Lotus
E-Commerce and the equity holders of Wuhan Lotus E-Commerce, Mr. Li Shufu (李书福), Mr. Feng Qingfeng (冯擎峰),
Mr. Li Donghui (李东辉) and Mr. Liu Bin (刘斌), as of March 8, 2022; (iii) four
Proxy Agreements (《授权委托书》) respectively executed and issued by the equity holders of
Wuhan Lotus E-Commerce, Mr. Li Shufu (李书福), Mr. Feng Qingfeng (冯擎峰), Mr. Li
Donghui (李东辉) and Mr. Liu Bin (刘斌), as of March 8, 2022; (iv) an Equity Pledge
Agreement (《股权质押协议》) entered into by and among Wuhan Lotus Technology, Wuhan
Lotus E-Commerce and the equity holders of Wuhan Lotus E-Commerce, Mr. Li Shufu (李书福), Mr. Feng Qingfeng
(冯擎峰), Mr. Li Donghui (李东辉) and Mr. Liu Bin (刘斌), as of March 8,
2022; and (v) three Letters of Spousal Consent (《配偶同意函》) respectively executed
and issued by the spouses of applicable equity holders of Wuhan Lotus E-Commerce, Ms. Wang Li (王丽), Ms. Du Li
(杜丽) and Ms. Wu Yinghong, as of March 8, 2022;
“Copyrights”
means copyrights, rights in works of authorship and mask works;
“COVID-19”
means SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemics or disease
outbreaks;
“COVID-19
Measures” means any quarantine, “shelter in place,” “stay at home,” workforce reduction, social
distancing, shut down, closure, sequester, safety or similar Law, directive, guidelines or recommendations promulgated by any Governmental
Authority, including the Centers for Disease Control and Prevention and the World Health Organization, in each case, in connection with
or in response to COVID-19;
“Data Protection
Laws” means, collectively: (a) all Privacy Laws and (b) all applicable Laws to the extent concerning protection of
cyber security, or privacy, data security or data protection or transfer (including cross-border transfer), including PRC Cybersecurity
Law and PRC Data Protection Law;
“Disclosure
Letter” means, as applicable, the Company Disclosure Letter and the SPAC Disclosure Letter;
“DTC”
means the Depository Trust Company;
“Encumbrance”
means any mortgage, charge (whether fixed or floating), pledge, lien, option, right of first offer, refusal or negotiation, license,
covenant not to sue, hypothecation, assignment, deed of trust, title retention or other similar encumbrance of any kind whether consensual,
statutory or otherwise;
“Environmental
Laws” means all Laws concerning pollution, protection of the environment, or human health or safety;
“Equity
Securities” means, with respect to any Person, (a) any capital stock, shares, equity interests, membership interests,
partnership interests or registered capital, joint venture or similar interest, or other voting securities of, or other ownership interests
in, such Person, (b) any securities of such Person (for the avoidance of doubt, including debt securities) that are directly
or indirectly convertible into, or exercisable or exchangeable for, such capital stock, shares, equity interests, membership interests,
partnership interests or registered capital, joint venture or similar interest, or other voting securities of, or other ownership interests
in, such Person (whether or not such derivative securities are issued by such Person), (c) any warrants, calls, notes, options or
other rights to acquire from such Person, or other obligations of such Person to issue, (i) any shares of capital stock, shares,
equity interests, membership interests, partnership interests or registered capital, joint venture or similar interest, or other voting
securities of, or other ownership interests in, or (ii) securities convertible into or exchangeable or exercisable for, shares of
capital stock, shares, equity interests, membership interests, partnership interests or registered capital, joint venture or similar
interest, or other voting securities of, or other ownership interests in, such Person, and (d) any restricted shares, stock appreciation
rights, restricted units, performance units, contingent value rights, “phantom” stock or similar securities or rights (including,
for the avoidance of doubt, interests with respect to an employee share ownership plan) issued by or with the approval of such Person
that are derivative of, or provide economic benefits based, directly or indirectly, on the value or price of, any shares of capital or
capital stock or other voting securities of, other ownership interests in, or any business, products or assets of, such Person;
“ERISA”
means the United States Employee Retirement Income Security Act of 1974, as amended;
“ERISA
Affiliate” of any entity means each entity that is or was at any time treated as a single employer with such entity
for purposes of Section 4001(b)(1) of ERISA or Section 414 of the Code;
“ESOP”
means the 2022 Stock Incentive Plan of the Company adopted on September 12, 2022, as may be amended from time to time;
“Event”
means any event, state of facts, development, change, circumstance, occurrence or effect;
“Exchange
Act” means the United States Securities Exchange Act of 1934, as amended;
“Extension Expenses”
means the costs and expenses incurred by SPAC, Sponsor or any of their Affiliates in connection with extending the Business Combination
Deadline beyond March 15, 2023, including any amount deposited by Sponsor in the Trust Account in connection with such extension;
“First
Plan of Merger” means the plan of merger substantially in the form attached hereto as Exhibit F and any
amendment or variation thereto made in accordance with the provisions of the Cayman Act with the consent of the Company and SPAC;
“Fully-Diluted
Company Shares” means, without duplication, (a) the aggregate number of Company Shares (i) that are issued
and outstanding immediately prior to the Recapitalization and (ii) that are issuable (A) upon the exercise of all Company Options
(calculated using the treasury stock method of accounting), and (B) upon the exercise, exchange or conversion of any other Equity
Securities of the Company, in each case of clauses (A) and (B), that are issued and outstanding immediately prior to the Recapitalization
(whether or not then vested or exercisable as applicable) minus (b) the Company Shares held by the Company or any Subsidiary
of the Company (if applicable) as treasury shares; provided that, notwithstanding anything to the contrary in the foregoing, “Fully-Diluted
Company Shares” shall not include any Company Shares issuable upon the exercise, exchange or conversion of the Equity Securities
listed on Section 1.1(a) of the Company Disclosure Letter or any Company Shares issuable upon the conversion, exchange
or exercise of any Equity Securities of the Company issued in connection with any Pre-Closing Financing that are convertible into or
exchangeable or exercisable for Company Shares;
“GAAP”
means generally accepted accounting principles in the United States as in effect from time to time;
“Government
Official” means any officer, cadre, civil servant, employee or any other person acting in an official capacity for any
Governmental Authority (including any government-owned or government-Controlled enterprise, political party, or public or international
organization), or any candidate (or those who act in an official capacity for any candidate) for governmental or political office;
“Governmental
Authority” means the government of any nation, province, state, city, locality or other political subdivision of any
thereof, any entity exercising executive, legislative, judicial, regulatory, taxing or administrative functions of or pertaining to government,
regulation or compliance, or any arbitrator or arbitral body, any self-regulated organization, stock exchange, or quasi-governmental
authority;
“Governmental
Order” means any applicable order, ruling, decision, verdict, decree, writ, subpoena, mandate, precept, command, directive,
consent, approval, award, judgment, injunction or other similar determination or finding by, before or under the supervision of any Governmental
Authority;
“Group”
or “Group Companies” means the Company and its Subsidiaries, and “Group Company” means any
of them;
“Indebtedness”
means with respect to any Person, without duplication, any obligations, contingent or otherwise, in respect of (a) the principal
of and premium (if any) in respect of all indebtedness for borrowed money, including accrued interest and any per diem interest accruals,
(b) the principal and accrued interest components of capitalized lease obligations under GAAP, (c) amounts drawn (including
any accrued and unpaid interest) on letters of credit, bank guarantees, bankers’ acceptances and other similar instruments (solely
to the extent such amounts have actually been drawn), (d) the principal of and premium (if any) in respect of obligations evidenced
by bonds, debentures, notes and similar instruments, (e) the termination value of interest rate protection agreements and currency
obligation swaps, hedges or similar arrangements (without duplication of other indebtedness supported or guaranteed thereby), (f) the
principal component of all obligations to pay the deferred and unpaid purchase price of property and equipment which have been delivered,
including “earn outs” and “seller notes” but excluding payables arising in the Ordinary Course, (g) breakage
costs, prepayment or early termination premiums, penalties, or other fees or expenses payable as a result of the consummation of the
Transactions in respect of any of the items in the foregoing clauses (a) through (f), and (h) all Indebtedness of another
Person referred to in clauses (a) through (g) above guaranteed directly or indirectly, jointly or severally;
“Intellectual
Property” means all intellectual property, industrial property and proprietary rights in any and all jurisdictions worldwide,
including: (a) Patents, (b) Trademarks, (c) Copyrights, (d) rights in Software, (e) Trade Secrets, (f) “moral”
rights, rights of publicity or privacy, data base or data collection rights and other similar intellectual property rights, (g) registrations,
applications, extensions, combinations, divisions, reissues and renewals for any of the foregoing in (a)-(d), and (h) all rights
in all of the foregoing (a)-(g), including all rights to claim for damages by reason of infringement, misappropriation or violation thereof,
with the right to sue for, and collect the same;
“Investment
Company Act” means the United States Investment Company Act of 1940;
“IT
Systems” means servers, hardware, Software (including in Company Products), websites, databases, circuits, networks, workstations,
routers, hubs, data communication or telecommunications equipment and lines, co-location facilities and other information technology,
computer and telecommunication systems, platforms, assets and equipment to the extent used or held for use by or for the Business;
“Knowledge
of SPAC” or any similar expression means the knowledge of the individuals listed on Section 1.1(a) of
the SPAC Disclosure Letter, or the knowledge that any of them would be deemed to have following a reasonable inquiry of his or her direct
reports responsible for the applicable subject matter;
“Knowledge
of the Company” or any similar expression means the knowledge of the individuals listed on Section 1.1(c) of
the Company Disclosure Letter, or the knowledge that any of them would be deemed to have following a reasonable inquiry of his or her
direct reports responsible for the applicable subject matter;
“Law”
means any statute, law, ordinance, rule, regulation or Governmental Order, in each case, of any Governmental Authority, or any
provisions or interpretations of the foregoing, including general principles of common and civil law and equity;
“Leased
Real Property” means any real property subject to a Company Lease;
“Liabilities”
means debts, liabilities and obligations (including Taxes), whether accrued or fixed, absolute or contingent, matured or unmatured,
deferred or actual, determined or determinable, known or unknown, including those arising under any law, action or Governmental Order
and those arising under any Contract;
“Material
Contracts” means, collectively, each currently effective Company Contract (other than any Benefit Plan, but including,
for the avoidance of doubt, any Company Contract with outstanding obligations) that:
| (i) | involves obligations (contingent or otherwise),
payments or revenues to or by the Company or any of its Subsidiaries in excess of $10,000,000
during the twelve-month period ended on September 30, 2022; |
| (ii) | is with each of the Top 10 Suppliers (other
than purchase orders under a master purchase, supply or services agreement); |
| (iii) | is with a Related Party (other than those
employment agreements, indemnification agreements, Contracts covered by any Benefit Plan,
confidentiality agreements, non-competition agreements or any other agreement of similar
nature entered into in the Ordinary Course with employees or technical consultants) with
an amount of over $10,000,000; |
| (iv) | involves (A) indebtedness for borrowed
money having an outstanding principal amount in excess of $10,000,000 or (B) an extension
of credit, a guaranty, surety, deed of trust, or the grant of an Encumbrance, in each case,
to secure any Indebtedness having a principal or stated amount in excess of $10,000,000; |
| (v) | involves the lease, license, sale, use,
disposition or acquisition of a business or assets constituting a business involving (A) purchase
price, payments or revenues in excess of $10,000,000, or (B) any “earn-out”
or deferred or contingent purchase price payment obligation, in each case, that remains outstanding
or under which there are continuing obligations (excluding acquisitions or dispositions in
the Ordinary Course or dispositions of tangible assets that are obsolete, worn out, surplus
or no longer used in the conduct of the Business); |
| (vi) | (A) relates to the license, sublicense,
grant of other rights (including covenant not to sue), creation, development, assignment
or transfer of any material Owned IP or any material Company Product or material Contemplated
Company Product, (B) restricts any Group Company’s ability to assign, transfer,
license, use or enforce any material Owned IP, (C) relates to the license, sublicense,
grant of other rights (including covenant not to sue) of material Company IP, (D) with
any Governmental Authority which restricts any Group Company’s ability to use any Intellectual
Property or Business Data in any material respect, (E) includes any obligation of any
Group Company to pay any royalties or other amounts in excess of $500,000 on an annual basis
for the use of any Company IP, or (F) relates to the disclosure of or access to any
Company Source Code; in the case of the foregoing clauses, other than (1) Open Source
Software licenses and non-exclusive licenses of commercially-available, off-the-shelf software
with an annual fee of less than $500,000, (2) any non-exclusive license of Company IP
granted by the Company in connection with the manufacture, sale and use of the Company’s
products in the Ordinary Course, and (3) assignments of Intellectual Property to the
Company or any of its Subsidiaries under Contracts with their (i) employees and (ii) contractors,
and in the case of (ii), similar in all material respects to the Company’s form entered
into in the Ordinary Course; |
| (vii) | involves
the waiver, compromise or settlement of any dispute, claim, litigation or arbitration resulting
in payment obligation of any Group Company with an amount higher than $1,000,000; |
| (viii) | grants
a right of first refusal, right of first offer or similar right with respect to any material
properties, assets or businesses of the Company and its Subsidiaries, taken as a whole; |
| (ix) | contains
covenants of the Company or any of the Company’s Subsidiaries (A) prohibiting
or limiting the right of the Company or any of the Company’s Subsidiaries to engage
in or compete with any Person in any line of business in any material respect, or (B) prohibiting
or restricting the Company’s or the Company’s Subsidiaries ability to conduct
their respective business with any Person in any geographic area in any material respect,
in each cases, other than Contracts entered into in the Ordinary Course which include exclusivity
provisions; |
| (x) | with
any Governmental Authority or state-owned enterprise which involves obligations (contingent
or otherwise), payments or revenues to or by the Group in excess of $1,000,000 in the twelve-month
period ended on September 30, 2022; |
| (xi) | involves
the establishment, contribution to, or operation of a partnership, joint venture or similar
arrangement, or involving a sharing of profits or losses, involving payments of an amount
higher than $10,000,000; |
| (xii) | explicitly
requires capital expenditure in a single transaction for the Company or any of its Subsidiaries
after the date of this Agreement in an amount in excess of $5,000,000; |
| (xiii) | contains
any exclusivity, “most favored nation”, minimum use or purchase requirements; |
| (xiv) | relates
to the sale, issuance, grant, exercise, award, exchange, conversion, purchase, repurchase
or redemption of any Equity Securities of a Group Company under which there is any outstanding
or continuing obligations on the part of any Group Company or the applicable counterparties;
or |
| (xv) | is
a collective bargaining agreement with a Union. |
“Merger Consideration”
means, collectively, the ADS Merger Consideration and the Ordinary Share Merger Consideration.
“NDA”
means the Confidential Disclosure Agreement, dated as of November 14, 2022, between SPAC and the Company;
“Open Source Software”
means any Software that is distributed or otherwise made available under “open source”, “community”, or “free
software” terms, including: (a) any license that has been approved by the Open Source Initiative, a list of which is available
at https://opensource.org/licenses; (b) any license that meets the Open Source Definition promulgated by the Open Source Initiative,
which is available at https://opensource.org/osd; (c) any copyleft license; and (d) any license that is substantially similar
to those described in any, all, or any combination of the foregoing clauses (a)-(c);
“Ordinary
Course” means, with respect to an action taken or refrained from being taken by a Person, that such action or omission
is taken in the ordinary course of the operations of such Person consistent with past practice, as the same may be varied, in good faith
and on a commercially reasonable basis, in connection with the Company’s conduct of any Contemplated Business;
“Ordinary
Shares” has the meaning given to that term in the Company Charter;
“Ordinary
Share Merger Consideration” means the right to receive such number of Company Ordinary Shares by the Founder Shareholders
pursuant to Section 2.3(c);
“Organizational
Documents” means, with respect to any Person that is not an individual, its certificate of incorporation and bylaws,
memorandum and articles of association, limited liability company agreement, or similar organizational documents, in each case, as amended
or restated;
“Owned
IP” means all Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries, including
all Intellectual Property set forth or required to be set forth in Section 3.15(a)(1) of the Company Disclosure Letter;
“Owned
Real Property” means any real property owned by the Company or any of its Subsidiaries;
“Patents”
means patents, including utility models, industrial designs and design patents, and applications therefor (and any patents that
issue as a result of those patent applications), and including all divisionals, continuations, continuations-in-part, continuing prosecution
applications, substitutions, reissues, re-examinations, renewals, provisionals and extensions thereof, and any counterparts worldwide
claiming priority therefrom;
“Permitted
Encumbrances” means (a) Encumbrances for Taxes, assessments and governmental charges or levies not yet due and
payable or that are being contested in good faith by appropriate proceedings and for which adequate reserves have been established in
accordance with GAAP; (b) mechanics’, carriers’, workmen’s, repairmen’s, materialmen’s or other Encumbrances
arising or incurred in the Ordinary Course in respect of amounts that are not yet due and payable; (c) rights of any third parties
that are party to or hold an interest in any Contract to which the Company or any of its Subsidiaries is a party (in each case not arising
as a result of any default by the Company or any of its Subsidiaries thereunder and other than any license or covenant not to sue with
respect to any Intellectual Property); (d) defects or imperfections of title, easements, encroachments, covenants, rights-of-way,
conditions, matters that would be apparent from a physical inspection or current, accurate survey of such real property, restrictions
and other similar charges or Encumbrances that do not materially interfere with the present use of the Leased Real Property, (e) with
respect to any Leased Real Property (i) the interests and rights of the respective lessors with respect thereto, including any statutory
landlord liens and any Encumbrances thereon, (ii) any Encumbrances permitted under the Company Lease, and (iii) any Encumbrances
encumbering the real property of which the Leased Real Property is a part, (iv) zoning, building, entitlement and other land use
and environmental regulations promulgated by any Governmental Authority that do not materially interfere with the current use of the
Leased Real Property, (f) licenses of Intellectual Property granted by the Company or any of its Subsidiaries in the Ordinary Course,
(g) Ordinary Course purchase money Encumbrances and Encumbrances securing rental payments under operating or capital lease arrangements
for amounts not yet due or payable, (h) other Encumbrances arising in the Ordinary Course and not incurred in connection with the
borrowing of money and on a basis consistent with past practice in connection with workers’ compensation, unemployment insurance
or other types of social security (in each case not arising as a result of any default by the Company or any of its Subsidiaries thereunder),
(i) reversionary rights in favor of landlords under any Company Leases with respect to any of the buildings or other improvements
owned by the Company or any of its Subsidiaries, (j) any other Encumbrances (other than with respect to Intellectual Property) that
have been incurred or suffered in the Ordinary Course and do not materially impair the existing use of the property affected by such
Encumbrance and (k) any Encumbrance disclosed in Section 1.1(d) of the Company Disclosure Letter;
“Person”
means any individual, firm, corporation, company, partnership, limited liability company, incorporated or unincorporated association,
trust, estate, joint venture, joint stock company, Governmental Authority or instrumentality or other entity of any kind;
“Personal
Data” means (a) all data and information that, whether alone or in combination with any other data or information,
identifies, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked, directly or indirectly,
with a natural person, household, or his, her or its device, including, to the extent constituting or comprising the foregoing, name,
street address, telephone number, email address, photograph, social security number, government-issued ID number, customer or account
number, health information, financial information, device identifiers, transaction identifier, cookie ID, browser or device fingerprint
or other probabilistic identifier, IP addresses, physiological and behavioral biometric identifiers, viewing history, platform behaviors,
and any other similar piece of data or information; and (b) all other personal data;
“PIPE
Financing Proceeds” means cash proceeds that will be funded prior to, concurrently with, or immediately after, the Closing
to the Company in connection with the PIPE Financing;
“PRC”
means the People’s Republic of China excluding, for the purposes of this Agreement only, the Hong Kong Special Administrative Region,
the Macau Special Administrative Region and Taiwan;
“Pre-Closing Financing
Proceeds” means cash proceeds that will be funded to the Company in connection with the Pre-Closing Financing;
“Preferred
Shares” means, collectively, Series Pre-A Preferred Shares and Series A Preferred Shares;
“Price
per Share” means $5,500,000,000 divided by the Fully-Diluted Company Shares;
“Privacy
Laws” means all applicable Laws concerning the Processing of Personal Data, including incident reporting and Security
Incident notifying requirements;
“Process,”
“Processing” or “Processed” means the access, use, collection, creation, processing, receipt,
storage, recording, organization, structuring, adaption, alteration, transfer, retrieval, consultation, transmit, sharing, distribution,
disclosure, dissemination, making available, alignment, combination, restriction, disposal, erasure or destruction of any information
or data (including Personal Data);
“Prohibited
Person” means any Person that is (a) a national or resident of or organized or located in any Sanctioned Territory,
(b) included on any Sanctions-related list of blocked or designated parties maintained by the U.S. Commerce Department, the U.S.
Department of Treasury, and the U.S. Department of State, the United Nations Security Council, HM Treasury of the United Kingdom, or
the European Union; (c) owned fifty percent or more, directly or indirectly, by a Person included on any Sanctions-related list
of blocked or designated parties, as described in clause (b) above; (d) is a Person acting in his or her official capacity
as a director, officer, employee, or agent of a Person included on any Sanctions-related list of blocked or designated parties, as described
in clause (b) above; or (e) a Person with whom business transactions, including exports and imports, are otherwise restricted
by Sanctions, including, in each clause above, any updates or revisions to the foregoing and any newly published rules;
“Proxy
Statement” means the proxy statement forming part of the Proxy/Registration Statement filed with the SEC, with respect
to the SPAC Shareholders’ Meeting and the Transactions, to be used for the purpose of soliciting proxies from SPAC Shareholders
to approve the Transaction Proposals;
“Recapitalization
Factor” means the quotient obtained by dividing the Price per Share by $10.00;
“Redeeming
SPAC Shares” means SPAC Ordinary Shares in respect of which the eligible (as determined in accordance with the SPAC
Charter) holder thereof has validly exercised (and not validly revoked, withdrawn or lost) his, her or its SPAC Shareholder Redemption
Right;
“Registered
IP” means Owned IP issued by, registered, recorded or filed with, renewed by or the subject of a pending application
before any Governmental Authority, Internet domain name registrar or other authority;
“Related Entity”
means Geely International (Hong Kong) Limited, Lotus Group International Limited, or any of their respective Affiliates (excluding the
Company or any of its Subsidiaries);
“Related
Party” means (a) any member, shareholder or equity interest holder who, together with its Affiliates, directly
or indirectly holds no less than 5% of the total outstanding share capital of the Company or any of its Subsidiaries, (b) any director
or officer of the Company or any of its Subsidiaries, in each case of clauses (a) and (b), excluding the Company or any of
its Subsidiaries;
“Representatives”
of a Person means, collectively, officers, directors, employees, accountants, consultants, legal counsel, agents and other representatives
of such Person or its Affiliates;
“Required
Governmental Authorizations” means all material franchises, approvals, permits, consents, qualifications, certifications,
authorizations, licenses, orders, registrations, certificates, variances or other similar permits, rights and all pending applications
therefor from or with the relevant Governmental Authority required to operate the business of the Company and any of its Subsidiaries,
as currently conducted, in accordance with applicable Law;
“Sanctioned Territory”
means, at any time, a country or territory which is itself the subject or target of any Sanctions and is subject to a general export,
import, financial or investment embargo (at the time of this Agreement, the Crimea region of Ukraine, Cuba, the so-called Donetsk and
Luhansk People’s Republic region of Ukraine, Iran, North Korea, and Syria).
“Sanctions”
means those trade, economic and financial sanctions and export controls laws, regulations, embargoes, and restrictive measures
(in each case having the force of law) administered, enacted or enforced from time to time by (a) the United States (including the
United States Commerce Department’s Denied Parties List, Entity List, and Unverified Lists, the U.S. Department of Treasury’s
Specially Designated Nationals and Blocked Persons List, Specially Designated Narcotics Traffickers List, or Specially Designated Terrorists
List, Specially Designated Global Terrorists List, or the Annex to Executive Order No. 13224, and the Department of State’s
Debarred List), (b) the European Union and enforced by its member states, (c) the United Nations Security Council, (d) His
Majesty’s Treasury of the United Kingdom and (e) any other applicable similar trade, economic and financial sanctions administered
by a Governmental Authority;
“Sarbanes-Oxley
Act” means the United States Sarbanes-Oxley Act of 2002;
“SEC”
means the United States Securities and Exchange Commission;
“Second
Plan of Merger” means the plan of merger substantially in the form attached hereto as Exhibit G and any
amendment or variation thereto made in accordance with the provisions of the Cayman Act with the consent of the Company and SPAC;
“Securities
Act” means the United States Securities Act of 1933;
“Security
Incident” means any actual or suspected data breach, ransomware, phishing or other security incident or Event that resulted
in the accidental, unauthorized or unlawful destruction, loss, alteration, corruption, or accidental, unauthorized or unlawful disclosure
of, or access to or use or Processing of, (i) any Personal Data included in the Business Data, which has been, or is required under
any Data Protection Laws to be, notified to a supervisory or regulatory authority or any other Person, or (ii) any Business Data
(including Personal Data) or IT Systems which exposes the Company or any of its Subsidiaries to any material Action or Liabilities or
results in any material disruption of any IT Systems or the Business;
“Series A
Preferred Shares” has the meaning given to that term in the Company Charter;
“Series Pre-A
Preferred Shares” has the meaning given to that term in the Company Charter;
“Shareholders
Agreement” means the Fourth Amended and Restated Shareholders Agreement in respect of the Company, dated as of September 20,
2022;
“Social
Insurance” means any form of social insurance required under applicable Laws, including without limitation, the PRC national
and local contributions for pensions, medical insurance, unemployment insurance, work-related injury insurance, pregnancy benefits,
and housing accumulation funds;
“Software”
means software of any type (including computer programs, applications, object code, binary code, source code, middleware, interfaces,
firmware, mask works, microcode, software development kits, libraries, tools, compiled or interpreted programmable logic, objects, bytecode,
machine code, subroutines or other code, and software implementations of algorithms, models and methodologies, whether embodied in hardware,
firmware or otherwise), integrated circuits, architecture, schematics, description language, and documentation to the extent related
to any of the foregoing, including intellectual property, industrial property and proprietary rights in and to any of the foregoing;
“SPAC
Acquisition Proposal” means: (a) any, direct or indirect, acquisition, merger, domestication, reorganization, business
combination, “initial business combination” under SPAC’s IPO prospectus or similar transaction, in one transaction
or a series of transactions, involving SPAC or involving all or a material portion of the assets, Equity Securities or businesses of
SPAC (whether by merger, consolidation, recapitalization, purchase or issuance of equity securities, purchase of assets, tender offer
or otherwise); or (b) any equity or similar investment in SPAC or any of its Controlled Affiliates, in each case, other than the
Transactions;
“SPAC
Charter” means the Amended and Restated Memorandum and Articles of Association of SPAC, adopted pursuant to a special
resolution passed on March 3, 2021, as amended and restated pursuant to a special resolution passed on March 10, 2023 and as
may be further amended from time to time;
“SPAC
Class A Ordinary Shares” means Class A ordinary shares of SPAC with a par value of $0.0001 each, as further
described in the SPAC Charter;
“SPAC
Class B Ordinary Shares” means Class B ordinary shares of SPAC with a par value of $0.0001 each, as further
described in the SPAC Charter;
“SPAC
Material Adverse Effect” means any Event that has had, or would reasonably be expected to have, individually or in the
aggregate, a material adverse effect on (i) the business, assets and liabilities, results of operations or financial condition of
SPAC or (ii) the ability of SPAC to consummate the Transactions; provided, however, that in no event would any of
the following, alone or in combination, be deemed to constitute, or be taken into account in determining whether there has been or will
be, a “SPAC Material Adverse Effect”: (a) any change in applicable Laws or GAAP or any interpretation thereof following
the date of this Agreement, (b) any change in interest rates or economic, political, business or financial market conditions generally,
(c) the taking or refraining from taking of any action expressly required to be taken or refrained from being taken under this Agreement
or the Original Merger Agreement, (d) any natural disaster (including hurricanes, storms, tornados, flooding, earthquakes, volcanic
eruptions or similar occurrences), epidemic or pandemic (including any COVID-19 Measures or any change in such COVID-19 Measures or interpretations
following the date of this Agreement), acts of nature or change in climate, (e) any acts of terrorism or war, the outbreak or escalation
of hostilities, geopolitical conditions, local, national or international political conditions, riots or insurrections, (f) any
action taken by the Company, or taken at the written request of the Company, (g) the announcement of this Agreement or the Original
Merger Agreement or the consummation of the Transactions, or (h) any change in the trading price or volume of the SPAC Units, SPAC
Ordinary Shares or SPAC Warrants (provided that any underlying Event of such changes referred to in this clause (h) may
be considered in determining whether there is a SPAC Material Adverse Effect except to the extent such Event is within the scope of any
other exception within this definition); provided, however, that in the case of each of clauses (b), (d) and
(e), any such Event to the extent it disproportionately affects SPAC relative to other special purpose acquisition companies shall not
be excluded from the determination of whether there has been, or would reasonably be expected to be, a SPAC Material Adverse Effect,
but only to the extent of the incremental disproportionate effect on SPAC relative to such other special purpose acquisition companies.
Notwithstanding the foregoing, with respect to SPAC, the number of SPAC Shareholders who exercise their SPAC Shareholder Redemption Right
or the failure to obtain SPAC Shareholders’ Approval shall not be deemed to be a SPAC Material Adverse Effect;
“SPAC
Ordinary Shares” means, collectively, SPAC Class A Ordinary Shares and SPAC Class B Ordinary Shares;
“SPAC
Preference Shares” means preference shares of SPAC with a par value of $0.0001 each, as further described in the SPAC
Charter;
“SPAC Related Party”
means any officer, director, employee, partner, member, manager, direct or indirect equityholder (including Sponsor) or Affiliate of
either SPAC or Sponsor (or any Affiliate of Sponsor);
“SPAC
Securities” means, collectively, the SPAC Shares and the SPAC Warrants;
“SPAC
Shareholder” means any holder of any SPAC Shares;
“SPAC
Shareholder Redemption Amount” means the aggregate amount payable with respect to all Redeeming SPAC Shares;
“SPAC
Shareholder Redemption Right” means the right of an eligible (as determined in accordance with the SPAC Charter) holder
of SPAC Ordinary Shares to redeem all or a portion of the SPAC Ordinary Shares held by such holder as set forth in the SPAC Charter in
connection with the Transaction Proposals or with the Extension Proposal;
“SPAC
Shareholders’ Approval” means the vote of SPAC Shareholders required to approve the Transaction Proposals, as
determined in accordance with applicable Law and the SPAC Charter;
“SPAC
Shares” means the SPAC Ordinary Shares and SPAC Preference Shares;
“SPAC
Transaction Expenses” means any fees and expenses paid or payable by SPAC or Sponsor or their respective Affiliates
(whether or not billed or accrued for) (i) as a result of or in connection with the negotiation, documentation and consummation
of the Transactions, or (ii) otherwise in connection with any business activities and operations of SPAC consistent with its final
prospectus, dated as of March 10, 2021 and filed with the SEC on March 12, 2021 (File No. 333-253334), including, without
duplication, (a) the Extension Expenses, (b) all fees (including deferred underwriting fees), costs, expenses, brokerage fees,
commissions, finders’ fees and disbursements of financial advisors, investment banks, data room administrators, attorneys, accountants
and other advisors and service providers, (c) any Indebtedness of SPAC owed to Sponsor, its Affiliates or its or their respective
shareholders or Affiliates, and (d) any and all filing fees to the Governmental Authorities in connection with the Transactions,
except that SPAC shall only be responsible for fifty percent (50%) of the fees, costs and expenses incurred in connection with (x) any
filing, submission or application for the Governmental Order pertaining to the anti-trust Laws applicable to the Transactions and (y) the
preparation, filing and mailing of the Proxy/Registration Statement in connection with the Transactions;
“SPAC
Unit” means the units issued by SPAC in SPAC’s IPO or the exercise of the underwriters’ overallotment option
each consisting of one SPAC Class A Ordinary Share and one-third of a SPAC Warrant;
“SPAC
Warrant” means all outstanding and unexercised warrants issued by SPAC to acquire SPAC Class A Ordinary Shares;
“Stock Exchange”
means NYSE or The Nasdaq Stock Market;
“Subsidiary”
means, with respect to a Person, any other Person Controlled, directly or indirectly, by such Person and, in case of a limited
partnership, limited liability company or similar entity, such Person is a general partner or managing member and has the power to direct
the policies, management and affairs of such Person, respectively;
“Tax”
or “Taxes” means all U.S. federal, state, local, non-U.S. or other taxes imposed by any Governmental Authority,
including all income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits,
escheat, unclaimed property, environmental, customs duties, capital stock, ad valorem, value added, inventory, franchise, profits, withholding,
social security (or similar), unemployment, disability, real property, personal property, sales, use, transfer, registration, alternative
or add-on minimum, or estimated taxes, and including any interest, penalty, or addition thereto;
“Tax
Returns” means all U.S. federal, state, local, provincial and non-U.S. income and other material returns, declarations,
computations, notices, statements, claims, reports, schedules, forms and information returns, including any attachment thereto or amendment
thereof, required or permitted to be supplied to, or filed with, a Governmental Authority with respect to Taxes;
“Top
10 Suppliers” means the top 10 suppliers of the Group Companies (calculated based on the aggregate consideration paid by the
Group Companies for the twelve (12) months ended December 31, 2021 and the nine (9) months ended September 30,
2022);
“Trade
Secrets” means all trade secrets and other confidential or proprietary information, including know-how and inventions
(whether or not patentable or reduced to practice), invention disclosures, improvements, source code, documentation, processes, models,
technology, formulae, customer lists, supplier lists, data, databases, and data collections and all rights therein, business and marketing
plans, methodologies and all other information, in each case, that derives economic value (actual or potential) from not being
generally known to other persons who can obtain economic value from its disclosure or use;
“Trademarks”
means trade names, logos, trademarks, service marks, service names, trade dress, company names, collective membership marks, certification
marks, slogans, toll-free numbers, domain names, social media handles and accounts, and other forms indicia of origin, whether or not
registerable as a trademark in any given jurisdiction, together with registrations, renewals, and applications therefor, and the goodwill
associated with any of the foregoing;
“Transaction
Documents” means, collectively, this Agreement, the NDA, the Sponsor Support Agreement, the Company Support Agreement,
the Distribution Agreement, each Put Option Agreement, the Registration Rights Agreement, the Assignment, Assumption and Amendment Agreement,
the First Merger Filing Documents, the Second Merger Filing Documents, the Lock-Up Agreements, and any other agreements, documents or
certificates entered into or delivered pursuant hereto or thereto (including, if any, any Subscription Agreements), and the expression
“Transaction Document” means any one of them;
“Transaction
Proposals” means the adoption and approval of each proposal reasonably agreed to by SPAC and the Company as necessary
or appropriate in connection with the consummation of the Transactions, but in any event including unless otherwise agreed upon in writing
by SPAC and the Company: (i) the approval and authorization of this Agreement and the Transactions as a Business Combination, (ii) the
approval and authorization of the First Merger and the First Plan of Merger, (iii) the approval and authorization of the Second
Merger and the Second Plan of Merger, (iv) the adoption and approval of a proposal for the adjournment of the SPAC Shareholders’
Meeting, if necessary, to permit further solicitation and vote of proxies because there are not sufficient votes to approve and adopt
any of the foregoing or in order to seek withdrawals from SPAC Shareholders who have exercised their SPAC Shareholder Redemption Right
if the number of Redeeming SPAC Shares is such that the condition in Section 8.3(c) would not be satisfied, and (v) the
adoption and approval of each other proposal that the Stock Exchange or the SEC (or staff members thereof) indicates (x) are necessary
in its comments to the Proxy/Registration Statement or correspondence related thereto and (y) are required to be approved by the
SPAC Shareholders or the Company Shareholders in order for the Closing to be consummated;
“Transactions”
means, collectively, the Mergers and each of the other transactions contemplated by this Agreement or any of the other Transaction
Documents;
“Union”
means any union, works council or other employee representative body;
“U.S.”
means the United States of America;
“Warrant
Agreement” means the Warrant Agreement, dated as of March 10, 2021, by and between SPAC and the SPAC Warrant Agent;
“Working Capital
Loans” means any loan made to SPAC by any of Sponsor, an Affiliate of Sponsor, or any of SPAC’s officers or directors,
and evidenced by a promissory note, for the purpose of financing costs incurred in connection with a Business Combination;
“Wuhan
Lotus Technology” means Wuhan Lotus Technology Co., Ltd. (武汉路特斯科技有限公司),
an indirect wholly owned PRC Subsidiary of the Company; and
“Wuhan
Lotus E-Commerce” means Wuhan Lotus E-Commerce Co., Ltd. (武汉路特斯电子商务有限公司),
an indirect wholly owned PRC Subsidiary of the Company.
Section 1.2. Construction.
(a) Unless
the context of this Agreement otherwise requires or unless otherwise specified, (i) words of any gender shall be construed as masculine,
feminine, neuter or any other gender, as applicable; (ii) words using the singular or plural number also include the plural or singular
number, respectively; (iii) the terms “hereof,” “herein,” “hereby,” “herewith,”
“hereto” and derivative or similar words refer to this entire Agreement; (iv) the terms “Article”
or “Section” refer to the specified Article or Section of this Agreement; (v) the terms “Schedule”
or “Exhibit” refer to the specified Schedule or Exhibit of this Agreement; (vi) the words “including,”
“included,” or “includes” shall mean “including, without limitation”; and shall not be construed
to limit any general statement that it follows to the specific or similar items or matters immediately following it; (vii) the word
“extent” in the phrase “to the extent” means the degree to which a subject or thing extends and such phrase shall
not simply mean “if”; (viii) the word “or” shall be disjunctive but not exclusive; (ix) the word “will”
shall be construed to have the same meaning as the word “shall”; (x) unless the context otherwise clearly indicates,
each defined term used in this Agreement shall have a comparable meaning when used in its plural or singular form; (xi) words in
the singular shall be held to include the plural and vice versa, and words of one gender shall be held to include the other gender as
the context requires; (xii) references to “written” or “in writing” include in electronic form; (xiii) a
reference to any Person includes such Person’s predecessors, successors and permitted assigns; and (xiv) “made available
to SPAC” (and all similar phrases used herein that mean such) shall mean present in the online data
room maintained for purposes of the Transactions at least two (2) Business Days prior to the date hereof, which online data room
(including all of its contents as of two (2) Business Days prior to the date hereof) shall be maintained by the Company without
any deletion or modification and continue to be available to SPAC and its Representatives following the date hereof until the Closing.
(b) Unless
the context of this Agreement otherwise requires, references to statutes shall include all regulations promulgated thereunder and references
to statutes or regulations shall be construed as including all statutory and regulatory provisions consolidating, amending or replacing
the statute or regulation.
(c) References
to “$,” “dollar,” or “cents” are to the lawful currency of the United States of America.
(d) Whenever
this Agreement refers to a number of days or months, such number shall refer to calendar days or months unless Business Days are expressly
specified. Time periods within or following which any payment is to be made or act is to be done under this Agreement shall be calculated
by excluding the calendar day on which the period commences and including the calendar day on which the period ends, and by extending
the period to the next following Business Day if the last calendar day of the period is not a Business Day.
(e) All
accounting terms used in this Agreement and not expressly defined in this Agreement shall have the meanings given to them under GAAP.
(f) Unless
the context of this Agreement otherwise requires, (i) references to SPAC with respect to periods following the First Effective Time
shall be construed to mean Surviving Entity 1 and vice versa and (ii) references to Merger Sub 2 with respect to periods following
the Second Effective Time shall be construed to mean Surviving Entity 2 and vice versa.
(g) The
table of contents and the section and other headings and subheadings contained in this Agreement and the Exhibits hereto are solely for
the purpose of reference, are not part of the agreement of the parties hereto, and shall not in any way affect the meaning or interpretation
of this Agreement or any Exhibit hereto.
(h) Unless
the context of this Agreement otherwise requires, references to agreements and other documents shall be deemed to include all subsequent
amendments and other modifications thereto.
(i) The
term “the date of this Agreement” or “the date hereof” means January 31, 2023.
(j) Capitalized
terms used in the Exhibits and the Disclosure Letter and not otherwise defined therein have the meanings given to them in this Agreement.
(k) With
regard to each and every term and condition of this Agreement, the parties hereto understand and agree that the same has been mutually
negotiated, prepared and drafted, and if at any time the parties hereto desire or are required to interpret or construe any such term
or condition or any agreement or instrument subject hereto, no consideration shall be given to the issue of which party actually prepared,
drafted or requested any term or condition of this Agreement.
Article II
TRANSACTIONS;
CLOSING
Section 2.1. Pre-Closing
Actions. On the Closing Date, immediately prior to the First Effective Time, the following actions shall take place or be effected
(in the order set forth in this Section 2.1):
(a) Preferred
Share Conversion. Each of the Preferred Shares that is issued and outstanding immediately prior to such time shall be converted into
one Ordinary Share on a one-for-one basis, by re-designation and re-classification, in accordance with the Company Charter (the “Preferred
Share Conversion”).
(b) Organizational
Documents of the Company. The amended and restated memorandum and articles of association of the Company attached hereto as Exhibit H
(the “A&R Company Charter”) shall be adopted and become effective.
(c) Re-designation.
Immediately following the Preferred Share Conversion and immediately prior to the Recapitalization, 500,000,000 authorized but unissued
Ordinary Shares shall be re-designated as shares of a par value of US$0.00001 each of such class or classes (however designated) as the
Company Board may determine in accordance with the A&R Company Charter (the “Re-designation”), such that the authorized
share capital of the Company shall be US$50,000 divided into 5,000,000,000 shares of par value of US$0.00001 each, consisting of 4,500,000,000
ordinary shares of a par value of US$0.00001 each, and 500,000,000 shares of a par value of US$0.00001 each of such class or classes
(however designated) as the Company Board may determine in accordance with the A&R Company Charter.
(d) Recapitalization.
(i) Immediately
following the Re-designation and prior to the First Effective Time, each issued Company Ordinary Share shall be recapitalized by way
of a repurchase in exchange for the issuance of such number of Company Ordinary Shares equal to the Recapitalization Factor (i.e.,
one such Company Ordinary Share multiplied by the Recapitalization Factor) (the “Recapitalization”); provided
that no fraction of a Company Ordinary Share will be issued by virtue of the Recapitalization, and each Company Shareholder that would
otherwise be so entitled to a fraction of a Company Ordinary Share (after aggregating all fractional Company Ordinary Shares that otherwise
would be received by such Company Shareholder) shall instead be entitled to receive such number of Company Ordinary Shares to which such
Company Shareholder would otherwise be entitled, rounded down to the nearest whole number.
(ii) Any
Company Options issued and outstanding immediately prior to the Recapitalization shall be adjusted to give effect to the foregoing transactions,
such that (a) each Company Option shall be exercisable for that number of Company Ordinary Shares equal to the product of (x) the
number of Ordinary Shares subject to such Company Option immediately prior to the Recapitalization multiplied by (y) the
Recapitalization Factor, such number of Company Ordinary Shares to be rounded down to the nearest whole number; and (b) the per
share exercise price for each Company Ordinary Share, as the case may be, issuable upon exercise of the Company Options, as adjusted,
shall be equal to the quotient (rounded up to the nearest whole cent) obtained by dividing (x) the per share exercise price
for each Ordinary Share subject to such Company Option immediately prior to the First Effective Time by (y) the Recapitalization
Factor (together with the adoption of the A&R Company Charter, Preferred Share Conversion, the Re-designation and the Recapitalization,
the “Capital Restructuring”). Subject to and without limiting anything contained in Section 6.1,
the Recapitalization Factor shall be adjusted to reflect appropriately the effect of any share subdivision, capitalization, share dividend
or share distribution (including any dividend or distribution of securities convertible into Company Shares), reorganization, recapitalization,
reclassification, consolidation, exchange of shares or other like change (in each case, other than the Capital Restructuring) with respect
to Company Shares occurring on or after the date hereof and prior to the Closing Date.
Section 2.2. The
Mergers.
(a) The
First Merger. Subject to Section 2.2(c), on the date which is three (3) Business Days after the first date on which
all conditions set forth in Article VIII that are required hereunder to be satisfied on or prior to the Closing shall have
been satisfied or waived (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction
or waiver thereof), or at such other time or in such other manner as shall be agreed upon by the Company and SPAC in writing, the closing
of the Transactions contemplated by this Agreement with respect to the Mergers (the “Closing”) shall take place remotely
by conference call and exchange of documents and signatures in accordance with Section 10.9. At the Closing, Merger Sub 1
shall merge with and into SPAC, with SPAC being the surviving company (as defined in the Cayman Act) in the First Merger (the day on
which the Closing occurs, the “Closing Date”). On the Closing Date, SPAC and Merger Sub 1 shall execute and cause
to be filed with the Cayman Registrar, the First Plan of Merger and such other documents as may be required in accordance with the applicable
provisions of the Cayman Act or by any other applicable Law to make the First Merger effective (collectively, the “First Merger
Filing Documents”). The First Merger shall become effective at the time when the First Plan of Merger is registered by the
Cayman Registrar or at such later time permitted by the Cayman Act as may be agreed by Merger Sub 1 and SPAC in writing and specified
in the First Plan of Merger (the “First Effective Time”).
(b) The
Second Merger. Immediately following the consummation of the First Merger, Surviving Entity 1 shall merge with and into Merger Sub
2, with Merger Sub 2 being the surviving company (as defined in the Cayman Act) in the Second Merger. Immediately following the consummation
of the First Merger, Surviving Entity 1 and Merger Sub 2 shall execute and cause to be filed with the Cayman Registrar, the Second Plan
of Merger and such other documents as may be required in accordance with the applicable provisions of the Cayman Act or by any other
applicable Law to make the Second Merger effective (collectively, the “Second Merger Filing Documents”). The Second
Merger shall become effective at the time when the Second Plan of Merger is registered by the Cayman Registrar or at such later time
permitted by the Cayman Act as may be agreed by Surviving Entity 1 and Merger Sub 2 in writing and specified in the Second Plan of Merger
(the “Second Effective Time”).
(c) Notice
to SPAC Shareholders Delivering Written Objection. If any SPAC Shareholder gives to SPAC, before the SPAC Shareholders’ Approval
is obtained at the SPAC Shareholders’ Meeting, written objection to the First Merger (each, a “Written Objection”)
in accordance with Section 238(2) of the Cayman Act:
(i) SPAC
shall, in accordance with Section 238(4) of the Cayman Act, promptly give written notice of the authorization of the First
Merger (the “Authorization Notice”) to each such SPAC Shareholder who has made a Written Objection, and
(ii) unless
SPAC and the Company elect by agreement in writing to waive this Section 2.2(c)(ii), no party shall be obligated to commence
the Closing, and the First Plan of Merger shall not be filed with the Cayman Registrar until at least twenty (20) days shall have elapsed
since the date on which the Authorization Notice is given (being the period allowed for written notice of an election to dissent under
Section 238(5) of the Cayman Act, as referred to in Section 239(1) of the Cayman Act), but in any event subject to
the satisfaction or waiver of all of the conditions set forth in Section 8.1, Section 8.2 and Section 8.3.
(d) PIPE
Financing Notices. Promptly following the First Effective Time, the Company shall deliver notices to the parties to the PIPE Financing,
if any, to cause the release of funds from escrow to the Company.
(e) Effect
of the Mergers. The Mergers shall have the effects set forth in this Agreement, the First Plan of Merger, the Second Plan of Merger
and the applicable provisions of the Cayman Act. Without limiting the generality of the foregoing, and subject thereto, (a) at the
First Effective Time, all the property, rights, privileges, agreements, powers and franchises, Liabilities and duties of Merger Sub 1
and SPAC shall become the property, rights, privileges, agreements, powers and franchises, Liabilities and duties of Surviving Entity
1 (including all rights and obligations with respect to the Trust Account), which shall include the assumption by Surviving Entity 1
of any and all agreements, covenants, duties and obligations of Merger Sub 1 and SPAC to be performed after the First Effective Time
set forth in this Agreement and the other Transaction Documents to which Merger Sub 1 or SPAC is a party, and Surviving Entity 1 shall
thereafter exist as a wholly owned Subsidiary of the Company and the separate corporate existence of Merger Sub 1 shall cease to exist,
and (b) at the Second Effective Time, all the property, rights, privileges, agreements, powers and franchises, Liabilities, and
duties of Surviving Entity 1 and Merger Sub 2 shall become the property, rights, privileges, agreements, powers and franchises, Liabilities
and duties of Surviving Entity 2, which shall include the assumption by Surviving Entity 2 of any and all agreements, covenants, duties
and obligations of Surviving Entity 1 and Merger Sub 2 to be performed after the Second Effective Time set forth in this Agreement and
the other Transaction Documents to which Surviving Entity 1 or Merger Sub 2 is a party, and Surviving Entity 2 shall thereafter exist
as a wholly owned Subsidiary of the Company and the separate corporate existence of Surviving Entity 1 shall cease to exist.
(f) Organizational
Documents of Surviving Entity 1. At the First Effective Time, in accordance with the First Plan of Merger, SPAC will adopt the memorandum
and articles of association of Merger Sub 1, as in effect immediately prior to the First Effective Time, as the memorandum and articles
of association of Surviving Entity 1, save and except that all references to the share capital of Surviving Entity 1 shall be amended
to refer to the correct authorized share capital of Surviving Entity 1 consistent with the First Plan of Merger, until thereafter amended
in accordance with the applicable provisions of the Cayman Act and such memorandum and articles of association.
(g) Organizational
Documents of Surviving Entity 2. At the Second Effective Time, in accordance with the Second Plan of Merger, the memorandum and articles
of association of Merger Sub 2, as so amended and restated, shall be the memorandum and articles of association of Surviving Entity
2, save and except that all reference to the share capital of Surviving Entity 2 shall be amended to refer to the correct authorized
share capital of Surviving Entity 2 consistent with the Second Plan of Merger, until thereafter amended in accordance with the applicable
provisions of the Cayman Act and such memorandum and articles of association.
(h) Directors
and Officers of Surviving Entity 1 and Surviving Entity 2. At the First Effective Time, the directors and officers of Merger Sub
1 immediately prior to the First Effective Time shall be the initial directors and officers of Surviving Entity 1, each to hold office
in accordance with the Organizational Documents of Surviving Entity 1. At the Second Effective Time, the directors and officers of Merger
Sub 2 immediately prior to the Second Effective Time shall be the initial directors and officers of Surviving Entity 2, each to hold
office in accordance with the Organizational Documents of Surviving Entity 2.
Section 2.3. Effect
of the Mergers on Issued Securities of SPAC, Merger Sub 1 and Merger Sub 2. At the Closing, by virtue of the Mergers and without
any action on the part of any party hereto or any other Person, the following shall occur:
(a) SPAC
Class B Conversion. Immediately prior to the First Effective Time, each SPAC Class B Ordinary Share shall be automatically
converted into one SPAC Class A Ordinary Share in accordance with the terms of the SPAC Charter (such automatic conversion, the
“SPAC Class B Conversion”) and each SPAC Class B Ordinary Share shall no longer be issued and outstanding
and shall be cancelled, and each former holder of SPAC Class B Ordinary Shares shall thereafter cease to have any rights with respect
to such shares.
(b) SPAC
Units. At the First Effective Time, each SPAC Unit outstanding immediately prior to the First Effective Time shall be automatically
detached and the holder thereof shall be deemed to hold one SPAC Class A Ordinary Share and one-third of a SPAC Warrant in accordance
with the terms of the applicable SPAC Unit (the “Unit Separation”), which underlying SPAC Securities shall be adjusted
in accordance with the applicable terms of this Section 2.3; provided that no fractional SPAC Warrant will be
issued in connection with the Unit Separation such that if a holder of SPAC Units would be entitled to receive a fractional SPAC Warrant
upon the Unit Separation, the number of SPAC Warrants to be issued to such holder upon the Unit Separation shall be rounded down to the
nearest whole number of SPAC Warrants.
(c) SPAC
Ordinary Shares. Immediately following the Unit Separation in accordance with Section 2.3(b), (i) each SPAC Class A
Ordinary Share (which, for the avoidance of doubt, includes the SPAC Class A Ordinary Shares (A) issued in connection with
the SPAC Class B Conversion and (B) held as a result of the Unit Separation) issued and outstanding immediately prior to the
First Effective Time (other than any SPAC Shares referred to in Section 2.3(e), Redeeming SPAC Shares, Dissenting SPAC Shares
or any SPAC Shares held by the Founder Shareholders) shall automatically be cancelled and cease to exist in exchange for the right to
receive one Company ADS; and (ii) each SPAC Share issued and outstanding immediately prior to the First Effective Time held by the
Founder Shareholders shall automatically be cancelled and cease to exist in exchange for the right to receive one Company Ordinary Share.
As of the First Effective Time, each SPAC Shareholder shall cease to have any other rights in and to such SPAC Shares, except as expressly
provided herein.
(d) Exchange
of SPAC Warrants. Each SPAC Warrant (which, for the avoidance of doubt, includes the SPAC Warrants held as a result of the Unit Separation)
outstanding immediately prior to the First Effective Time shall cease to be a warrant with respect to SPAC Ordinary Shares and be assumed
by the Company and converted into a warrant to purchase one Company Ordinary Share in the form of Company ADS (each, a “Company
Warrant”). Each Company Warrant shall continue to have and be subject to substantially the same terms and conditions as were
applicable to such SPAC Warrant immediately prior to the First Effective Time (including any repurchase rights and cashless exercise
provisions) in accordance with the provisions of the Assignment, Assumption and Amendment Agreement.
(e) SPAC
Treasury Shares. Notwithstanding Section 2.3(c) above or any other provision of this Agreement to the contrary,
if there are any SPAC Shares that are owned by SPAC as treasury shares or any SPAC Shares owned by any direct or indirect Subsidiary
of SPAC immediately prior to the First Effective Time, such SPAC Shares shall be cancelled and shall cease to exist without any conversion
thereof or payment or other consideration therefor.
(f) Redeeming
SPAC Shares. Each Redeeming SPAC Share issued and outstanding immediately prior to the First Effective Time shall automatically be
cancelled and cease to exist and shall thereafter represent only the right of the holder thereof to be paid a pro rata share of the SPAC
Shareholder Redemption Amount in accordance with the SPAC Charter.
(g) Dissenting
SPAC Shares. Each Dissenting SPAC Share issued and outstanding immediately prior to the First Effective Time held by a Dissenting
SPAC Shareholder shall automatically be cancelled and cease to exist in accordance with Section 2.7(a) and shall
thereafter represent only the right of such Dissenting SPAC Shareholder to be paid the fair value of such Dissenting SPAC Share and such
other rights as are granted by the Cayman Act.
(h) Merger
Sub 1 Share. At the First Effective Time, each ordinary share, par value $0.00001 per share, of Merger Sub 1, issued and outstanding
immediately prior to the First Effective Time shall remain issued and outstanding and continue existing and constitute the only issued
and outstanding share capital of Surviving Entity 1 and shall not be affected by the First Merger.
(i) Surviving
Entity 1 Share; Merger Sub 2 Share. At the Second Effective Time, (i) each ordinary share of Surviving Entity 1 that is issued
and outstanding immediately prior to the Second Effective Time will be automatically cancelled and cease to exist without any payment
therefor, and (ii) each ordinary share, par value $0.00001 per share, of Merger Sub 2 issued and outstanding immediately prior to
the Second Effective Time shall remain issued and outstanding and continue existing and constitute the only issued and outstanding share
capital of Surviving Entity 2 and shall not be affected by the Second Merger.
Section 2.4. Closing
Deliverables.
(a) No
later than two (2) Business Days prior to the Closing Date:
(i) SPAC
shall deliver to the Company written notice (the “SPAC Closing Statement”) setting forth: (i) the amount of cash
in the Trust Account (after deducting the SPAC Shareholder Redemption Amount) as of the Closing Date, (ii) the amount of Aggregate
Cash Proceeds, (iii) the number of SPAC Class A Ordinary Shares, SPAC Class B Ordinary Shares and SPAC Warrants to be
issued and outstanding as of immediately prior to the Closing after giving effect to the Unit Separation and any valid exercise of SPAC
Shareholder Redemption Right, (iv) the calculation of the Merger Consideration pursuant to Section 2.3(c), and (v) SPAC’s
good faith estimate of the amount of SPAC Transaction Expenses, including the respective amounts and wire transfer instructions for the
payment thereof; provided, that SPAC will consider in good faith the Company’s comments to the SPAC Closing Statement, and
if any adjustments are made to the SPAC Closing Statement prior to the Closing, such adjusted SPAC Closing Statement shall thereafter
become the SPAC Closing Statement for all purposes of this Agreement; and
(ii) The
Company shall deliver to SPAC written notice (the “Company Closing Statement”) setting forth: (i) the number
of Company Ordinary Shares to be issued and outstanding as of immediately prior to the Closing after giving effect to the Capital Restructuring,
and (ii) the Company’s good faith estimate of the amount of Company Transaction Expenses, including the respective amounts
and wire transfer instructions for the payment thereof; provided, that the Company will consider in good faith SPAC’s comments
to the Company Closing Statement, and if any adjustments are made to the Company Closing Statement prior to the Closing, such adjusted
Company Closing Statement shall thereafter become the Company Closing Statement for all purposes of this Agreement.
(b) At
the Closing,
(i) SPAC
shall deliver or cause to be delivered to the Company, a certificate signed by an authorized director or officer of SPAC, dated as of
the Closing Date, certifying that the conditions specified in Section 8.3(a), Section 8.3(b) and Section 8.3(c) have
been fulfilled;
(ii) The
Company shall deliver or cause to be delivered to SPAC, a certificate signed by an authorized director or officer of the Company, dated
as of the Closing Date, certifying that the conditions specified in Section 8.2(a) and Section 8.2(b) have
been fulfilled;
(iii) The
Company shall deliver or cause to be delivered to SPAC, evidence of the appointment of the director(s) designated by SPAC to the
board of directors of the Company pursuant to Section 5.6;
(iv) SPAC
or Surviving Entity 2, as applicable, shall pay, or cause the Trustee to pay at the direction and on behalf of Surviving Entity 2, by
wire transfer of immediately available funds from the Trust Account (i) as and when due all amounts payable on account of the SPAC
Shareholder Redemption Amount to former SPAC Shareholders pursuant to their exercise of the SPAC Shareholder Redemption Right, (ii) (A) all
accrued and unpaid Company Transaction Expenses, as set forth on the Company Closing Statement, and (B) all accrued and unpaid SPAC
Transaction Expenses, as set forth on the SPAC Closing Statement, and (iii) immediately thereafter, all remaining amounts then available
in the Trust Account (if any) (the “Remaining Trust Fund Proceeds”) to a bank account designated by Surviving Entity
2 for its immediate use, subject to this Agreement and the Trust Agreement, and thereafter, the Trust Account shall terminate, except
as otherwise provided in the Trust Agreement.
(v) If
a bank account of the Company or any of its Subsidiaries is designated by Surviving Entity 2 under Section 2.4(b)(iv), the
payment of the Remaining Trust Fund Proceeds to such bank account may be treated as (i) an advance from Surviving Entity 2 to the
Company or such Subsidiary of the Company, or (ii) a dividend from Surviving Entity 2 to the Company, in each case, as determined
by Surviving Entity 2 in its sole discretion, subject to applicable Laws.
Section 2.5. Establishment
of ADS Facility; Distribution of Merger Consideration.
(a) Prior
to the First Effective Time, the Company shall cause a sponsored American depositary share facility for the Company Ordinary Shares (the
“ADS Facility”) to be established with a reputable depositary bank reasonably acceptable to SPAC (such bank or any
successor depositary bank, the “Depositary Bank”) for the purpose of issuing and distributing the Company ADSs, including
specifically and without limitation (i) entering into a customary deposit agreement with the Depositary Bank (the “Deposit
Agreement”) establishing the ADS Facility, to be effective as of the First Effective Time, in form and substance reasonably
acceptable to SPAC, and (ii) filing with the SEC a registration statement on Form F-6 relating to the registration under the
Securities Act for the issuance of the Company ADSs (the “Form F-6”). The Company shall use its reasonable best
efforts to cause the Depositary Bank to file such Form F-6 with the SEC prior to or in conjunction with the declaration of the effectiveness
of the Proxy/Registration Statement by the SEC.
(b) SPAC
shall, as promptly as reasonably practicable following SPAC’s receipt of the final determination of such number from the Trustee,
notify the Company in writing of the number of the Redeeming SPAC Shares. As soon as practicable upon receipt of the foregoing notification
from SPAC and in any event prior to the First Effective Time, the Company shall (i) allot and issue, or cause to be allotted and
issued, to the Depositary Bank (or its custodian), credited as fully paid and free of all Encumbrance, such number of Company Ordinary
Shares equal to the aggregate number of Company ADSs to be issued to the applicable holders of SPAC Shares pursuant to Section 2.3(c) (such
holder, the “SPAC ADS Recipients”), and (ii) deposit or cause to be deposited with the Depositary Bank (or its
custodian) such Company Ordinary Shares representing the aggregate number of such Company ADSs to be issued for the benefit of the SPAC
ADS Recipients, for exchange in accordance with this Article II, and (iii) the Depositary Bank shall be authorized to
issue and distribute the ADS Merger Consideration to the SPAC ADS Recipients in accordance with this Agreement and the Deposit Agreement
and an instruction provided by the Company.
(c) At
or prior to the First Effective Time, the Company shall take all corporate actions necessary to reserve for future issuance, and shall
maintain such reservation for so long as any of the Company Warrants remain outstanding, a sufficient number of Company Ordinary Shares
for delivery to the Depositary Bank upon the exercise of such Company Warrants. After the First Effective Time, upon any exercise of
the Company Warrants by the holders thereof (the “Exercising Warrantholders”), the Company shall, in accordance with
the Warrant Agreement (as amended by the Assignment, Assumption and Amendment Agreement), promptly (i) allot and issue, or cause
to be allotted and issued, and deposit with the Depositary Bank (or its custodian) such number of Company Ordinary Shares underlying
such exercised Company Warrants credited as fully paid and free of all Encumbrance, and (ii) instruct the Depositary Bank to issue,
register and deliver a number of Company ADSs equal to such Company Ordinary Shares underlying such exercised Company Warrants to the
Exercising Warrantholders in accordance with the Warrant Agreement (as amended by the Assignment, Assumption and Amendment Agreement)
and the Deposit Agreement; provided, that the Company shall deliver to the Depositary Bank its written consent to the delivery
of Company ADSs representing any of those Company Ordinary Shares underlying any exercised Company Warrants that are Restricted Securities
(to be defined in the Deposit Agreement), which consent will be subject to the conditions that those Company ADSs will not be eligible
for holding through DTC and those Company ADSs will be subject to a legend describing the applicable transfer restrictions. The Company
ADSs are at all times subject to the terms of the Deposit Agreement.
(d) Following
the First Effective Time, (i) the Depositary Bank shall distribute the ADS Merger Consideration to the SPAC ADS Recipients in accordance
with this Section 2.5 and the Deposit Agreement; and (ii) the Company shall distribute the Ordinary Share Merger Consideration
to the Founder Shareholders pursuant to Section 2.3(c).
(e) The
Company ADSs (other than the Company ADSs representing those Company Ordinary Shares that are Restricted Securities (to be defined in
the Deposit Agreement)) shall be accepted into the DTC, and each of the SPAC ADS Recipients and Exercising Warrantholders that holds
Company ADSs shall be entitled to receive a book-entry authorization representing the number of Company ADSs that such holder has the
right to receive pursuant to this Agreement, the Warrant Agreement (as amended by the Assignment, Assumption
and Amendment Agreement), and the terms of the Company Warrant, as applicable.
(f) The
Depositary Bank will hold the Company Ordinary Shares from time to time in accordance with the terms of the Deposit Agreement, and holders
of Company ADSs will have the rights with respect to the Company Ordinary Shares underlying the Company ADSs they hold that are specified
in the Deposit Agreement.
(g) From
and after the First Effective Time, there shall be no further registration of transfers of SPAC Shares thereafter on the records of SPAC.
If, after the First Effective Time, any SPAC Shares are presented to the Company, Surviving Entity 2 or the Depositary Bank for any reason,
they shall be cancelled and exchanged for the applicable portion of the Merger Consideration with respect thereto in accordance with
the procedures set forth in, or as otherwise contemplated by, this Article II.
Section 2.6. Further
Assurances. If, at any time after the First Effective Time, any further action is necessary, proper or advisable to carry out the
purposes of this Agreement, the Parties (or their respective designees) shall take all such actions as are necessary, proper or advisable
under applicable Laws, so long as such action is consistent with and for the purposes of implementing the provisions of this Agreement.
Section 2.7. Dissenter’s
Rights.
(a) Subject
to Section 2.2(c)(ii) but notwithstanding any other provision of this Agreement to the contrary and to the extent available
under the Cayman Act, SPAC Shares that are issued and outstanding immediately prior to the First Effective Time and that are held by
SPAC Shareholders who shall have validly exercised their dissenters’ rights for such SPAC Shares in accordance with Section 238
of the Cayman Act and otherwise complied with all of the provisions of the Cayman Act relevant to the exercise and perfection of dissenters’
rights (the “Dissenting SPAC Shares,” and the holders of such Dissenting SPAC Shares being the “Dissenting
SPAC Shareholders”) shall not be converted into, and such Dissenting SPAC Shareholders shall have no right to receive, the
applicable Merger Consideration unless and until such Dissenting SPAC Shareholder fails to perfect or withdraws or otherwise loses his,
her or its right to dissenters’ rights under the Cayman Act. The SPAC Shares owned by any SPAC Shareholder who fails to perfect
or who effectively withdraws or otherwise loses his, her or its dissenters’ rights pursuant to the Cayman Act shall cease to be
Dissenting SPAC Shares and shall thereupon be deemed to have been converted into, and to have become exchangeable for, as of the First
Effective Time, the right to receive the applicable Merger Consideration, without any interest thereon in accordance with Section 2.3(c).
(b) Prior
to the Closing, SPAC shall give the Company (i) prompt written notice of any demands for dissenters’ rights received by SPAC
from SPAC Shareholders and any withdrawals of such demands and (ii) the opportunity to direct all negotiations and proceedings with
respect to any such notice or demand for dissenters’ rights under the Cayman Act. SPAC shall not, except with the prior written
consent of the Company, make any offers or payment or otherwise agree or commit to any payment or other consideration with respect to
any exercise by a SPAC Shareholder of its rights to dissent from the First Merger or any demands for appraisal or offer or agree or commit
to settle or settle any such demands or approve any withdrawal of any such dissenter rights or demands.
Section 2.8. Withholding.
Notwithstanding anything to the contrary in this Agreement, each of the Parties (and their respective Affiliates and Representatives)
shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement such amount as it is required
to deduct and withhold with respect to the making of such payment under the Code, or any provision of state, local or non-U.S. Tax Law.
Other than in respect of amounts subject to compensatory withholding, each of the Parties (or their respective Affiliates or Representatives)
shall use commercially reasonable efforts to notify the Person in respect of whom such deduction or withholding is expected to be made
at least five (5) Business Days prior to making any such deduction or withholding, which notice shall be in writing and include
the amount of and basis for such deduction or withholding. Each of the Parties (or their Affiliates or Representatives), as applicable,
shall use commercially reasonable efforts to cooperate with such Person to reduce or eliminate any such requirement to deduct or withhold
to the extent permitted by Law. To the extent that amounts are so withheld by the Parties (or their Affiliates or Representatives), as
the case may be, and timely paid over to the appropriate taxing authority, such withheld amounts shall be treated for all purposes of
this Agreement as having been paid to the Person in respect of which such deduction and withholding was made.
Article III
REPRESENTATIONS
AND WARRANTIES OF THE COMPANY
Except
as set forth in the disclosure letter delivered to SPAC by the Company on the date of this Agreement (the “Company Disclosure
Letter”), the Company represents and warrants to SPAC as follows, (a) in respect of the entirety of this Article III
(other than Section 3.1, Section 3.5 and Section 3.6), as of January 31, 2023, and (b) solely
in respect of Section 3.1, Section 3.5 and Section 3.6, as of October 11, 2023 (in each case of clauses
(a) and (b), except for any such representation and warranty (or part thereof) that expressly speaks as of a particular date or
period of time, in which case as of such particular date or period of time):
Section 3.1. Organization,
Good Standing and Qualification. The Company (a) is an exempted company duly incorporated, validly existing and in good standing
under the Laws of the Cayman Islands, (b) has requisite corporate power and authority to own and operate its properties and assets,
to carry on its business as presently conducted and contemplated to be conducted, and (c) is duly licensed or qualified and in good
standing as a foreign or extra-provincial corporation (or other entity, if applicable) in each jurisdiction in which its ownership of
property or the character of its activities is such as to require it to be so licensed or qualified or in good standing, as applicable,
except in the case of clause (c), where the failure to be so licensed or qualified or in good standing would not be material to the business
of the Company and its Subsidiaries, taken as a whole. Prior to the execution of the Original Merger Agreement, true and accurate copies
of the Company Charter, the Shareholders Agreement, and any Organizational Documents of the Merger Subs, each as in effect as of the
date of the Original Merger Agreement, have been made available by or on behalf of the Company to SPAC and each as so delivered is in
full force and effect. Neither the Company nor any of the Merger Subs is in default of any term or provision of such Organizational Documents
in any material respect.
Section 3.2. Subsidiaries.
(a) A
complete list, as of the date of this Agreement, of each Subsidiary of the Company and its jurisdiction of incorporation, formation or
organization, outstanding Equity Securities, and holders of Equity Securities, as applicable, is set forth on Section 3.2(a) of
the Company Disclosure Letter. Except as set forth in Section 3.2(a) of the Company Disclosure Letter, the Company does
not directly or indirectly own any equity or similar interests in, or any interest convertible into or exchangeable or exercisable for
any equity or similar interest in, any other corporation, company, partnership, joint venture or business association or other entity.
Each Subsidiary of the Company has been duly organized and is validly existing and in good standing under the Laws of its jurisdiction
of incorporation and has requisite corporate power and authority to own and operate its properties and assets, to carry on its business
as presently conducted and contemplated to be conducted. Each Subsidiary of the Company is duly licensed or qualified and in good standing
(to the extent such concept is applicable in such Subsidiary’s jurisdiction of formation) as a foreign or extra-provincial corporation
(or other entity, if applicable) in each jurisdiction in which its ownership of property or the character of its activities is such as
to require it to be so licensed or qualified or in good standing (to the extent such concept is applicable in such Subsidiary’s
jurisdiction of formation), as applicable, except where the failure to be so licensed or qualified or in good standing would not be material
to the business of the Company and its Subsidiaries, taken as a whole.
(b) All
the Control Documents have been duly executed and delivered and constitute legally binding obligations of the parties hereto in accordance
with their respective terms. As a result, Wuhan Lotus Technology has established effective Control over Wuhan Lotus E-Commerce through
the Control Documents. The equity pledge by the equity holders of Wuhan Lotus E-Commerce in favor of Wuhan Lotus Technology pursuant
to the Control Documents has been registered with Governmental Authorities (the “Equity Pledge Registration”). The
Equity Pledge Registration remains effective and valid, and there is no Encumbrance held by any Person on the Equity Securities in Wuhan
Lotus E-Commerce other than the Equity Pledge Registration.
Section 3.3. Capitalization
of the Company.
(a) As
of the date of this Agreement, the authorized share capital of the Company is $50,000 divided into 5,000,000,000 shares of $0.00001 par
value each, comprised of (x) 4,691,947,371 ordinary shares of the Company, par value of $0.00001 each, of which 2,142,922,222 ordinary
shares are issued and outstanding as of the date of this Agreement and (y) 308,052,629 Preferred Shares, of which (i) 184,596,297
shares are designated Series Pre-A Preferred Shares, all of which are issued and outstanding as of the date of this Agreement, and
(ii) 123,456,332 shares are designated Series A Preferred Shares, all of which are issued and outstanding as of the date of
this Agreement.
(b) Set
forth in Section 3.3(b) of the Company Disclosure Letter are (i) a true and correct list of each holder of Company
Shares and the number and class of Company Shares held by each such holder as of the date hereof, and (ii) the number and class
of securities (if applicable) of all of the issued and outstanding Equity Securities (other than the Company Shares) of the Company as
of the date hereof. Except as set forth in Section 3.3(b) of the Company Disclosure Letter, there are no other Equity
Securities of the Company issued or outstanding as of the date of this Agreement. All of the issued and outstanding Company Shares (w) have
been duly authorized and validly issued and allotted and are fully paid and non-assessable; (x) have been offered, sold and
issued by the Company in compliance with applicable Law, including the Cayman Act, U.S. federal and state securities Laws, and all requirements
set forth in (1) the Company Charter and (2) any other applicable Contracts governing the issuance or allotment of such securities
to which the Company is a party or otherwise bound; and (y) are not subject to, nor have they been issued in violation of, any Encumbrance,
purchase option, call option, pre-emptive right, subscription right or any similar right under any provision of any applicable Law, the
Company Charter, the Shareholders Agreement or any other Contract, in any such case to which the Company is a party or otherwise bound.
(c) All
Company Options outstanding as of the date of this Agreement were granted pursuant to the ESOP and an option award agreement, in each
case, in substantially the forms previously made available to SPAC.
(d) Except
as otherwise set forth in this Section 3.3 or on Section 3.3(d) of the Company Disclosure Letter or as contemplated
by this Agreement or the other Transaction Documents, there are no outstanding subscriptions, options, warrants, rights or other securities
(including debt securities) exercisable or exchangeable for Company Shares, any other commitments, calls, conversion rights, rights of
exchange or privilege (whether pre-emptive, contractual or by matter of Law), plans or other agreements of any character providing for
the issuance of additional shares, the sale of treasury shares or other Equity Securities of the Company, or for the repurchase or redemption
by the Company of shares or other Equity Securities of the Company or the value of which is determined by reference to shares or other
Equity Securities of the Company, and there are no voting trusts, proxies or agreements of any kind which may obligate the Company to
issue, purchase, register for sale, redeem or otherwise acquire any Company Shares or other Equity Securities of the Company.
(e) The
Company Ordinary Shares (including those to be issued in respect of the Company Warrants), when issued in accordance with the terms hereof,
shall be duly authorized and validly issued, fully paid and non-assessable and issued in compliance with all applicable federal and state
securities Laws, and not subject to, and shall be free and clear of all Encumbrances, except for such restrictions arising under any
provision of any applicable Law, the Organizational Documents of the Company or any applicable Transaction Document.
Section 3.4. Capitalization
of Subsidiaries.
(a) The
share capital of each Subsidiary of the Company as of the date of this Agreement are set forth on Section 3.4(a) of
the Company Disclosure Letter. Except as set forth on Section 3.4(a) of the Company Disclosure Letter or as contemplated
by this Agreement or the other Transaction Documents, the outstanding share capital or other Equity Securities of each of the Company’s
Subsidiaries (i) have been duly authorized and validly issued and allotted, and are, to the extent applicable, fully paid and non-assessable;
(ii) have been offered, sold, issued and allotted in compliance with applicable Law, including federal and state securities Laws,
and all requirements set forth in (1) the Organizational Documents of each such Subsidiary, and (2) any other applicable Contracts
governing the issuance or allotment of such securities to which such Subsidiary is a party or otherwise bound; and (iii) are not
subject to, nor have they been issued in violation of, any purchase option, call option, right of first refusal, pre-emptive right, subscription
right or any similar right under any provision of any applicable Law, the Organizational Documents of each such Subsidiary or any other
Contract, in any such case to which each such Subsidiary is a party or otherwise bound.
(b) Except
as contemplated by this Agreement or the other Transaction Documents, the Company owns, directly or indirectly through its Subsidiaries,
of record and beneficially all the issued and outstanding Equity Securities of such Subsidiaries free and clear of any Encumbrances other
than Permitted Encumbrances.
(c) Except
as set forth in Section 3.4(a) of the Company Disclosure Letter and as contemplated by this Agreement or the other Transaction
Documents, there are no outstanding subscriptions, options, warrants, rights or other securities (including debt securities) of any such
Subsidiary exercisable or exchangeable for any Equity Securities of such Subsidiary, any other commitments, calls, conversion rights,
rights of exchange or privilege (whether pre-emptive, contractual or by matter of Law), plans or other agreements of any character providing
for the issuance by any such Subsidiary of additional shares, the sale of treasury shares or other Equity Securities, or for the repurchase
or redemption by such Subsidiary of shares or other Equity Securities of such Subsidiary the value of which is determined by reference
to shares or other Equity Securities of such Subsidiary, and there are no voting trusts, proxies or agreements of any kind which may
obligate any such Subsidiary to issue, purchase, register for sale, redeem or otherwise acquire any of its Equity Securities.
Section 3.5. Authorization.
(a) Other
than the Company Shareholders’ Approval, each of the Company and the Merger Subs has all corporate power, and authority to (i) enter
into, execute and deliver this Agreement and each of the other Transaction Documents to which it is or will be a party, and (ii) consummate
the Transactions and perform all of its obligations hereunder and thereunder. The execution and delivery of this Agreement and the other
Transaction Documents to which the Company or any Merger Sub is a party and the consummation of Transactions have been duly and validly
authorized and approved by the Company Board, and the board of directors of each Merger Sub, and other than the Company Shareholders’
Approval, no other company or corporate proceeding on the part of the Company or either Merger Sub is necessary to authorize this Agreement
and the other Transaction Documents to which the Company or either Merger Sub is a party and to consummate the transactions contemplated
hereby and thereby. This Agreement has been, and on or prior to the Closing, the other Transaction Documents to which the Company or
either Merger Sub is a party will be, duly and validly executed and delivered by the Company or either Merger Sub, as applicable, and,
assuming due and valid authorization, execution and delivery by each other party hereto and thereto, this Agreement constitutes, and
on or prior to the Closing, the other Transaction Documents to which the Company or either Merger Sub is a party will constitute, a legal,
valid and binding obligation of the Company or either Merger Sub, as applicable, enforceable against the Company or either Merger Sub,
as applicable, in accordance with its terms, except (a) as limited by applicable bankruptcy, insolvency, reorganization, moratorium,
and other applicable Laws now or hereafter in effect of general application affecting enforcement of creditors’ rights generally,
and (b) as limited by applicable Laws relating to the availability of specific performance, injunctive relief, or other equitable
remedies (collectively, the “Enforceability Exceptions”).
(b) The
Company Shareholders’ Approval are the only votes and approvals of holders of Company Shares and other Equity Securities of the
Company necessary in connection with execution by the Company of this Agreement and the other Transaction Documents to which the Company
is a party and the consummation of the Transactions.
(c) On
or prior to the date of the Original Merger Agreement, the Company Board has duly adopted resolutions (i) determining that the Original
Merger Agreement and the other Transaction Documents to which the Company is a party and the Transactions would be in the best interests
of the Company and (ii) authorizing and approving the execution, delivery and performance by the Company of the Original Merger
Agreement and the other Transaction Documents to which the Company is a party and the consummation of the Transactions. On or prior to
the date of this Agreement, the Company Board has duly adopted resolutions authorizing and approving the execution and delivery of such
amendments and additions to the Original Merger Agreement and the other Transaction Documents to which the Company is a party as the
authorized persons deem necessary or appropriate.
(d) On
or prior to the date of the Original Merger Agreement, the sole director of Merger Sub 1 has (i) determined that it is desirable
and in the commercial interests of Merger Sub 1 to enter into the Original Merger Agreement and to consummate the First Merger and the
other Transactions, (ii) approved and declared desirable the Original Merger Agreement (with such amendments and additions thereto
as the sole director approves in its sole discretion) and the First Plan of Merger and the execution, delivery and performance of the
Original Merger Agreement (with such amendments and additions thereto as the sole director approves in its sole discretion) and the First
Plan of Merger and the consummation of the Transactions. On or prior to the date of this Agreement, the Company, in its capacity as the
sole shareholder of Merger Sub 1, has approved the First Plan of Merger by a written resolution;
(e) On
or prior to the date of the Original Merger Agreement, the sole director of Merger Sub 2 has (i) determined that it is desirable
and in the commercial interests of Merger Sub 2 to enter into the Original Merger Agreement and to consummate the Second Merger and the
other Transactions, (ii) approved and declared desirable the Original Merger Agreement (with such amendments and additions thereto
as the sole director approves in its sole discretion) and the Second Plan of Merger and the execution, delivery and performance of the
Original Merger Agreement (with such amendments and additions thereto as the sole director approves in its sole discretion) and the Second
Plan of Merger and the consummation of the Transactions. On or prior to the date of this Agreement, the Company, in its capacity as the
sole shareholder of Merger Sub 2 and in its capacity as the sole shareholder of Surviving Entity 1 at the time of the Second Merger,
respectively, has approved the Second Plan of Merger by a written resolution.
Section 3.6. Consents;
No Conflicts. Assuming the representations and warranties in Article IV are true and correct, except (a) for the
Company Shareholders’ Approval, (b) for the registration or filing with the Cayman Registrar, the SEC or applicable state
blue sky or other securities laws filings with respect to the Transactions and the publication of notification of the Mergers in the
Cayman Islands Government Gazette pursuant to the Cayman Act and (c) for such other filings, notifications, notices, submissions,
applications or consents the failure of which to be obtained or made would not, individually or in the aggregate, have, or reasonably
be likely to have, a material effect on the ability of the Company to enter into and perform its obligations under this Agreement, all
filings, notifications, notices, submissions, applications, or consents from or with any Governmental Authority or any other Person required
in connection with the valid execution, delivery and performance of this Agreement and the other Transaction Documents, and the consummation
of the Transactions, in each case on the part of the Company, have been duly obtained or completed (as applicable) and are in full
force and effect. The execution, delivery and performance of this Agreement and the other Transaction Documents to which it is or will
be a party by the Company does not, and the consummation by the Company of the transactions contemplated hereby and thereby will not,
assuming the representations and warranties in Article IV are true and correct, and except for the matters referred to in
clauses (a) through (c) of the immediately preceding sentence, (i) result in any violation of, be in conflict
with, or constitute a default under, require any consent under, or give any Person rights of termination, amendment, acceleration (including
acceleration of any obligation of any Group Company) or cancellation under, (A) any Governmental Order, (B) any provision
of the Organizational Documents of any Group Company, each as currently in effect, (C) any applicable Law, (D) any Company
Contract, (E) any Required Governmental Authorization, or (ii) result in the creation of any Encumbrance upon any of the properties
or assets of any Group Company other than any restrictions under federal or state securities laws, this Agreement, the Company Charter
and Permitted Encumbrances, except in the case of sub-clauses (A), (C), (D) and (E) of clause (i) or clause (ii),
as would not have a Company Material Adverse Effect.
Section 3.7. Compliance
with Laws; Consents; Permits. Except as disclosed in Section 3.7 of the Company Disclosure Letter:
(a) Except
as would not be or reasonably be expected to be material to the business of the Company and its Subsidiaries, taken as a whole, in the
three (3) years prior to the date hereof, (i) the Company and its Subsidiaries are, and have been, in compliance with all applicable
Laws; (ii) neither the Company nor any of its Subsidiaries, to the Knowledge of the Company, is or has been subject to any investigation
by or for any Governmental Authority with respect to any violation of any applicable Laws.
(b) Except
as set forth in Section 3.7 of the Company Disclosure Letter, in the three (3) years prior to the date hereof, neither
the Company nor any of its Subsidiaries has received any letter or other written communication from, and, to the Knowledge of the Company,
there has not been any public notice of a type customary as a form of notification of such matters in the jurisdiction by, any Governmental
Authority threatening in writing or providing notice of (i) the revocation or suspension of any Required Governmental Authorizations
issued to the Company or any of its Subsidiaries, (ii) the need for compliance or remedial actions in respect of the activities
carried out by the Company or any of its Subsidiaries, or (iii) any alleged or finding of any violation of Law, in each case, except
as would not reasonably be expected to be material to the business of the Company and its Subsidiaries, taken as a whole.
(c) Neither
the Company nor any of its Subsidiaries is engaged in any proceedings, demands, inquiries, hearings, or investigations, before any court,
statutory or governmental body, department, board or agency relating to applicable Anti-Corruption Laws, Anti-Money Laundering Laws or
Sanctions, and to the Knowledge of the Company, no such proceeding, demand, inquiry, investigation or hearing has been threatened in
writing.
(d) Neither
the Company, any of its Subsidiaries, any of their respective directors, or officers, nor to the Knowledge of the Company, any employees,
agents or any other Persons acting for or on behalf of the Company or any of its Subsidiaries has at any time in the three (3) years
prior to the date hereof: (i) made any bribe, influence payment, kickback, payoff, or any other type of payment (whether tangible
or intangible) or provided any benefits that would be unlawful under any applicable anti-bribery or anti-corruption (governmental
or commercial) laws (including, for the avoidance of doubt, any guiding, detailing or implementing regulations), including Laws
that prohibit the corrupt payment, offer, promise or authorization of the payment or transfer of anything of value (including gifts or
entertainment), directly or indirectly, to any Government Official or commercial entity to obtain a business advantage, such as the Foreign
Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, the Anti-Corruption Act (As Revised) of the Cayman Islands, or
any other local or foreign anti-corruption or anti-bribery Law, as may be applicable (collectively, “Anti-Corruption Laws”);
(ii) been in violation of any Anti-Corruption Law, offered, paid, promised to pay, or authorized any payment or transfer of anything
of value, directly or indirectly, to any person for the purpose of (A) influencing any act or decision of any Government Official
in his official capacity, (B) inducing a Government Official to do or omit to do any act in relation to his lawful duty, (C) securing
any improper advantage, (D) inducing a Government Official to influence or affect any act, decision or omission of any Governmental
Authority, or (E) assisting the Company or any of its Subsidiaries, or any agent or any other Person acting for or on behalf of
the Company or any of its Subsidiaries, in obtaining or retaining business for or with, or in directing business to, any Person;
or (iii) accepted or received any contributions, payments, gifts, or expenditures that would be unlawful under any Anti-Corruption
Laws.
(e) Neither
the Company, any of its Subsidiaries, any of their respective directors or officers, nor to the Knowledge of the Company, any employees
or agents acting for or on behalf of the Company or any of its Subsidiaries, has at any time in the three (3) years prior to the
date hereof been found by a Governmental Authority to have violated any Anti-Corruption Laws, Anti-Money Laundering Laws or Sanctions,
or is subject to any indictment or any government investigation with respect to any Anti-Corruption Laws, Anti-Money Laundering Laws
or Sanctions.
(f) Neither
the Company, any of its Subsidiaries, any of their respective directors, or officers, nor to the Knowledge of the Company, any employees,
agents or any other Person acting for or on behalf of the Company or any of its Subsidiaries, is a Prohibited Person, and no Prohibited
Person has at any time in the three (3) years prior to the date hereof been given an offer to become an employee, officer, consultant
or director of the Company or any of its Subsidiaries. None of the Company nor any of its Subsidiaries has at any time in the three (3) years
prior to the date hereof conducted or agreed to conduct any business, or entered into or agreed to enter into any transaction with a
Prohibited Person or otherwise violated Sanctions.
(g) The
Company and its Subsidiaries have maintained a system of internal controls designed to reasonably prevent, detect, and deter violations
of Anti-Corruption Laws, Anti-Money Laundering Laws, and Sanctions.
(h) To
the Knowledge of the Company, no monies injected into the Company have been derived from unlawful activities or otherwise in violation
of Anti-Money Laundering Laws.
(i) Except
as set forth in Section 3.7(i) of the Company Disclosure Letter, each of the Group Companies has in effect all material
approvals, authorizations, clearances, licenses, registrations, permits or certificates of a Governmental Authority (each, a “Material
Permit”) that are required for such Group Company to own, lease or operate its properties and assets and to conduct its business
as currently conducted in all material respects. Except as set forth in Section 3.7(i) of the Company Disclosure Letter,
each of the Group Companies is in compliance with all Material Permits, except for the failure to comply with which would not, individually
or in the aggregate, be material to the business of the Company and its Subsidiaries, taken as a whole.
Section 3.8. Tax
Matters.
Except as set forth in Section 3.8
of the Company Disclosure Letter:
(a) All
material Tax Returns required to be filed by or with respect to each Group Company have been timely filed (taking into account any extensions) and
such Tax Returns are true, correct and complete in all material respects. All material Taxes due and payable by any Group Company have
been or will be timely paid, except with respect to matters being contested in good faith by appropriate proceeding and with respect
to which adequate reserves have been made in accordance with GAAP.
(b) No
material deficiencies for any Taxes that are currently outstanding with respect to any Tax Returns of a Group Company have been asserted
in writing by, and no written notice of any action, audit, assessment or other proceeding, in each case that is currently pending, with
respect to such Tax Returns or any Taxes of a Group Company has been received from, any Tax authority, and no dispute or assessment relating
to such Tax Returns or such Taxes with any such Tax authority is currently outstanding.
(c) Within
the past three (3) years, no material claim that is currently outstanding has been made in writing by any Governmental Authority
in a jurisdiction where a Group Company does not file Tax Returns of a particular type that such Group Company is or may be subject to
taxation of such particular type by that jurisdiction and the Company does not otherwise have Knowledge of any such claim.
(d) There
are no liens for material Taxes (other than such liens that are Permitted Encumbrances) upon the assets of the Company or its Subsidiaries.
(e) Except
as contemplated by this Agreement, the Transaction Documents, or the Transactions, the Company has not taken any action (nor permitted
any action to be taken), and is not aware of any fact or circumstance, that would reasonably be expected to prevent, impair or impede
the Intended Tax Treatment.
(f) The
Company does not expect that the Company will be treated as a PFIC for its current taxable year. Neither the Company nor any of its Subsidiaries
is subject to Tax in a country other than the country of its incorporation or formation solely by virtue of having a permanent establishment
or other place of business in such other country.
(g) The
Company and Merger Sub 1 each is and since its formation has been treated as a foreign corporation (within the meaning of the Code) for
U.S. federal and applicable state and local income Tax purposes. Merger Sub 2 has elected (or will elect, effective prior to the Closing)
to be treated as an entity which is disregarded as an entity separate from its owner (within the meaning of Section 301.7701-2 of
the Treasury Regulations) for U.S. federal and applicable state and local income Tax purposes and has not subsequently changed such classification.
(h) Each
Group Company is in compliance with all terms and conditions of any material Tax incentives, exemption, holiday or other material Tax
reduction agreement or order of a Governmental Authority applicable to a Group Company, and to the Knowledge of the Company the consummation
of the Transactions will not have any material adverse effect on the continued validity and effectiveness of any such material Tax incentives,
exemption, holiday or other material Tax reduction agreement or order.
Section 3.9. Financial
Statements.
(a) The
Company has made available to SPAC true and complete copies of the audited consolidated balance sheet of the Company and its Subsidiaries
as of December 31, 2021, and the related audited consolidated statements of income and profit and loss, and cash flows, for the
fiscal year then ended (the “Audited Financial Statements”).
(b) The
Company has made available to SPAC true and complete copies of the unaudited consolidated balance sheet of the Company and its Subsidiaries
as of September 30, 2022, and the related unaudited consolidated statements of income and profit and loss, and cash flows, for the
period then ended (the “Management Accounts” and together with the Audited Financial Statements, the “Company
Financial Statements”).
(c) The
Company Financial Statements delivered by the Company (i) have been prepared in accordance with the books and records of the Company
and its Subsidiaries, (ii) fairly present, in all material respects, the financial condition and the results of operations and cash
flow of the Company and its Subsidiaries on a consolidated basis as of the dates indicated therein and for the periods indicated therein,
except in the case of the Management Accounts, subject to (A) normal year-end adjustments and (B) the absence of footnotes
required under GAAP, and (iii) were prepared in accordance with GAAP applied on a consistent basis throughout the periods involved
(except as may be indicated in the notes thereto), except that in the case of the Management Accounts, subject to (A) normal year-end
adjustments and (B) the absence of footnotes required under GAAP. Any audited financial statements delivered in accordance with
Section 5.8 will, when so delivered, (A) be audited in accordance with the standards of the U.S. Public Company Accounting
Oversight Board and (B) comply in all material respects with the applicable accounting requirements and with the rules and
regulations of the SEC, the Exchange Act and the Securities Act applicable to a registrant, in effect as of the respective dates thereof
(including, to the extent applicable to the Company, Regulation S-X under the Securities Act).
(d) The
Company maintains a system of internal accounting controls which is reasonably sufficient to provide reasonable assurance that (i) transactions
are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary
to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets
is permitted only in accordance with management’s general or specific authorization and (iv) the recorded accountability for
assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
(e) In
the past three (3) years, none of the Company or any of its Subsidiaries nor, to the Knowledge of the Company, an independent auditor
of the Company or its Subsidiaries, has identified or been made aware in writing of (i) any significant deficiency or material weakness
in the system of internal accounting controls utilized by the Company and its Subsidiaries, (ii) any fraud, whether or not material,
that involves the Company’s or any Subsidiary’s management or other employees who have a role in the preparation of financial
statements or the internal accounting controls utilized by the Company and its Subsidiaries, or (iii) to the Knowledge of the Company,
any allegation, assertion or claim regarding any of the foregoing.
Section 3.10. Absence
of Changes. Except as disclosed in Section 3.10 of the Company Disclosure Letter, since December 31, 2021, (a) to
the date of this Agreement the Group Companies have operated their business in the Ordinary Course, (b) there has not been
any occurrence of any Event which would have a Company Material Adverse Effect, and (c) to the date of this Agreement none of the
Group Companies have sold, assigned, transferred, licensed, sublicensed, granted other rights (including covenant not to sue) under,
abandoned, permitted to lapse, or disposed of, or subject to any Encumbrance (other than Permitted Encumbrances), any material Intellectual
Property or material Business Data (other than licenses, sublicenses and covenants not to sue granted by Group Companies in the Ordinary
Course).
Section 3.11. Actions.
(a) There is no Action pending or, to the Knowledge of the Company, threatened in writing against or affecting the Company or any
of its Subsidiaries, or any of their respective directors or officers (solely in their capacity as such), and (b) there is no judgment
or award unsatisfied against the Company or any of its Subsidiaries, nor is there any Governmental Order in effect and binding on the
Company or any of its Subsidiaries or their respective directors or officers (solely in their capacity as such) or assets or properties,
except in each case, as would not, individually or in the aggregate, (i) have, or reasonably be expected to have, a material adverse
effect on the ability of the Company to enter into and perform its obligations contemplated hereby, or (ii) reasonably be expected
to be material to the business of the Company and its Subsidiaries, taken as a whole.
Section 3.12. Undisclosed
Liabilities. Neither the Company nor any of its Subsidiaries has any Liabilities, except for Liabilities (a) set forth in the
Audited Financial Statements that have not been satisfied since December 31, 2021, (b) that are Liabilities incurred since
December 31, 2021 in the Ordinary Course (none of which is a Liability for breach of contract, tort, infringement, misappropriation
or violation of Intellectual Property, or violation of Law), (c) that are executory obligations under any Contract to which the
Company or any of its Subsidiaries is a party or by which it is bound, (d) set forth in Section 3.12 of the Company
Disclosure Letter, (e) arising under this Agreement, the Original Merger Agreement or other Transaction Documents, (f) that
will be discharged or paid off prior to the Closing, or (g) which would not have a Company Material Adverse Effect.
Section 3.13. Material
Contracts and Commitments.
(a) Section 3.13(a) of
the Company Disclosure Letter sets forth a true and correct list of all Material Contracts as of the date of this Agreement. True and
complete copies of all Material Contracts, including all material amendments, modifications, supplements, exhibits and schedules and
addenda thereto, have been made available to SPAC.
(b) Except
for any Material Contract that will terminate upon the expiration of the stated term thereof prior to the Closing Date or the termination
of which is otherwise contemplated by this Agreement, each Material Contract is (A) in full force and effect and (B) represents
the legal, valid and binding obligations of the applicable Group Company which is a party thereto and, to the Knowledge of the Company,
represents the legal, valid and binding obligations of the counterparties thereto. Except as set forth in Section 3.13(b) of
the Company Disclosure Letter, and except, in each case, where the occurrence of such breach or default or failure to perform would not
be material to the business of the Company and its Subsidiaries, taken as a whole, (x) the applicable Group Company has duly performed
all of its material obligations under each such Material Contract to which it is a party to the extent such obligations to perform have
accrued, (y) no breach or default thereunder by the Group with respect thereto, or, to the Knowledge of the Company, any other party
or obligor with respect thereto, has occurred, and (z) no event has occurred that with notice or lapse of time, or both, would constitute
such a default or breach of such Material Contract by the Company or any of its Subsidiaries or, to the Knowledge of the Company, any
other party thereto, or would entitle any third party to prematurely terminate any Material Contract.
(c) Except
as set forth in Section 3.13(c) of the Company Disclosure Letter, none of the Group Companies has within the last twelve
(12) months provided to or received from the counterparty to any Material Contract any written notice or written communication to terminate,
or not renew, any Material Contract.
(d) Other
than in the Ordinary Course, none of the Top 10 Suppliers has within the twelve (12) months prior to the date hereof terminated or materially
changed, or given written or, to the Knowledge of the Company, oral notice that it intends to terminate or materially change any of its
business relationship with the Company or any of its Subsidiaries. There has been no material dispute or controversy or, to the Knowledge
of the Company, threatened material dispute or controversy in writing between the Company or any of its Subsidiaries, on the one hand,
and any Top 10 Suppliers, on the other hand.
Section 3.14. Title;
Properties.
(a) Section 3.14(a) of
the Company Disclosure Letter sets forth a true and accurate list of all Owned Real Properties. Except as set forth in Section 3.14(a) of
the Company Disclosure Letter, with respect to each parcel of Owned Real Property: (i) the
applicable Group Company has sole legal and beneficial entitlement to such Owned Real Property and has good, valid and marketable fee
title, free and clear of all Encumbrances (other than Permitted Encumbrances), (ii) such Group Company has in its possession and
under its control all of the land use right certificates, building ownership certificates, construction permits and other documents necessary
to prove its title to, and right to use and construct, such Owned Real Property and all such documents are legally binding and valid;
(iii) no Group Company is in breach or default under any land purchase agreement, construction agreement and other related agreements
in relation to such Owned Real Property; (iv) such Group Company is in physical possession and actual occupation of the whole of
such Owned Real Property on an exclusive basis and no part of such Owned Real Property is vacant or not subject to any leases, underleases,
tenancies, licenses or other agreements or arrangements; (v) neither the Company nor any of its Subsidiaries have leased or otherwise
granted to any Person the right to use or occupy such Owned Real Property or any portion thereof, and (vi) there are no options,
rights of first refusal or rights of first offer to purchase such Owned Real Property or any portion thereof or interest therein, in
each case except as would not have a Company Material Adverse Effect. No Group Company has received any written notice alleging a material
breach of any covenant, restriction, burden or stipulation from any person or Governmental Authority in relation to the occupation, planning,
construction or use of any Owned Real Property, nor has any Group Company been imposed of any penalty from Governmental Authority for
the occupation, planning, construction or use of any Owned Real Property.
(b) Each
of the Group Companies has good and valid title to all of the assets owned by it, whether tangible or intangible (including all
assets acquired thereby since September 30, 2022, but excluding any (i) Intellectual Property and Business Data (which are
addressed in Section 3.15), and (ii) tangible or intangible assets that have been disposed of since September 30,
2022 in the Ordinary Course), and in each case free and clear of all Encumbrances, other than Permitted Encumbrances.
(c) Except
as set forth in Section 3.14(c) of the Company Disclosure Letter, no Group Company owns or has ever owned or has a leasehold
interest in any real property other than as held pursuant to their respective leases or leasehold interests (including tenancies) in
such property (each Contract evidencing such interest, a “Company Lease”). Section 3.14(c) of the
Company Disclosure Letter sets forth as of the date of this Agreement each Company Lease and the address of the property demised under
each such Company Lease. Except as set forth in Section 3.14(c) of the Company Disclosure Letter, and except as would
not individually or in the aggregate, reasonably be expected to be material to the business of the Company and its Subsidiaries, taken
as a whole, (i) each Company Lease is in compliance with applicable Law, and (ii) all Governmental Orders required under applicable
Law in respect of any Company Lease have been obtained, including with respect to the operation of such property and conduct of business
on such property as now conducted by the applicable Group Company which is a party to such Company Lease.
(d) Each
Company Lease is a valid and binding obligation of the applicable Group Company, enforceable in accordance with its terms against such
Group Company, and to the Knowledge of the Company, each other party thereto, subject to the Enforceability Exceptions. There is no material
breach by the relevant Group Company under any Company Lease.
(e) To
the Knowledge of the Company, no Person or Governmental Authority has challenged, disputed, or threatened in writing to challenge or
dispute, a Group Company’s right to occupy, use or enjoy each Leased Real Property subject to the Company Leases as such Leased
Real Property is currently occupied, used or enjoyed.
(f) No
Group Company has received any written notice alleging a material breach of any covenant, restriction, burden or stipulation from any
person or Governmental Authority in relation to the existing use of any Leased Real Property, and to the Knowledge of the Company, no
circumstance exists which constitutes a breach of this type or nature.
Section 3.15. Intellectual
Property and Data Protection.
(a) Section 3.15(a)(1) of
the Company Disclosure Letter sets forth a true and accurate list as of the date of this Agreement of all Registered IP. Either the Company
or its applicable Subsidiary has made all required filings and registrations (and corresponding payments of fees therefor) to Governmental
Authorities in connection with issuances, registrations and applications for the Registered IP in all material respects. Each item of
Registered IP is subsisting and, to the Knowledge of the Company and other than any Registered IP in the application process, valid and
enforceable. The Company and its Subsidiaries have good and valid title to and exclusively own all right, title and interest in and to
each item of Registered IP and other material Owned IP, free and clear of any Encumbrances other than Permitted Encumbrances. No interference,
opposition, cancellation, reissue, reexamination or other Action (other than ex parte ordinary course prosecution of Intellectual Property
before a patent, trademark or copyright office) or written claim is, or in the three (3) years prior to the date hereof has
been, pending or, to the Knowledge of the Company, threatened in writing in which the ownership, use, scope, validity or enforceability
of any Owned IP is being, or in the three (3) years prior to the date hereof has been, challenged. Except as licensed to the Company
and its Subsidiaries under the Material Contracts set forth in Section 3.15(a)(2) of the
Company Disclosure Letter, no Related Entities own (i) any Company IP or Business Data material to the Business, or (ii) any
other Intellectual Property material to the Business or Contemplated Business. Except as licensed to the Company and its Subsidiaries
under the Material Contracts set forth in Section 3.15(a)(2) of the Company Disclosure Letter, no Related Entities own
any right, title or interest in or to any Intellectual Property or Data primarily related to, used or held for use in, or developed for,
and in each case material to, the Business or Contemplated Business.
(b) The
Company and its Subsidiaries own, or have valid and enforceable rights to use, all Intellectual Property and Business Data (i) used
or held for use in, or necessary for, the conduct of the Business (including the offering, marketing, sale, distribution, importation
and exportation of Company Products), as currently conducted (including Company IP and Business Data) or (ii) to the Knowledge of
the Company, used or held for use in, or necessary for, the conduct of the Contemplated Business (including the offering, marketing,
sale, distribution, importation and exportation of Contemplated Company Products), in the current stage, in each such case of such conduct,
as of the date hereof or with regards to the Charging Business as currently contemplated as of the date hereof to be conducted by the
Company; in each case, free and clear of any Encumbrances other than Permitted Encumbrances. Assuming the representations and warranties
in Article IV are true and correct, and except for the matters referred to in clauses (a) through (c) of Section 3.6, all
material Company IP and material Business Data will be available immediately after the Closing for use and enjoyment by the Company and
its Subsidiaries on terms substantially similar to those under which the Company and its Subsidiaries owned or used such Company IP and
Business Data immediately prior to Closing.
(c) Each
Person (including any current or former employee, contractor or consultant of the Company or any of its Subsidiaries) who is or has been
involved in the authorship, discovery, development, conception, or reduction to practice of any Intellectual Property owned or purported
to be owned for, on behalf of, or under the direction or supervision of, the Company or its Subsidiaries or primarily related to the
Business or Contemplated Business (including in connection with any Company Product or Contemplated Company Product) (each an “IP
Contributor”) has signed a valid and enforceable Contract containing (or has obligations by operation of Law providing): (i) an
irrevocable present assignment to the Company or the applicable Subsidiary of all such Intellectual Property authored, discovered, developed,
conceived, or reduced to practice by such IP Contributor; and (ii) customary confidentiality provisions protecting such Intellectual
Property. To the Knowledge of the Company, no such IP Contributor has been in the past three (3) years or is in breach of any such
agreement in any material respect. No funding, facilities, personnel or resources of any government, international organization, university,
college, other educational or research institution were used in the development of the Company Products or Contemplated Company Products
or material Owned IP such that such government, international organization, university, college, other educational or research institution
has, contingent or otherwise, any license, ownership or other rights in any such Company Product or Contemplated Company Product or material
Owned IP in any material respect.
(d) Except
as disclosed in Section 3.15(d) of the Company Disclosure Letter, neither the Company nor any of its Subsidiaries nor
the operation of the Business violates, infringes or misappropriates, or in the three (3) years prior to the date hereof, has violated,
infringed or misappropriated, any Intellectual Property of any Person in any material respect, nor has the Company or any of its Subsidiaries
received in the three (3) years prior to the date hereof any written notice alleging any of the foregoing. During the three (3) years
prior to the date hereof, (i) to the Knowledge of the Company, no Person has violated, infringed or misappropriated any Owned IP
in any material respect and (ii) neither the Company nor any of its Subsidiaries has given any written notice to any other Person
alleging any of the foregoing. No Company Product, Contemplated Company Product, Owned IP, or, to the Knowledge of the Company, any other
Company IP (in the case of such other Company IP, in connection with the Business) is subject to any Action or outstanding order or settlement
agreement or stipulation that materially restricts the ownership, use, provision, enforcement, transfer, assignment, licensing or sublicensing
thereof by the Company or any of its Subsidiaries or materially impairs the validity, scope, or enforceability thereof.
(e) To
the Knowledge of the Company, neither the Company Products nor any IT Systems contain any “back door,” “drop dead device,”
“time bomb,” “Trojan horse,” “virus,” or “worm” (as such terms are commonly understood
in the software industry) or any other code designed or intended to have any of the following functions: (i) materially disrupting,
disabling, harming or otherwise impeding in any manner the operation of, or providing unauthorized access to, a computer system or network
or other device on which such code is stored or installed or (ii) materially damaging or destroying any material data or file without
the user’s consent. To the Knowledge of the Company, none of the material Company Products contain any bug, defect, or error
in such a manner that would materially and adversely affect the functionality of such Company Products. The Company and its Subsidiaries
have taken commercially reasonable steps to prevent the introduction into any Company Product or IT System any of the foregoing.
(f) In
connection with the Personal Data, the Company and its Subsidiaries are in compliance, and for the three (3) years prior to the
date hereof, have complied with in all material respects: all (i) applicable Laws then effective, (ii) the Group’s published
external or internal data privacy and data security policies and procedures, and consents obtained by or on behalf of the Company or
any of its Subsidiaries, (iii) applicable and generally observed self-regulatory standards and enforceable industry standards, and
(iv) obligations under Contracts made by the Company or any of its Subsidiaries, relating to privacy, data security, data protection,
or the use, collection, retention, storage, security, disclosure, transfer, disposal, or other Processing or dealing, in whole or in
part, of any Personal Data (the foregoing clauses (i) through (iv), collectively, the “Data Protection Obligations”).
The Company and its Subsidiaries have contractually obligated all Persons Processing material Business Data on behalf of the Company
or any of its Subsidiaries to comply with applicable Data Protection Obligations, in each case if required by applicable Data Protection
Obligations.
(g) The
Company and its Subsidiaries have implemented and maintained commercially reasonable and appropriate policies and technical, physical,
administrative and organizational security measures and information security programs designed to protect the security, confidentiality,
integrity and availability of Trade Secrets, Personal Data, Business Data and the IT Systems, including commercially reasonable business
continuity and disaster recovery plans. The Company and its Subsidiaries have taken other reasonable steps consistent with industry practices
of companies offering similar products or services to safeguard material Trade Secrets, Personal Data, Business Data and IT Systems and
as reasonably appropriate for the risk. Except as set forth in Section 3.15(g) of the Company Disclosure Letter, there
have been no Security Incidents or breach of security or unauthorized access by third parties relating to (i) to the Knowledge of
the Company, the IT Systems, Business Data or confidential information in any material respect, or (iii) any Personal Data collected,
held, or otherwise managed or Processed by or on behalf of the Company or any of its Subsidiaries in any material respect.
(h) The
Company and its Subsidiaries have taken commercially reasonable steps, consistent with industry practices of companies offering similar
products or services, to (a) protect, maintain, and enforce the Owned IP material to the conduct of the Business and Contemplated
Business, and (b) protect the confidentiality of (i) material Trade Secrets of the Company and its Subsidiaries or of any third
party to whom the Company or any of its Subsidiaries owe a contractual obligation of confidentiality and (ii) Business Data. The
Company or its Subsidiaries have entered into written valid and enforceable confidentiality agreements containing reasonable and customary
confidentiality obligations (or pursuant to similar obligations by operation of Law) with each Person provided with access to any such
Trade Secrets or Business Data, and to the Knowledge of the Company, no such Person has materially breached any such agreements or obligations.
The Company IP, Business Data and IT Systems owned or used (or held for use) by the Company and its Subsidiaries are sufficient
in all material respects for conduct of the Business as presently conducted and as conducted during the three (3) years prior to
the date of this Agreement. During the three (3) years prior to the date of this Agreement, there has been no material failure or
other material substandard performance of any IT System, in each case, which has caused a material disruption to the IT Systems or the
Business and has not been reasonably remedied.
(i) The
Company and its Subsidiaries have valid and enforceable rights to use and exploit the IT Systems as currently used and exploited in connection
with the Business. The IT Systems (i) are sufficient for the immediate and currently anticipated future needs of the Business, including
as to capacity, scalability and ability to process current and anticipated peak volumes in a timely manner, and (ii) are in sufficiently
good working condition to effectively perform all information technology operations as necessary for the conduct of the Business in all
material respects and include a sufficient number of licenses (whether licensed by seats or otherwise) for all Software as necessary
for the conduct of the Business.
(j) No
material source code included in Owned IP (including any such source code contained in the Company Products) (collectively, the “Company
Source Code”), has been delivered, licensed, or made available to any escrow agent or other Person (other than an employee
or contractor of the Company or any of its Subsidiaries and subject to reasonable and customary confidentiality obligations under written
valid and enforceable agreements or similar obligations by operation of Law), nor does the Company or any of its Subsidiaries have any
duty or obligation (whether present, contingent, or otherwise) to do so. No event has occurred, and no circumstance or condition exists
including the execution, delivery or performance of this Agreement or any other agreements referred to in this Agreement or the consummation
of any of the Transactions contemplated by this Agreement that, with or without notice or lapse of time, will result in the delivery,
license, or disclosure of any Company Source Code to any Person (other than an employee or contractor of the Company or any of its Subsidiaries
and subject to reasonable and customary confidentiality obligations under written valid and enforceable agreements or similar obligations
by operation of Law). The Company and its Subsidiaries possess all Company Source Code and other documentation and materials necessary
to compile and operate the Company Products.
(k) Neither
the Company nor any of its Subsidiaries has used during the three (3) years prior to the date of this Agreement or is currently
using any Open Source Software in any manner that, with respect to any of the Company Products, Company Source Code, or other Company
IP (other than the Open Source Software itself) in each case in any material respect: (i) requires its disclosure or distribution
in source code form, (ii) requires the licensing thereof for the purpose of making derivative works, (iii) imposes any material
restriction on the consideration to be charged for the distribution or licensing thereof, (iv) creates, or purports to create, material
obligations for Company or any of its Subsidiaries with respect to any Company IP, or grants, or purports to grant, to any Person, any
material rights or immunities under any Company IP or (v) imposes any other material limitation, restriction, or condition on the
right of the Company or any of its Subsidiaries with respect to its use, licensing or distribution of any Company IP in connection with
the Business. The Company and its Subsidiaries are, and have been during the three (3) years prior to the date of this Agreement,
in compliance with all applicable Open Source Software licenses in all material respects.
(l) During
the three (3) years prior to the date of this Agreement, neither the Company nor any of its Subsidiaries has: (i) received
any written notice of any Action relating to or alleged material violations of any Data Protection Obligations; (ii) received any
written complaints, correspondence or other communications from or on behalf of an individual or any other Person claiming a right to
compensation under any applicable Data Protection Obligations, or alleging any material breach of any applicable Data Protection Obligations;
or (iii) been subject to any data protection enforcement Action (including any investigation, fine or other sanction) from any Governmental
Authority with respect to Personal Data under the custody or control of the Company or any of its Subsidiaries. Assuming the representations
and warranties in Article IV are true and correct, and except for the matters referred to in clauses (a) through
(c) of Section 3.6, neither the execution, delivery or performance of this Agreement or any of the other Transaction Documents
referred to in this Agreement nor the consummation of any of the Transactions contemplated by this Agreement will result in any material
Liabilities in connection with any Data Protection Obligations.
Section 3.16.
Labor and Employee Matters.
(a) Section 3.16(a) of
the Company Disclosure Letter sets forth a complete and correct list of each Benefit Plan.
(b) Except
as disclosed in Section 3.16(c) of the Company Disclosure Letter and except as would not be material to the business
of the Company and its Subsidiaries, taken as a whole, (i) the Company and each of its Subsidiaries is, and for the three (3) years
prior to the date hereof has been, in compliance with all applicable Law related to labor or employment, including provisions thereof
relating to wages and payrolls, working hours and resting hours, overtime, working conditions, benefits, recruitment, retrenchment, retirement,
pension, minimum employment and retirement age, equal opportunity, discrimination, worker classification, occupational health and safety,
wrongful discharge, layoffs or plant closings, immigration, employees provident fund (including compulsory housing fund), social security
organization and collective bargaining, trade union, compulsory employment insurance, work and residence permits, public holiday and
leaves, labor disputes, statutory labor or employment reporting and filing obligations and contracting arrangements; (ii) there
is no pending or, to the Knowledge of the Company, threatened in writing Action relating to the violation of any applicable Law by the
Company or any of its Subsidiaries related to labor or employment, including any charge or complaint filed by any of its current or former
employees, directors, officers, individual consultants, or individual contractors with any Governmental Authority or the Company or any
of its Subsidiaries; and (iii) the Company and its Subsidiaries have properly classified for all purposes (including (x) for
Tax purposes, (y) for purposes of minimum wage and overtime and (z) for purposes of determining eligibility to participate
in any statutory and non-statutory Benefit Plan) all Persons who have performed services for or on behalf of each such entity, and
have properly withheld and paid all applicable Taxes and statutory contributions and made all required filings in connection with services
provided by such persons to the Company and its Subsidiaries in accordance with such classifications.
(c) Except
as disclosed in Section 3.16(c) of the Company Disclosure Letter or as would not be material to the business of the
Group taken as a whole, (i) each of the Benefit Plans (A) has been operated and administered in accordance with its terms,
(B) is in compliance with all applicable Law, and, all contributions to each Benefit Plan have been timely made, and, to the Knowledge
of the Company, no event, transaction or condition has occurred or exists that would, or would reasonably be expected to, result in any
material Liability to any of the Company and any of its Subsidiaries under any Benefit Plan; (ii) there are no pending or, to the
Knowledge of the Company, threatened in writing Actions involving any Benefit Plan (except for routine claims for benefits payable
in the normal operation of any Benefit Plan) and, to the Knowledge of the Company, no facts or circumstances exist that could give
rise to any such Actions; (iii) no Benefit Plan is under investigation or audit by any Governmental Authority and, to the Knowledge
of the Company, no such investigation or audit is contemplated or under consideration; and (iv) the Company and each of its Subsidiaries
is in all material respects in compliance with all applicable Laws and Contracts relating to its provision of any form of social insurance,
and has paid, or made provision for the payment of, all social insurance contributions required under applicable Law and Contracts.
(d) Neither
the execution or delivery of any of the Transaction Documents to which the Company is a party nor the consummation of the transactions
contemplated thereunder (either alone or in combination with another event) will or will reasonably be expected to (i) result
in any payment or benefit becoming due to any Company employees or any current or former director, officer, employee, individual independent
contractor or individual consultant of the Company or any of its Subsidiaries; (ii) increase the amount of compensation or any benefits
otherwise payable under any of the Benefit Plans; (iii) result in any acceleration of the time of payment, exercisability, funding
or vesting of any such benefits; (iv) limit or restrict the ability of the Company to merge, amend, or terminate any Benefit Plan;
or (v) result in the payment of any amount (whether in cash or property or the vesting of property) that could, individually or
in combination with any other such payment, constitute an “excess parachute payment” within the meaning of Section 280G(b) of
the Code.
(e) Neither
the Company nor any of its Subsidiaries or any ERISA Affiliate thereof has any Liability with respect to or under: (i) a “multiemployer
plan” within the meaning of Section 3(37) or 4001(a)(3) of ERISA; (ii) a “defined benefit plan” (as
defined in Section 3(35) of ERISA, whether or not subject to ERISA) or a plan that is or was subject to Title IV of ERISA or Section 412
of the Code; or (iii) a “multiple employer plan” within the meaning of Section 413(c) of the Code or Section 210
of ERISA.
(f) Except
as would not have a Company Material Adverse Effect, as of the date of this Agreement (i) no employee of the Company or any of its
Subsidiaries is represented by a Union; (ii) neither the Company nor any of its Subsidiaries is negotiating any collective bargaining
agreement or other Contract with any Union; (iii) to the Knowledge of the Company, there is no effort currently being made
or threatened by or on behalf of any Union to organize any employees of the Company or any of its Subsidiaries; and (iv) there are
no labor disputes (including any work slowdown, lockout, stoppage, picketing or strike) pending, or to the Knowledge of the Company,
threatened against the Company or any of its Subsidiaries. No notice, consent or consultation obligations with respect to any employee
of the Company or any of its Subsidiaries or any Union will be a condition precedent to, or triggered by, the execution of the Original
Merger Agreement or the consummation of the transactions contemplated thereby.
Section 3.17.
Brokers. Except as set forth
in Section 3.17 of the Company Disclosure Letter, no broker, finder or investment banker is entitled to any brokerage, finder’s
or other fee or commission or expense reimbursement in connection with the Transactions contemplated based upon arrangements made by
and on behalf of the Company or any of its Controlled Affiliates.
Section 3.18.
Environmental Matters. (a) The
Group Companies are, and, in the three (3) years prior to the date hereof, have been, in compliance in all material respects with
all Environmental Laws, except where the failure to be, or to have been, in compliance with such Environmental Laws has not had a Company
Material Adverse Effect; and (b) in the three (3) years prior to the date hereof, to the Knowledge of the Company, no Group
Company has received any notice, report, Governmental Order or other information regarding any actual or alleged material violation by
any Group Company of, or material liabilities of the Group under, Environmental Laws.
Section 3.19.
Insurance. Section 3.19
of the Company Disclosure Letter sets forth each insurance policy (excluding, for the avoidance of doubt, the social insurance and
other statutory insurance mandated by Law) of the Group Companies. Except as would not reasonably be expected to be material to the business
of the Company and its Subsidiaries, taken as a whole: (a) each of the Group Companies has insurance policies covering such risks
as are customarily carried by Persons conducting business in the industries and geographies in which the Group Companies operate; and
(b) all such policies are in full force and effect, all premiums due and payable thereon as of the date of this Agreement have been
paid in full as of the date of this Agreement. To the Knowledge of the Company, (i) no material claims have been made which remain
outstanding and unpaid under such insurance policies, and (ii) no circumstances exist that would reasonably be expected to give
rise to a material claim under such insurance policies.
Section 3.20.
Company Related Parties. Except
as set forth in Section 3.20 of the Company Disclosure Letter, the Company has not engaged in any transactions with Related
Parties that would be required to be disclosed in the Proxy/Registration Statement.
Section 3.21.
Proxy/Registration Statement.
The information supplied or to be supplied by the Company, any of its Subsidiaries or their respective Representatives in writing specifically
for inclusion in the Proxy/Registration Statement shall not, at (a) the time the Proxy/Registration Statement is declared effective,
(b) the time the Proxy/Registration Statement (or any amendment thereof or supplement thereto) is first mailed to the SPAC Shareholders,
and (c) the time of the SPAC Shareholders’ Meeting, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. Notwithstanding the foregoing, the Company makes no representation, warranty or covenant with respect to any
information supplied by or on behalf of SPAC, its Affiliates or their respective Representatives.
Section 3.22.
Company Product.
(a) During
the three (3) years preceding the date of this Agreement, there have been no claims made, or to the Knowledge of the Company, threatened
in writing against the any Group Company by a customer or any other person alleging that (i) any Company Product (A) did not
comply with any express or implied warranty regarding such Company Product, or (B) was otherwise contaminated, adulterated, mislabeled,
defective or improperly packaged or transported, or (ii) any Group Company or any of their licensees, distributors or agents breached
any duty to warn, test, inspect or instruct of the risks, limitations, precautions or dangers related to the use, application, or transportation
of any such Company Product.
(b) During
the three (3) years preceding the date of this Agreement, there have been no recalls, market withdrawals or replacements (voluntary
or involuntary) with respect to any Company Product or any similar actions, investigations, written notices or written threats of recalls
by any Governmental Entity with respect to any Company Product.
Section 3.23.
No Additional Representation or
Warranties. Except as set forth in Article IV, the Company acknowledges and agrees that neither SPAC nor any of its Affiliates,
agents or Representatives is making any representation or warranty whatsoever to the Company pursuant to this Agreement.
Article IV
REPRESENTATIONS
AND WARRANTIES OF SPAC
Except
(a) as set forth in any SPAC SEC Filings filed or submitted on or prior to the date hereof (excluding any disclosures in any risk
factors section that do not constitute statements of fact, any disclosures in any forward-looking statements disclaimer and any other
disclosures that are generally cautionary, predictive or forward-looking in nature) (it being acknowledged that nothing disclosed in
such SPAC SEC Filings will be deemed to modify or qualify the representations and warranties set forth in Section 4.2, Section 4.6
and Section 4.13); or (b) as set forth in the disclosure letter delivered by SPAC to the Company on the date of
this Agreement (the “SPAC Disclosure Letter”), SPAC represents and warrants to the Company and the Merger Subs
as follows, (i) in respect of the entirety of this Article IV (other than Section 4.1, Section 4.4 and Section 4.5),
as of January 31, 2023, and (ii) solely in respect of Section 4.1, Section 4.4 and Section 4.5, as of October
11, 2023 (in each case of clauses (i) and (ii), except for any such representation and warranty (or part thereof) that expressly
speaks as of a particular date or period of time, in which case as of such particular date or period of time):
Section 4.1.
Organization, Good
Standing, Corporate Power and Qualification. SPAC is an exempted company duly incorporated, validly existing and in good standing
under the Laws of the Cayman Islands and has requisite corporate power and authority to own and operate its properties and assets, to
carry on its business as presently conducted and contemplated to be conducted. SPAC is duly licensed or qualified and in good standing
as a foreign or extra-provincial corporation in each jurisdiction in which its ownership of property or the character of its activities
is such as to require it to be so licensed or qualified or in good standing, as applicable, except where the failure to be so licensed
or qualified or in good standing would not be material to SPAC. Prior to the execution of the Original Merger Agreement, a true and correct
copy of the SPAC Charter has been made available by or on behalf of SPAC to the Company, the SPAC Charter is in full force and effect,
and SPAC is not in default of any term or provision of the SPAC Charter in any material respect.
Section 4.2.
Capitalization and
Voting Rights.
(a) Capitalization
of SPAC. As of the date of this Agreement, the authorized share capital of SPAC consists of $22,200 divided into (i) 200,000,000
SPAC Class A Ordinary Shares, of which 28,650,874 SPAC Class A Ordinary Shares are issued and outstanding as of the date of
this Agreement, (ii) 20,000,000 SPAC Class B Ordinary Shares, of which 7,162,718 SPAC Class B Ordinary Shares are
issued and outstanding as of the date of this Agreement, and (iii) 2,000,000 SPAC Preference Shares, of which no SPAC Preference
Share is issued and outstanding as of the date of this Agreement. There are no other issued or outstanding SPAC Shares as of the date
of this Agreement. All of the issued and outstanding SPAC Shares (i) have been duly authorized and validly issued and allotted and
are fully paid and non-assessable; (ii) have been offered, sold and issued by SPAC in compliance with applicable Law, including
the Cayman Act, U.S. federal and state securities Laws, and all requirements set forth in (1) the SPAC Charter, and (2) any
other applicable Contracts governing the issuance or allotment of such securities to which SPAC is a party or otherwise bound; and (iii) are
not subject to, nor have they been issued in violation of, any Encumbrance, purchase option, call option, right of first refusal, pre-emptive
right, subscription right or any similar right under any provision of any applicable Law, the SPAC Charter or any Contract to which SPAC
is a party or otherwise bound.
(b) As
of the date of this Agreement, 28,650,874 SPAC Units are issued and outstanding (in respect of which 28,650,874 SPAC Class A Ordinary
Shares and up to 9,550,291 SPAC Warrants would be issued if these SPAC Units were separated on the date hereof pursuant to Section 2.3(a)).
There are no other issued or outstanding SPAC Units as of the date of this Agreement. All of the issued and outstanding SPAC Units (i) have
been duly authorized and validly issued; (ii) have been offered, sold and issued by SPAC in compliance with applicable Law, including
the Cayman Act, U.S. federal and state securities Laws, and all requirements set forth in (1) the SPAC Charter, and (2) any
other applicable Contracts governing the issuance of such SPAC Units to which SPAC is a party or otherwise bound; and (iii) are
not subject to, nor have they been issued in violation of, any Encumbrance, purchase option, call option, right of first refusal, pre-emptive
right, subscription right or any similar right under any provision of any applicable Law, the SPAC Charter or any Contract to which SPAC
is a party or otherwise bound.
(c) As
of the date of this Agreement, 15,037,075 SPAC Warrants are issued and outstanding. The SPAC Warrants are exercisable for 15,037,075
SPAC Class A Ordinary Shares. The SPAC Warrants are not exercisable until the later of (x) thirty (30) days after
the closing of a Business Combination and (y) twelve (12) months from the closing of the IPO. All outstanding SPAC Warrants (i) have
been duly authorized and validly issued and constitute valid and binding obligations of SPAC, enforceable against SPAC in accordance
with their terms, subject to the Enforceability Exceptions; (ii) have been offered, sold and issued by SPAC in compliance with applicable
Law, including federal and state securities Laws, and all requirements set forth in (1) the SPAC Charter and (2) any other
applicable Contracts governing the issuance of such securities to which SPAC is a party or otherwise bound; and (iii) are not subject
to, nor have they been issued in violation of, any Encumbrance, purchase option, call option, right of first refusal, pre-emptive right,
subscription right or any similar right under any provision of any applicable Law, the SPAC Charter or any Contract to which SPAC is
a party or otherwise bound. Except for the SPAC Charter or this Agreement, there are no outstanding Contracts of SPAC to repurchase,
redeem or otherwise acquire any SPAC Shares.
(d) Except
as set forth in this Section 4.2 or Section 4.2 of the SPAC Disclosure Letter, there are no outstanding subscriptions,
options, warrants, rights or other securities (including debt securities) of SPAC exercisable or exchangeable for SPAC Shares, any other
commitments, calls, conversion rights, rights of exchange or privilege (whether pre-emptive, contractual or by matter of Law), plans
or other agreements of any character providing for the issuance of additional shares, the sale of treasury shares or other Equity Securities
of SPAC, or for the repurchase or redemption of shares or other Equity Securities of SPAC or the value of which is determined by reference
to shares or other Equity Securities of SPAC, and there are no voting trusts, proxies or agreements of any kind which may obligate SPAC
to issue, purchase, register for sale, redeem or otherwise acquire any SPAC Shares or other Equity Securities of SPAC.
Section 4.3.
Corporate Structure;
Subsidiaries. SPAC has no Subsidiaries, and does not own, directly or indirectly, any Equity Securities or other interests or investments
(whether equity or debt) in any Person, whether incorporated or unincorporated. SPAC is not obligated to make any investment in or capital
contribution to or on behalf of any other Person.
Section 4.4.
Authorization.
(a) Other
than the SPAC Shareholders’ Approval, SPAC has all requisite corporate power and authority to (i) enter into, execute and
deliver this Agreement and each of the other Transaction Documents to which it is or will be a party, and (ii) consummate the Transactions
and perform all of its obligations hereunder and thereunder. The execution and delivery of this Agreement and the other Transaction Documents
to which SPAC is a party and the consummation of the Transactions have been duly and validly authorized and approved by the SPAC Board
and, other than the SPAC Shareholders’ Approval, no other company or corporate proceeding on the part of SPAC is necessary to authorize
this Agreement and the other Transaction Documents to which SPAC is a party and to consummate the transactions contemplated hereby
and thereby. This Agreement has been, and at or prior to the Closing, the other Transaction Documents to which SPAC is a party will be,
duly and validly executed and delivered by SPAC, and this Agreement constitutes, and on or prior to the Closing, the other Transaction
Documents to which SPAC is a party will constitute, a legal, valid and binding obligation of SPAC, enforceable against SPAC in accordance
with its terms, subject to the Enforceability Exceptions.
(b) Assuming
that a quorum (as determined pursuant to the SPAC Charter) is present:
(i) The
approval and authorization of the First Merger and the First Plan of Merger shall require approval by a special resolution passed by
the affirmative vote of SPAC Shareholders holding at least two-thirds of the outstanding SPAC Shares which, being so entitled, are voted
thereon in person or by proxy at a general meeting of SPAC of which notice specifying the intention to propose the resolution as a special
resolution has been duly given, pursuant to the terms and subject to the conditions of the SPAC Charter and applicable Law; and
(ii) The
approval and authorization of this Agreement and the Transactions as a Business Combination and the adoption and approval of a proposal
for the adjournment of the SPAC Shareholders’ Meeting in each case shall require approval by an ordinary resolution passed by the
affirmative vote of SPAC Shareholders holding at least a majority of the outstanding SPAC Shares which, being so entitled, are voted
thereon in person or by proxy at a general meeting of SPAC, pursuant to the terms and subject to the conditions of the SPAC Charter and
applicable Law.
(c) The
SPAC Shareholders’ Approval are the only votes of any SPAC Shares necessary in connection with execution of this Agreement and
the other Transaction Documents to which SPAC is a party by SPAC and the consummation of the Transactions.
(d) On
or prior to the date of the Original Merger Agreement, the SPAC Board has duly adopted resolutions (i) determining that the Original
Merger Agreement and the other Transaction Documents to which SPAC is a party contemplated thereby and the Transactions are advisable
and fair to, and in the best interests of, SPAC and constitute a Business Combination, (ii) authorizing and approving the execution,
delivery and performance by SPAC of the Original Merger Agreement and the other Transaction Documents to which SPAC is a party contemplated
thereby and the Transactions, (iii) making the SPAC Board Recommendation, (iv) directing that the Original Merger Agreement,
the Transaction Documents and the Transactions be submitted to the SPAC Shareholders for adoption at an extraordinary general meeting
called for such purpose pursuant to the terms and conditions of the Original Merger Agreement, and (v) authorizing each director
or officer of SPAC to negotiate, execute and deliver, to the extent permitted by applicable Law, such amendments to (or waivers or consents
under) the Original Merger Agreement and the other Transaction Documents, for and on behalf of and in the name of SPAC, as such director
or officer of SPAC shall determine to be in the best interests of SPAC, with such determination to be conclusively evidenced by such
director or officer’s execution thereof.
Section 4.5.
Consents; No Conflicts.
Assuming the representations and warranties in Article III are true and correct, except (a) as otherwise set forth in
Section 4.5 of the SPAC Disclosure Letter, (b) for the SPAC Shareholders’ Approval, (c) for the registration
or filing with the Cayman Registrar, the SEC or applicable state blue sky or other securities laws filings with respect to the Transactions
and the publication of notification of the Mergers in the Cayman Islands Government Gazette pursuant to the Cayman Act and (d) for
such other filings, notifications, notices, submissions, applications, or consents the failure of which to be obtained or made would
not, individually or in the aggregate, have, or reasonably be likely to have, a material effect on the ability of SPAC to enter into
and perform its obligations under this Agreement, all filings, notifications, notices, submissions, applications, or consents from or
with any Governmental Authority or any other Person required in connection with the valid execution, delivery and performance of this
Agreement and the other Transaction Documents, and the consummation of the Transactions, in each case on the part of SPAC, have been
duly obtained or completed (as applicable) and are in full force and effect. The execution, delivery and performance of this Agreement
and the other Transaction Documents to which it is or will be a party by SPAC does not, and the consummation by SPAC of the transactions
contemplated hereby and thereby will not (assuming the representations and warranties in Article III are true and correct,
except for the matters referred to in clauses (a) through (d) of the immediately preceding sentence) (i) result
in any violation of, be in conflict with, or constitute a default under, require any consent under, or give any Person rights of termination,
amendment, acceleration (including acceleration of any obligation of SPAC) or cancellation under, (A) any Governmental Order,
(B) the SPAC Charter, (C) any applicable Law, (D) any Contract to which SPAC is a party or by which its assets are bound,
or (ii) result in the creation of any Encumbrance upon any of the properties or assets of SPAC other than any restrictions under
federal or state securities laws, this Agreement or the SPAC Charter, except in the case of sub-clauses (A), (C), and (D) of
clause (i) or clause (ii), as would not have a SPAC Material Adverse Effect.
Section 4.6.
Tax Matters.
(a) All
material Tax Returns required to be filed by or with respect to SPAC have been timely filed (taking into account any extensions) and
such Tax Returns are true, correct and complete in all material respects. All material Taxes due and payable by SPAC have been or will
be timely paid, except with respect to matters being contested in good faith by appropriate proceeding and with respect to which adequate
reserves have been made in accordance with GAAP.
(b) No
material deficiencies for any Taxes that are currently outstanding with respect to any Tax Returns of SPAC have been asserted in writing
by, and no written notice of any action, audit, assessment or other proceeding, in each case that is currently pending, with respect
to such Tax Returns or any Taxes of SPAC has been received from, any Tax authority, and no dispute or assessment relating to such Tax
Returns or such Taxes with any such Tax authority is currently outstanding.
(c) No
material claim that is currently outstanding has been made in writing by any Governmental Authority in a jurisdiction where SPAC does
not file Tax Returns that SPAC is or may be subject to taxation by that jurisdiction and SPAC does not otherwise have Knowledge of any
such claim.
(d) There
are no liens for material Taxes (other than such liens that are Permitted Encumbrances) upon the assets of SPAC.
(e) Except
as contemplated by this Agreement, the Transaction Documents, or the Transactions, SPAC has not taken any action (nor permitted any action
to be taken), and is not aware of any fact or circumstance, that would reasonably be expected to prevent, impair or impede the Intended
Tax Treatment.
(f) SPAC
is not subject to Tax in a country other than the country of its incorporation or formation solely by virtue of having a permanent establishment
in such other country.
(g) SPAC
is and since its formation has been treated as a foreign corporation (within the meaning of the Code) for U.S. federal and applicable
state and local income Tax purposes
(h) SPAC
is in compliance with all terms and conditions of any material Tax incentives, exemption, holiday or other material Tax reduction agreement
or order of a Governmental Authority applicable to SPAC, and to the Knowledge of SPAC the consummation of the Transactions will not have
any material adverse effect on the continued validity and effectiveness of any such material Tax incentives, exemption, holiday or other
material Tax reduction agreement or order.
Section 4.7.
Financial Statements.
(a) The
financial statements of SPAC contained in SPAC SEC Filings (the “SPAC Financial Statements”) (i) have been prepared
in accordance with the books and records of SPAC, (ii) fairly present in all material respects the financial condition of SPAC on
a consolidated basis as of the dates indicated therein, and the results of operations and cash flows of SPAC on a consolidated basis
for the periods indicated therein, (iii) were prepared in accordance with GAAP applied on a consistent basis throughout the periods
involved, and (iv) comply in all material respects with the applicable accounting requirements and with the rules and regulations
of the SEC, the Exchange Act and the Securities Act applicable to SPAC, in effect as of the respective dates thereof (including, to the
extent applicable to SPAC, Regulation S-X under the Securities Act).
(b) SPAC
has in place disclosure controls and procedures that are (i) designed to reasonably ensure that material information relating to
SPAC is made known to the management of SPAC by others within SPAC; and (ii) effective in all material respects to perform the functions
for which they were established. SPAC maintains a system of internal accounting controls sufficient to provide reasonable assurance that
(w) transactions are executed in accordance with management’s general or specific authorizations, (x) transactions are
recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (y) access
to assets is permitted only in accordance with management’s general or specific authorization and (z) the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
(c) SPAC
has no Liability, and there is no existing condition, situation or set of circumstances which is reasonably expected to result in any
Liability, other than (i) Liabilities incurred after January 5, 2021 in the Ordinary Course or other Liabilities that individually
and in the aggregate are immaterial, (ii) Liabilities reflected, or reserved against, in the SPAC Financial Statements or (iii) any
SPAC Transaction Expenses (disregarding any limitation of amounts set forth in the definition of “SPAC Transaction Expenses”).
(d) Neither
SPAC, nor, to the Knowledge of SPAC, an independent auditor of SPAC, has identified or been made aware in writing of (i) any significant
deficiency or material weakness in the system of internal accounting controls utilized by SPAC, (ii) any fraud, whether or not material,
that involves SPAC’s management or other employees who have a role in the preparation of financial statements or the internal accounting
controls utilized by SPAC, or (iii) to the Knowledge of SPAC, any allegation, assertion or claim regarding any of the foregoing.
Section 4.8.
Absence of Changes.
Since January 5, 2021, (a) to the date of this Agreement, SPAC has operated its business in the Ordinary Course, and (b) there
has not been any SPAC Material Adverse Effect.
Section 4.9.
Actions. (a) There
is no Action pending or, to the Knowledge of SPAC, threatened in writing against or affecting SPAC; and (b) there is no judgment
or award unsatisfied against SPAC, nor is there any Governmental Order in effect and binding on SPAC or its assets or properties.
Section 4.10.
Brokers. Except as set forth
in Section 4.10 of the SPAC Disclosure Letter, no broker, finder or investment banker is entitled to any brokerage, finder’s
or other fee or commission or expense reimbursement in connection with the Transactions contemplated based upon arrangements made by
and on behalf of SPAC or any of its Affiliates.
Section 4.11.
Proxy/Registration Statement.
The information supplied or to be supplied by SPAC, its Affiliates or their respective Representatives in writing specifically for inclusion
in the Proxy/Registration Statement shall not, at (a) the time the Proxy/Registration Statement is declared effective, (b) the
time the Proxy/Registration Statement (or any amendment thereof or supplement thereto) is first mailed to the SPAC Shareholders, and
(c) the time of the SPAC Shareholders’ Meeting, contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. Notwithstanding the foregoing, SPAC makes no representation, warranty or covenant with respect to any information
supplied by or on behalf of Company, its Subsidiaries or their respective Representatives.
Section 4.12.
SEC Filings. SPAC has timely
filed or furnished all statements, prospectuses, registration statements, forms, reports and documents required to be filed or furnished
by it with the SEC, pursuant to the Exchange Act or the Securities Act (collectively, as they have been amended since the time of their
filing or furnishing through the date of this Agreement, the “SPAC SEC Filings”). Each of the SPAC SEC Filings, as
of the respective date of its filing, and as of the date of any amendment, complied in all material respects with the requirements of
the Securities Act, the Exchange Act or the Sarbanes-Oxley Act applicable to such SPAC SEC Filings. Except as set forth in Section 4.12
of the SPAC Disclosure Letter, as of the respective date of its filing (or if amended or superseded by a filing prior to the date
of this Agreement or the Closing Date, then on the date of such filing), the SPAC SEC Filings did not contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein,
in light of the circumstances under which they were made, not misleading. As of the date of this Agreement, there are no outstanding
or unresolved comments in comment letters received from the SEC with respect to any SPAC SEC Filing. To the Knowledge of SPAC, none of
the SPAC SEC Filings filed on or prior to the date of this Agreement is subject to ongoing SEC review or investigation as of the date
of this Agreement. All documents that SPAC is responsible for filing with the SEC in connection with the Transactions will comply as
to form and substance in all material respects with the applicable requirements of the Securities Act and the Exchange Act.
Section 4.13.
Trust Account. As of the date
of this Agreement, SPAC has at least $288,240,632 in the Trust Account (including an aggregate of approximately $10,027,806 of deferred
underwriting commissions and other fees being held in the Trust Account), such monies invested in United States government securities
or money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act pursuant to the Investment
Management Trust Agreement, dated as of March 10, 2021, between SPAC and Continental Stock Transfer & Trust Company, as
trustee (in such capacity, the “Trustee,” and such Investment Management Trust Agreement, the “Trust Agreement”).
There are no separate Contracts or side letters that would cause the description of the Trust Agreement in the SPAC SEC Filings to be
inaccurate in any material respect or that would entitle any Person (other than SPAC Shareholders holding SPAC Ordinary Shares (prior
to the First Effective Time) sold in SPAC’s IPO who shall have elected to redeem their SPAC Ordinary Shares (prior to the First
Effective Time) pursuant to the SPAC Charter and the underwriters of SPAC’s IPO with respect to deferred underwriting commissions)
to any portion of the proceeds in the Trust Account. Prior to the Closing, none of the funds held in the Trust Account may be released
other than to pay Taxes and payment to SPAC Shareholders who have validly exercised their SPAC Shareholder Redemption Right. There are
no Actions pending or, to the Knowledge of SPAC, threatened with respect to the Trust Account. SPAC has performed all material obligations
required to be performed by it to date under, and is not in default, breach or delinquent in performance or any other respect (claimed
or actual) in connection with, the Trust Agreement, and no event has occurred which, with due notice or lapse of time or both, would
constitute such a default or breach thereunder. As of the Closing, the obligations of SPAC to dissolve or liquidate pursuant to
the SPAC Charter shall terminate, and as of the Closing, SPAC shall have no obligation whatsoever pursuant to the SPAC Charter to dissolve
and liquidate the assets of SPAC by reason of the consummation of the Transactions. To the Knowledge of SPAC, as of the date of this
Agreement, following the Closing, no SPAC Shareholder is entitled to receive any amount from the Trust Account except to the extent such
SPAC Shareholder has exercised his, her or its SPAC Shareholder Redemption Right. As of the date of this Agreement, assuming the accuracy
of the representations and warranties contained in Article III and the compliance by the Company with its obligations hereunder,
SPAC has no reason to believe that any of the conditions to the use of funds in the Trust Account will not be satisfied or funds available
in the Trust Account will not be available to SPAC on the Closing Date.
Section 4.14.
Investment Company Act; JOBS Act.
SPAC is not an “investment company” or a Person directly or indirectly “controlled” by or acting on behalf of
an “investment company,” in each case within the meaning of the Investment Company Act. SPAC constitutes an “emerging
growth company” within the meaning of the Jumpstart Our Business Startups Act of 2012.
Section 4.15.
Business Activities.
(a) Since
its incorporation, SPAC has not conducted any business activities other than activities related to SPAC’s IPO or directed toward
the accomplishment of a Business Combination. Except as set forth in the SPAC Charter or as otherwise contemplated or by which SPAC is
bound by the Transaction Documents and the Transactions, there is no Contract to which SPAC is a party which has or would reasonably
be expected to have the effect of prohibiting or impairing in any material respect any business practice of SPAC or any acquisition of
property by SPAC or the conduct of business by SPAC as currently conducted or as contemplated to be conducted as of the Closing.
(b) Except
for the Transactions, SPAC does not own or have a right to acquire, directly or indirectly, any interest or investment (whether equity
or debt) in any corporation, partnership, joint venture, business, trust or other entity. Except for this Agreement and the Transaction
Documents and the transactions contemplated hereby and thereby, SPAC has no material interests, rights, obligations or liabilities with
respect to, and is not party to, bound by or has its assets or property subject to, in each case whether directly or indirectly, any
Contract or transaction which is, or would reasonably be interpreted as constituting, a Business Combination.
Section 4.16.
Nasdaq Quotation. SPAC Class A
Ordinary Shares, SPAC Warrants and SPAC Units are each registered pursuant to Section 12(b) of the Exchange Act and are listed
for trading on the Nasdaq Stock Markets (“Nasdaq”) under the symbol “LCAA,” “LCAAW” and “LCAAU,”
respectively. SPAC is in compliance with the rules of Nasdaq and the rules and regulations of the SEC related to such listing
and there is no Action pending or, to the Knowledge of SPAC, threatened against SPAC by Nasdaq or the SEC with respect to any intention
by such entity to deregister SPAC Class A Ordinary Shares, SPAC Warrants or SPAC Units or terminate the listing thereof on Nasdaq.
SPAC has not taken any action in an attempt to terminate the registration of SPAC Class A Ordinary Shares, SPAC Warrants or SPAC
Units under the Exchange Act except as contemplated by this Agreement.
Section 4.17.
SPAC Related Parties. Except
as set forth in Section 4.17 of the SPAC Disclosure Letter, SPAC has not engaged in any transactions with SPAC Related Parties
that would be required to be disclosed in the Proxy/Registration Statement.
Section 4.18.
No Additional Representations
and Warranties. Except as set forth in Article III, SPAC acknowledges and agrees that neither the Company nor any of
its Affiliates, agents or Representatives is making any representation or warranty whatsoever to the Company pursuant to this Agreement.
Article V
COVENANTS
OF THE COMPANY
Section 5.1.
Conduct of Business.
Except (i) as contemplated or permitted by the Transaction Documents or the Original Merger Agreement (including as contemplated
by the Capital Restructuring, any Pre-Closing Financing and any PIPE Financing), (ii) as required by applicable Law (including for
this purpose any COVID-19 Measures) or relevant Governmental Authorities, (iii) as set forth on Section 5.1 of the Company
Disclosure Letter, or (iv) as consented to by SPAC in writing (which consent shall not be unreasonably conditioned, withheld, delayed
or denied and regardless of whether such consent was granted pursuant to the Original Merger Agreement or this Agreement), from the date
of this Agreement through the earlier of the Closing or valid termination of this Agreement pursuant to Article IX (the “Interim
Period”), the Company (1) shall use commercially reasonable efforts to operate the business of the Company and its Subsidiaries
in all material respects in the Ordinary Course, (2) shall use commercially reasonable efforts to preserve the Group’s
business and operational relationships in all material respects with the suppliers, customers and others having business relationships
with the Group that are material to the Group taken as a whole, in each case where commercially reasonable to do so, and (3) shall
not, and shall cause its Subsidiaries not to:
(a) (i) amend
its memorandum and articles of association or other Organizational Documents (whether by merger, consolidation, amalgamation or otherwise),
except in the case of any of the Company’s Subsidiaries only, for any such amendment which is not material to the business of the
Company and its Subsidiaries, taken as a whole; or (ii) liquidate, dissolve, reorganize or otherwise wind up its business and operations,
or propose or adopt a plan of complete or partial liquidation or dissolution, consolidation, restructuring, recapitalization, reclassification
or similar change in capitalization or other reorganization (other than liquidation or dissolution of any dormant Subsidiary);
(b) incur,
assume, guarantee or repurchase or otherwise become liable for any Indebtedness for borrowed money, or issue or sell any debt securities
or options, warrants or other rights to acquire debt securities, in any such case in a principal amount exceeding $1,000,000, except
for any guarantee provided by any Group Company in connection with any investments to be made by certain Governmental Authorities pursuant
to the agreements disclosed in Section 5.1(b) of the Company Disclosure Letter;
(c) transfer,
issue, sell, grant, pledge or otherwise dispose of (i) any of the Equity Securities of the Company or its Subsidiaries to a third
party, or (ii) any options, warrants, rights of conversion or other rights, agreements, arrangements or commitment obligations of
the Company or any of its Subsidiaries to purchase or obtain any Equity Securities of the Company or any of its Subsidiaries to a third
party, other than (A) the grant of awards in accordance with the terms of the ESOP, (B) the issuance of Company Shares upon
the exercise of Company Options in accordance with the terms of the ESOP, (C) the issuance of Equity Securities of the Company or
its Subsidiaries in connection with any investments to be made by certain Governmental Authorities pursuant to the agreements disclosed
in Section 5.1(b) of the Company Disclosure Letter, or (D) the issuance of Equity Securities by a Subsidiary of
the Company (x) to the Company or a wholly owned Subsidiary of the Company or (y) on a pro rata basis to all shareholders of
such Subsidiary;
(d) sell,
lease, sublease, exclusively license, transfer, abandon, allow to lapse or dispose of any material property or assets (other than Intellectual
Property), in any single transaction or series of related transactions, except for (i) transactions pursuant to Contracts entered
into in the Ordinary Course, or (ii) (other than transactions involving the exclusive license of any material property or assets)
transactions that do not exceed $2,000,000 individually and $5,000,000 in the aggregate or (iii) dispositions of obsolete, surplus
or worn out assets that are no longer useful in the conduct of the business of the Company or its Subsidiaries in the Ordinary Course;
(e) sell,
assign, transfer, license, sublicense, grant other rights (including covenant not to sue) under, abandon, permit to lapse, or otherwise
dispose of, or subject to any Encumbrance, any material Company IP or Business Data (other than non-exclusive licenses granted by Group
Companies in the Ordinary Course);
(f) disclose
any material Trade Secrets or Personal Data to any Person (other than in the Ordinary Course in circumstances in which it has imposed
reasonable and customary confidentiality restrictions);
(g) make
any acquisition of, or investment in, a business, by purchase of stock, securities or assets, merger or consolidation, or contributions
to capital, or loans or advances, in any such case with a value or purchase price in excess of $35,000,000 individually and $70,000,000
in the aggregate;
(h) settle
any Action by any Governmental Authority, or any other third-party material to the business of the Company and its Subsidiaries taken
as a whole, in excess of $1,000,000 individually and $5,000,000 in the aggregate;
(i) (i) subdivide,
split, consolidate, combine or reclassify its Equity Securities, except for any such transaction by a wholly owned Subsidiary of the
Company that remains a wholly owned Subsidiary of the Company after consummation of such transaction, (ii) redeem, repurchase, cancel
or otherwise acquire or offer to redeem, repurchase, or otherwise acquire any of its Equity Securities, except for the redemption of
Equity Securities issued under the ESOP or as disclosed in Section 5.1(i) of the Company Disclosure Letter, (iii) declare,
set aside, make or pay any dividend or other distribution, payable in cash, shares, property or otherwise, with respect to any of its
share capital other than dividends or distributions by any Subsidiary of the Company on a pro rata basis to its shareholders, or (iv) amend
any term or alter any rights of any of its outstanding Equity Securities;
(j) authorize,
make or incur any capital expenditures or obligations or liabilities in connection therewith, except in the Ordinary Course or other
than any capital expenditures or obligations or liabilities in an amount not to exceed $10,000,000 in the aggregate;
(k) enter
into any Material Contract, or amend any such Material Contract in any material respect, or extend, transfer, terminate or waive any
right or entitlement of material value under any Material Contract, in each case in a manner that is adverse to the Company and its Subsidiaries,
taken as a whole, except in the Ordinary Course; provided, however, that to the extent that another sub-section of this
Section 5.1 would permit the entry into of a Material Contract in a higher dollar threshold than in the definition of “Material
Contract,” then this Section 5.1(k) shall not prevent the entry into of such Material Contract in such higher
dollar threshold;
(l) except
as required under the terms of any Benefit Plan as in effect on the date of this Agreement or as otherwise required by Law, (w) increase
the compensation or benefits payable or provided, or to become payable or provided to, any employees, directors, officers or other individual
service providers of the Company or any Subsidiary, whose total annual compensation opportunity exceeds $1,000,000, except for immaterial
increases in base salary (and any corresponding annual target bonus that is determined based on the employee’s base salary rate)
in the Ordinary Course, (x) grant or announce any cash or equity or equity-based incentive awards, bonuses, transaction, retention,
severance or other additional compensation or benefits to any employees, directors, officers, or consultants of the Company or any Subsidiary,
except for any annual bonus granted in the Ordinary Course or the grant of awards in accordance with the terms of the ESOP, (y) accelerate
the time of payment, vesting or funding of any compensation or increase in the benefits or compensation provided under any Benefit Plan
or otherwise due to any current or former employees, directors, officers or other individual service providers of the Company or any
Subsidiary, or (z) hire, engage, terminate (other than for “cause”), furlough or temporary layoff any employee of the
Company or any Subsidiary whose annual base compensation exceeds $1,000,000;
(m) except
as required under the terms of any Benefit Plan as in effect on the date of this Agreement or as otherwise required by Law, materially
amend, materially modify, or terminate any Benefit Plan or, adopt, enter into or establish a new Benefit Plan (or any plan, policy program,
agreement or other arrangement that would be a Benefit Plan if in effect as of the date of this Agreement);
(n) waive
or release any noncompetition or non-solicitation obligation of any current or former employees, directors, officers or other individual
service providers of the Company or any Subsidiary;
(o) voluntarily
terminate (other than expiration in accordance with its terms), suspend, abrogate, amend or modify any Material Permit except in the
Ordinary Course or as would not be material to the business of the Company and its Subsidiaries, taken as a whole;
(p) make
any material change in its accounting principles or methods unless required by GAAP or applicable Laws;
(q) except
in the Ordinary Course, (i) make, change or revoke any material Tax election; (ii) change or revoke any material accounting
method with respect to Taxes; or (iii) enter into any material closing agreement or other binding written agreement with any Governmental
Authority with respect to any material Tax;
(r) except
as contemplated by this Agreement, the Original Merger Agreement or the Transaction Documents, or the Transactions, take any action (or
knowingly fail to take any action) where such action or inaction would reasonably be expected to prevent, impair or impede the Intended
Tax Treatment; or
(s) enter
into any agreement or otherwise make a commitment to do any of the foregoing (except to the extent that such an agreement or commitment
would be permitted by a subsection of the foregoing subsections (a) through (r)).
For the avoidance of doubt,
if any action taken or refrained from being taken by the Company or a Subsidiary is covered by a subsection of this Section 5.1
and not prohibited thereunder, the taking or not taking of such action shall be deemed not to be in violation of any other part of
this Section 5.1.
Section 5.2.
Access to Information.
Upon reasonable prior notice and subject to applicable Law or appropriate COVID-19 Measures, during the Interim Period, the Company shall,
and shall cause each of its wholly owned Subsidiaries and each of its and its wholly owned Subsidiaries’ officers, directors and
employees to, and shall use its commercially reasonable efforts to cause its Representatives to, afford SPAC and its Representatives,
following reasonable notice from SPAC in accordance with this Section 5.2, in such manner as to not interfere with
the normal business operation of the Company and its Subsidiaries, reasonable access during normal business hours to the officers, employees,
agents, properties, offices and other facilities, books and records of each of it and its wholly owned Subsidiaries, and financial and
operating data, and other information concerning the affairs of the Company and its Subsidiaries that are in the possession of the Company
and its Subsidiaries, in each case, as shall be reasonably requested solely for purposes of and that are necessary for consummating the
Transactions; provided, however, that in each case, the Company and its Subsidiaries shall not be required to disclose
any document or information, or permit any inspection, that would, in the reasonable judgment of the Company, (a) result in the
disclosure of any trade secrets or violate the terms of any confidentiality provisions in any agreement with a third party, (b) result
in a violation of applicable Law, including any fiduciary duty, (c) result in the loss of the protection of any attorney-client
work product or other applicable privilege (provided that the Company shall use commercially reasonable efforts to provide any
information described in the foregoing clauses (b) and (c) in a manner that would not be so prohibited by Law or would not
jeopardize privilege), or (d) result in the disclosure of any sensitive or personal information that would expose the Company to
the risk of Liabilities. All information and materials provided pursuant to this Agreement or the Original Merger Agreement will be subject
to the provisions of the NDA.
Section 5.3.
Company Listing.
The Company will use its commercially reasonable efforts to cause: (a) the Company’s initial listing application with the
Stock Exchange in connection with the Transactions to be approved, (b) immediately following the Closing, the Company to satisfy
any applicable initial and continuing listing requirements of the Stock Exchange, and (c) the Company ADSs and the Company Warrants
to be issued in connection with the Transactions to be approved for listing on the Stock Exchange, subject to official notice of issuance.
Section 5.4.
Acquisition Proposals and
Alternative Transactions. During the Interim Period, the Company shall not, and it shall cause its Controlled Affiliates and its
and their respective Representatives not to, directly or indirectly: (a) solicit, initiate, submit, facilitate (including by means
of furnishing or disclosing information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral)
with any third-party (including any Competing SPAC) with respect to a Company Acquisition Proposal; (b) furnish or disclose any
non-public information to any third-party (including to any Competing SPAC) in connection with or that would reasonably be expected to
lead to a Company Acquisition Proposal; (c) enter into any agreement, arrangement or understanding with any third party (including
a Competing SPAC) regarding a Company Acquisition Proposal; (d) prepare or take any steps in connection with any public offering
of any Equity Securities of the Company, any of its Subsidiaries, or a newly-formed holding company of the Company or such Subsidiaries
or (e) otherwise cooperate in any way with, or assist or participate in, or knowingly facilitate or encourage any effort or attempt
by any Person to do or seek to do any of the foregoing.
Section 5.5.
D&O Indemnification
and Insurance.
(a) From
and after the Closing, the Company and Surviving Entity 2 shall jointly and severally indemnify and hold harmless each present and former
director and officer, as the case may be, of SPAC (in each case, solely to the extent acting in his or her capacity as such and to the
extent such activities are related to the business of SPAC) (each, a “SPAC D&O Indemnified Parties”) against any
costs or expenses (including reasonable attorneys’ fees), judgments, fines, losses, claims, damages or liabilities incurred in
connection with any Action, whether civil, criminal, administrative or investigative, arising out of or pertaining to matters existing
or occurring at or prior to the Closing, whether asserted or claimed prior to, at or after the Closing, to the fullest extent that SPAC
would have been permitted under applicable Law and its respective certificate of incorporation, certificate of formation, bylaws, memorandum
and articles of association, limited liability company agreement, limited liability partnership agreement, limited liability limited
partnership agreement or other Organizational Documents in effect on the date of this Agreement to indemnify such SPAC D&O Indemnified
Parties (including the advancing of expenses as incurred to the fullest extent permitted under applicable Law). Without limiting the
foregoing, the Company and Surviving Entity 2 shall, (i) for a period of not less than six years from the Closing, maintain in effect
provisions in their Organizational Documents concerning the indemnification and exoneration (including provisions relating to expense
advancement) of SPAC’s former and current officers, directors, employees, and agents that are no less favorable to those Persons
than such provisions in SPAC’s Organizational Documents as in effect as of the date of this Agreement, and (ii) not amend,
repeal or otherwise modify such provisions in any respect that would adversely affect the rights of those Persons thereunder, in each
case, except as required by Law.
(b) For
a period of six years from the Closing, the Company shall, at its cost and expense, maintain in effect directors’ and officers’
liability insurance (a “SPAC D&O Insurance”) covering those Persons who are currently covered by SPAC’s
directors’ and officers’ liability insurance policies (including, in any event, the SPAC D&O Indemnified Parties) on
terms not less favorable than the terms of such current insurance coverage; provided that the aggregate cost of the SPAC D&O
Insurance shall not be in excess of 300% of the aggregate annual premium payable by SPAC for such insurance policy for the year ended
December 31, 2021; provided, however, that (i) SPAC may, at the Company’s cost and expense, cause
coverage to be extended under the current directors’ and officers’ liability insurance by obtaining a six-year “tail”
policy with respect to claims existing or occurring at or prior to the Closing and if and to the extent such policies have been obtained
prior to the Closing with respect to any such Persons, SPAC shall maintain such policies in effect and continue to honor the obligations
thereunder, and (ii) if any claim is asserted or made within such six-year period, any insurance required to be maintained under
this Section 5.5 shall be continued in respect of such claim until the final disposition thereof.
(c) Notwithstanding
anything contained in this Agreement to the contrary, this Section 5.5 shall survive the Closing and shall be binding, jointly
and severally, on the Company and Surviving Entity 2 and all of their respective successors and assigns. In the event that the Company
and Surviving Entity 2 or any of their respective successors or assigns consolidates with or merges into any other Person and shall not
be the continuing or surviving company or entity of such consolidation or merger or transfers or conveys all or substantially all of
its properties and assets to any Person, then, and in each such case, the Company and Surviving Entity 2 shall ensure that proper provision
shall be made so that the successors and assigns of the Company and Surviving Entity 2, as the case may be, shall succeed to the obligations
set forth in this Section 5.5.
(d) The
provisions of Section 5.5(a) through (c) (i) are intended to be for the benefit of, and shall be enforceable
by, each Person who is now, or who has been at any time prior to the date of this Agreement or who becomes prior to the Closing, a SPAC
D&O Indemnified Party, his or her heirs and his or her personal representatives, (ii) are in addition to, and not in substitution
for, any other rights to indemnification or contribution that any such Person may have, whether pursuant to Law, Contract, Organizational
Documents, or otherwise and (iii) shall not be terminated or modified in such a manner as to adversely affect any SPAC D&O Indemnified
Party without the consent of such SPAC D&O Indemnified Party.
Section 5.6.
Post-Closing Board
of Directors of the Company. Subject to the terms of the A&R Company Charter, the Company shall take all such action within its
power as may be necessary or appropriate such that immediately following the Closing, the board of directors of the Company (i) shall
include one director designated by SPAC pursuant to a written notice to be delivered to the Company sufficiently in advance of the date
on which the Proxy/Registration Statement is declared effective under the Securities Act, subject to such Person being reasonably acceptable
to the Company and passing customary background checks (all such directors of the Company following the Closing, the “Company
Directors”) and (ii) shall have reconstituted its applicable committees to consist of the directors designated by the
Company prior to the Closing Date; provided, however, that any such directors designated by the Company in accordance with
clause (ii) of this sentence as members of the audit committee shall qualify as “independent” under the listing
rules of the Stock Exchange.
Section 5.7.
Notice of Developments.
During the Interim Period, the Company shall promptly (and in any event prior to the Closing) notify SPAC in writing, and SPAC shall
promptly (and in any event prior to the Closing) notify the Company in writing, upon any of the Group Companies or SPAC, as applicable,
becoming aware (awareness being determined with reference to the Knowledge of the Company or the Knowledge of SPAC, as the case may be)
(i) of the occurrence or non-occurrence of any event the occurrence or non-occurrence of which has caused or is reasonably likely
to cause any condition to the obligations of any Party to effect the Transactions not to be satisfied or (ii) of any notice or other
communication from any Governmental Authority which is reasonably likely to have a material adverse effect on the ability of the parties
hereto to consummate the Transactions or to materially delay the timing thereof. The delivery of any notice pursuant to this Section 5.7
shall not cure any breach of any representation or warranty requiring disclosure of such matter or any breach of any covenant, condition
or agreement contained in this Agreement or any other Transaction Document or otherwise limit or affect the rights of, or the remedies
available to, SPAC or the Company, as applicable. Notwithstanding anything to the contrary contained herein, any failure to give such
notice pursuant to this Section 5.7 shall not give rise to any liability of the Company or SPAC or be taken into account
in determining whether the conditions in Article VIII have been satisfied or give rise to any right of termination set forth
in Article IX.
Section 5.8.
Financials. As
promptly as reasonably practicable after the date of this Agreement, the Company shall deliver to SPAC (i) the audited consolidated
balance sheet of the Company and its Subsidiaries as of December 31, 2022, and the related audited consolidated statements of income
and profit and loss, and cash flows, for the fiscal year then ended together with the auditor’s reports thereon and (ii) any
other audited and unaudited consolidated balance sheets of the Company and its Subsidiaries and the related audited or unaudited consolidated
statements of income and profit and loss, and cash flows that are required to be included in the Proxy/Registration Statement (in each
case to the extent not already delivered by the Company to SPAC prior to the date hereof) (collectively, the “Additional Financial
Statements”). The Company and SPAC shall each use its reasonable efforts (a) to assist the other, upon advance written
notice, during normal business hours and in a manner such as to not unreasonably interfere with the normal operation of the Company or
any of its Subsidiaries or SPAC, in preparing in a timely manner any other financial information or statements (including customary
pro forma financial statements) that are required to be included in the Proxy/Registration Statement and any other filings to be made
by SPAC or the Company with the SEC in connection with the Transactions and (b) to obtain the consents of its auditors with respect
thereto as may be required by applicable Law or requested by the SEC in connection therewith. Upon delivery of the Additional Financial
Statements, the representations and warranties set forth in Section 3.9(c) shall be deemed to apply to the Additional
Financial Statements in the same manner as the Company Financial Statements, mutatis mutandis, with the same force and effect
as if included in Section 3.9(c) as of the date of this Agreement.
Section 5.9.
No Trading.
The Company acknowledges and agrees that it is aware, and that its Controlled Affiliates have been made aware of the restrictions imposed
by U.S. federal securities laws and the rules and regulations of the SEC promulgated thereunder or otherwise and other applicable
foreign and domestic Laws on a Person possessing material nonpublic information about a publicly traded company. The Company hereby agrees
that it shall not purchase or sell any securities of SPAC in violation of such Laws, or cause or encourage any Person to do the foregoing.
Section 5.10.
Distribution Agreement and Put
Option Agreements.
(a) Prior
to the Closing, the Company agrees to use its reasonable best efforts to procure the parties to the Distribution Agreement to take such
actions as may be necessary for the performance of such parties’ respective obligations thereunder.
(b) Prior
to the Closing, the Company shall procure that the parties to the Distribution Agreement and each of the Put Option Agreements not to
amend or modify, or waive (in whole or in part) of any provision or remedy under, or make any replacements of, the Distribution Agreement
or the Put Option Agreements, in each case, without the prior written consent of SPAC (such consent not to be unreasonably withheld,
conditioned or delayed).
Section 5.11.
Additional Pre-Closing Actions. During
the Interim Period, the Company shall, and shall cause its Subsidiaries to, use their respective commercially reasonable efforts to undertake
the actions set forth on Section 5.11 of the Company Disclosure Letter
Section 5.12.
Additional Agreements.
(a) Prior
to the Closing, the Company shall (i) deliver, or cause to be delivered to SPAC lock-up agreements substantially in the form attached
hereto as Exhibit J (the “Lock-Up Agreement”) executed by each Company Shareholder listed on Section 5.12(a) of
the Company Disclosure Letter, and (ii) use its commercially reasonable efforts to deliver, or cause to be delivered, to SPAC Lock-Up
Agreements executed by each Company Shareholder (prior to giving effect to any PIPE Financing) who is not a party to the Company Support
Agreement and who is not listed on Section 5.12(a) of the Company Disclosure Letter, each of which shall be effective
as of the Closing. The Company shall not, without the prior written consent of SPAC, permit any amendment or modification to, or any
waiver (in whole or in part) of any provision under, any of the Lock-Up Agreements (or in the case of any amendment or modification,
the form of the Lock-Up Agreement).
(b) The
Company shall (i) require, as a condition to any Pre-Closing Financing Investor receiving any Equity Securities of the Company (other
than any convertible notes of the Company) in connection with the Pre-Closing Financing, that such Pre-Closing Financing Investor enter
into a Lock-Up Agreement, prior to such Person receiving any Equity Security from the Company; provided that a Pre-Closing Financing
Investor shall not be required to enter into any Lock-Up Agreement to the extent such Pre-Closing Financing Investor is only issued convertible
notes of the Company in connection with any Pre-Closing Financing, and any Company Ordinary Shares that are issued to such Pre-Closing
Financing Investor upon conversion of such convertible notes of the Company issued to such Pre-Closing Financing Investor in connection
with any Pre-Closing Financing shall not be subject to any lock-up restrictions, and (ii) procure some or all of the Pre-Closing
Financing Investors to enter into a Shareholder Support Agreement, substantially in the form of the Company Support Agreement, in the
event that the Company Shareholders who are parties to the Company Support Agreement collectively hold less than two-thirds (2/3) of
the issued and outstanding Company Shares after taking account of the Pre-Closing Financing.
Article VI
COVENANTS
OF SPAC
Section 6.1.
Conduct of Business.
Except (i) as contemplated or permitted by the Transaction Documents or the Original Merger Agreement (including as contemplated
by any PIPE Financing), (ii) as required by applicable Law (including for this purpose any COVID-19 Measures) or relevant Governmental Authorities,
(iii) as set forth on Section 6.1 of the SPAC Disclosure Letter or (iv) as consented to by the Company in writing
(which consent shall not be unreasonably withheld, conditioned or delayed and regardless of whether such consent was granted pursuant
to the Original Merger Agreement or this Agreement), during the Interim Period, SPAC (1) shall operate its business in the Ordinary
Course and (2) shall not:
(a) (i)
seek any approval from SPAC Shareholders to change, modify or amend the Trust Agreement or the SPAC Charter, except as contemplated by
the Transaction Proposals or (ii) change, modify or amend the Trust Agreement or its Organizational Documents, except as expressly
contemplated by the Transaction Proposals;
(b) (i) subdivide,
consolidate, reclassify or amend any terms of its Equity Securities, (ii) redeem, repurchase, cancel or otherwise acquire or offer
to redeem, repurchase, or otherwise acquire any of its Equity Securities, other than a redemption of SPAC Class A Ordinary Shares
in connection with the exercise of any SPAC Shareholder Redemption Right by any SPAC Shareholder or upon conversion of SPAC Class B
Ordinary Shares in accordance with the SPAC Charter, or (iii) declare, set aside, make or pay any dividend or other distribution,
payable in cash, shares, property or otherwise, with respect to any of its share capital;
(c) merge,
consolidate or amalgamate with or into, or acquire (by purchasing a substantial portion of the assets of or any equity in, or by any
other manner) or make any advance or loan to or investment in any other Person or be acquired by any other Person;
(d) except
in the Ordinary Course, (i) make, change or revoke any material Tax election; (ii) change or revoke any material accounting
method with respect to Taxes; or (iii) enter into any material closing agreement or other binding written agreement with any Governmental
Authority with respect to any material Tax;
(e) except
as contemplated by this Agreement, the Original Merger Agreement, the Transaction Documents, or the Transactions, take any action (or
knowingly fail to take any action) where such action or inaction would reasonably be expected to prevent, impair or impede the Intended
Tax Treatment;
(f) enter
into, renew or amend in any material respect, any transaction or material Contract of SPAC, except for material Contracts entered into
in the Ordinary Course; provided, however, that notwithstanding anything to the contrary contained in this Agreement, even
if done in the Ordinary Course, SPAC shall not enter into, renew or amend in any respect, any transaction or Contract involving any SPAC
Related Party, except as expressly provided in the Transaction Documents (other than Working Capital Loans that the SPAC may obtain in
the Ordinary Course);
(g) incur,
assume, guarantee or repurchase or otherwise become liable for any Indebtedness, or issue or sell any debt securities or options, warrants
or other rights to acquire debt securities, in any such case in a principal amount, as applicable, exceeding $500,000 in the aggregate,
other than (i) Indebtedness or other Liabilities expressly set out in the SPAC Disclosure Letter, and (ii) Liabilities that
qualify as SPAC Transaction Expenses (including, for the avoidance of doubt, any Working Capital Loans in an aggregate amount not exceeding
$1,500,000 (provided that any Working Capital Loans obtained by SPAC in connection with the Extension Proposal or in connection
with obtaining the SPAC Shareholder Extension Approval shall not be taken into account in determining whether such $1,500,000 threshold
has been met));
(h) make
any change in its accounting principles or methods unless required by GAAP or applicable Laws;
(i) (i) issue
any Equity Securities, other than (A) the issuance of SPAC Class A Ordinary Shares upon conversion of SPAC Class B Ordinary
Shares in accordance with the SPAC Charter, or (B) the issuance of SPAC Warrants pursuant to any Working Capital Loans, or (ii) grant
any options, warrants or other equity-based awards;
(j) settle
or agree to settle any Action before any Governmental Authority or any other third party or that imposes injunctive or other non-monetary
relief on SPAC;
(k) form
any Subsidiary;
(l) liquidate,
dissolve, reorganize or otherwise wind-up the business and operations of SPAC or propose or adopt a plan of complete or partial liquidation
or dissolution, consolidation, restructuring, recapitalization, reclassification or similar change in capitalization or other reorganization
of SPAC; or
(m) enter
into any agreement or otherwise make any commitment to do any action prohibited under this Section 6.1.
For the avoidance of doubt,
if any action taken or refrained from being taken by SPAC is covered by a subsection of this Section 6.1 and not prohibited
thereunder, the taking or not taking of such action shall be deemed not to be in violation of any other part of this Section 6.1.
Section 6.2.
Access to Information.
Upon reasonable prior notice and subject to applicable Law and appropriate COVID-19 Measures, during the Interim Period, SPAC shall,
and shall cause each of its officers, directors and employees to, and shall use its commercially reasonable efforts to cause its Representatives
to, afford the Company and its Representatives, following reasonable notice from SPAC in accordance with this Section 6.2,
in such manner as to not interfere with the normal operation of SPAC, reasonable access during normal business hours to the officers,
employees, agents, properties, offices and other facilities, books and records of it, and financial and operating data, and other information
concerning the affairs of SPAC that are in the possession of SPAC, in each case, as shall be reasonably requested solely for purposes
of and that are necessary for consummating the Transactions; provided, however, that in each case, SPAC shall not be required to disclose
any document or information, or permit any inspection, that would, in the reasonable judgment of SPAC, (a) result in the disclosure
of any trade secrets or violate the terms of any confidentiality provisions in any agreement with a third party, (b) result in a
violation of applicable Law, including any fiduciary duty, (c) result in the loss of the protection of the protection of any attorney-client
work product or other applicable privilege (provided that SPAC shall use commercially reasonable efforts to provide any information
described in the foregoing clauses (b) and (c) in a manner that would not be so prohibited by Law or would not jeopardize privilege),
or (d) result in the disclosure of any sensitive or personal information that would expose SPAC to the risk of Liabilities. All
information and materials provided pursuant to this Agreement or the Original Merger Agreement will be subject to the provisions of the
NDA.
Section 6.3.
Acquisition Proposals
and Alternative Transactions. During the Interim Period, SPAC will not, and it will cause its Affiliates and its and their respective
Representatives not to, directly or indirectly: (a) solicit, initiate, submit, facilitate (including by means of furnishing or disclosing
information), discuss or negotiate, directly or indirectly, any inquiry, proposal or offer (written or oral) with respect to a SPAC Acquisition
Proposal; (b) furnish or disclose any non-public information to any person or entity in connection with or that could reasonably
be expected to lead to a SPAC Acquisition Proposal; (c) enter into any agreement, arrangement or understanding regarding a SPAC
Acquisition Proposal; or (d) otherwise cooperate in any way with, or assist or participate in, or knowingly facilitate or encourage
any effort or attempt by any Person to do or seek to do any of the foregoing.
Section 6.4.
Nasdaq Listing.
From the date of this Agreement through the Closing, SPAC shall use reasonable best efforts to ensure SPAC remains listed as a public
company on Nasdaq.
Section 6.5.
SPAC Public Filings.
From the date of this Agreement through the Closing, SPAC will accurately and timely file all reports required to be filed or furnished
with the SEC and otherwise comply in all material respects with its reporting obligations under applicable Laws.
Section 6.6.
Section 16
Matters. Prior to the Closing Date, SPAC shall take all such steps (to the extent permitted under applicable Law) as are reasonably
necessary to cause any acquisition or disposition of SPAC Class A Ordinary Shares or any derivative thereof that occurs or is deemed
to occur by reason of or pursuant to the Transactions by each Person who is or will be or may become subject to Section 16 of the
Exchange Act with respect to the Company, including by virtue of being deemed a director by deputization, to be exempt under Rule 16b-3 promulgated
under the Exchange Act.
Section 6.7.
SPAC Extension.
Prior to February 15, 2023, SPAC shall (a) use its reasonable best efforts to cause the SPAC Board as promptly as practicable
following the date of this Agreement to approve such amendment to the SPAC Charter to provide that (x) the date by which SPAC must
consummate a Business Combination in accordance with the SPAC Charter is extended from March 15, 2023 to June 15, 2023 (such
date by which SPAC must consummate a Business Combination in accordance with the SPAC Charter, as amended, and as may be extended in
accordance with the provisions of this Section 6.7, the “Business Combination Deadline”), and (y) the
SPAC Board may, in its discretion and without any action on the part of the SPAC Shareholders, if requested by Sponsor, extend the Business
Combination Deadline on a monthly basis for up to nine (9) times by an additional one (1) month each time after the extension
described in the foregoing clause (x), upon five (5) days prior written notice from Sponsor prior to the applicable Business Combination
Deadline, until March 15, 2024, unless the Transactions shall have been consummated (such proposal, the “Extension Proposal”)
and resolve to recommend that the SPAC Shareholders approve such Extension Proposal by special resolution (the “Extension Recommendation”),
and not change or modify or propose to change or modify the Extension Recommendation, and (b) prepare and file with the SEC a proxy
statement (such proxy statement, together with any amendments or supplements thereto, the “Extension Proxy Statement”)
for the purpose of soliciting proxies from SPAC Shareholders for the Extension Proposal, which shall include, among other things, (x) a
description and introduction of the Company, (y) a statement that the Original Merger Agreement and other Transaction Documents
have been entered into, and (z) additional economic incentives for SPAC Shareholders that approve the Extension Proposal. SPAC shall
(i) comply in all material respects with all applicable Laws, any applicable rules and regulations of Nasdaq, the SPAC Charter
and the Original Merger Agreement in connection with the preparation, filing and distribution of the Extension Proxy Statement, any solicitation
of proxies thereunder, the holding of an extraordinary general meeting of SPAC Shareholders to consider, vote on and approve the Extension
Proposal (the “SPAC Shareholder Extension Approval”), exercise of the SPAC Shareholder Redemption Right related thereto
and making any necessary filings with the Cayman Registrar, and (ii) respond to any comments or other communications, whether written
or oral, that SPAC or its counsel may receive from time to time from the SEC or its staff with respect to the Extension Proxy Statement.
SPAC or Sponsor shall be responsible for funding any Extension Expenses prior to the Closing Date. Section 7.2(b) shall
apply mutatis mutandis to the Extension Proxy Statement, the Extension Recommendation and the SPAC Shareholder Extension Approval,
including with respect to the actions to be taken by the SPAC Board in connection therewith.
Article VII
JOINT
COVENANTS
Section 7.1.
Regulatory Approvals;
Other Filings.
(a) Each
of the Parties shall use their commercially reasonable efforts to cooperate in good faith with any Governmental Authority and to undertake
promptly any and all action required to obtain any necessary or advisable regulatory approvals, consents, Actions, nonactions or waivers
in connection with the Transactions (the “Regulatory Approvals”) as soon as practicable and any and all action necessary
to consummate the Transactions as contemplated hereby. Each of the Parties shall use commercially reasonable efforts to cause the expiration
or termination of the waiting, notice or review periods under any applicable Regulatory Approval with respect to the Transactions as
promptly as possible after the execution of this Agreement.
(b) With
respect to each of the Regulatory Approvals and any other requests, inquiries, Actions or other proceedings by or from Governmental Authorities,
each of the Parties shall (i) diligently and expeditiously defend and use commercially reasonable efforts to obtain any necessary
clearance, approval, consent or Regulatory Approval under any applicable Laws prescribed or enforceable by any Governmental Authority
for the Transactions and to resolve any objections as may be asserted by any Governmental Authority with respect to the Transactions;
and (ii) cooperate fully with each other in the defense of such matters. To the extent not prohibited by Law, the Company shall
promptly furnish to SPAC, and SPAC shall promptly furnish to the Company, copies of any material, substantive notices or written communications
received by such party or any of its Affiliates from any Governmental Authority with respect to the Transactions, and each such party
shall permit counsel to the other parties an opportunity to review in advance, and each such party shall consider in good faith the views
of such counsel in connection with, any proposed material, substantive written communications by such party or its Affiliates to any
Governmental Authority concerning the Transactions; provided, however, no Party may enter into any agreement with any Governmental
Authority relating to any Regulatory Approval contemplated in this Agreement without the prior written consent of the other Parties.
To the extent not prohibited by Law, the Company agrees to provide SPAC and its counsel, and SPAC agrees to provide to the Company and
its counsel, the opportunity, to the extent practical, on reasonable advance notice, to participate in any material substantive meetings
or discussions, either in person or by telephone, between such party or any of its Affiliates or Representatives, on the one hand, and
any Governmental Authority, on the other hand, concerning or in connection with the Transactions. Each of the Parties agrees to make
all filings, to provide all information required of such party and to reasonably cooperate with each other, in each case, in connection
with the Regulatory Approvals; provided, further, that such party shall not be required to provide information to the extent
that (w) any applicable Law requires it or its Affiliates to restrict or prohibit access to such information, (x) in the reasonable
judgment of such party, the information is subject to confidentiality obligations to a third party, (y) in the reasonable judgment
of such party, the information is commercially sensitive and disclosure of such information would have a material impact on the business,
results of operations or financial condition of such party, or (z) disclosure of any such information would reasonably be likely
to result in the loss or waiver of the attorney-client work product or other applicable privilege. The Company and SPAC shall jointly
devise and implement the strategy for obtaining any necessary clearance or approval, for responding to any request, inquiry, or investigation,
for electing whether to defend, and, if so, defending any lawsuit challenging the Transactions, and for all meetings and communications
with any Governmental Authority concerning the Transactions.
(c) Subject
to Section 10.6, the Company, on the one hand, and SPAC, on the other, shall each be responsible for and pay fifty percent
(50%) of the fees, costs and expenses incurred in connection with any filing, submission or application for the Governmental Order
applicable to the Transactions.
Section 7.2.
Proxy/Registration
Statement; SPAC Shareholders' Meeting and Approvals; Company Shareholders' Approval.
(a) Proxy/Registration
Statement.
(i) As
promptly as reasonably practicable after the execution of this Agreement, the Company and SPAC shall jointly prepare, and the Company
shall file with the SEC, a registration statement on Form F-4 (as amended or supplemented from time to time, and including the Proxy
Statement, the “Proxy/Registration Statement”) relating to (x) the SPAC Shareholders’ Meeting to approve
and adopt the Transaction Proposals and (y) the registration under the Securities Act of the Company ADSs representing the ADS Merger
Consideration (and the Company Ordinary Shares represented thereby), the Company Warrants and the Company Ordinary Shares issuable upon
exercise of the Company Warrants in the form of Company ADSs. Each of the Company and SPAC shall use their respective reasonable best
efforts to (1) cause the Proxy/Registration Statement when filed with the SEC to comply in all material respects with all Laws applicable
thereto and rules and regulations promulgated by the SEC, (2) respond as promptly as reasonably practicable to and resolve
all comments received from the SEC concerning the Proxy/Registration Statement, (3) cause the Proxy/Registration Statement to be
declared effective under the Securities Act as promptly as practicable and (4) keep the Proxy/Registration Statement effective as
long as is necessary to consummate the Transactions. Prior to the effective date of the Proxy/Registration Statement, the Company and
SPAC shall take all or any action required under any applicable federal or state securities Laws in connection with the issuance of Company
ADSs and Company Warrants pursuant to this Agreement. Each of the Company and SPAC also agrees to use its reasonable best efforts to
obtain all necessary state securities law or “Blue Sky” permits and approvals required to carry out the Transactions, and
the Company and SPAC shall furnish all information respectively, concerning SPAC and the Company and its Subsidiaries and any of their
respective members or shareholders as may be reasonably requested in connection with any such action. As promptly as practicable after
finalization and effectiveness of the Proxy/Registration Statement, SPAC shall (and shall use commercially reasonable efforts to do so
within five (5) Business Days of such finalization and effectiveness) mail the Proxy/Registration Statement to the SPAC Shareholders.
Each of the Company and SPAC shall furnish to the other parties all information concerning itself, its Subsidiaries, officers, directors,
managers, shareholders, and other equityholders and information regarding such other matters as may be reasonably necessary or advisable
or as may be reasonably requested by any of them or any Governmental Authority in connection with the Proxy/Registration Statement, or
any other statement, filing, notice or application made by or on behalf of the Company, SPAC, or their respective Affiliates to any Governmental
Authority (including the Stock Exchange) in connection with the Transactions (collectively, the “Transaction Filings”).
Subject to Section 10.6, the Company, on the one hand, and SPAC, on the other, shall each be responsible for and pay fifty
percent (50%) of the fees, costs and expenses incurred in connection with the preparation, filing and mailing of the Proxy/Registration
Statement in connection with the Transactions.
(ii) Any
filing of, or amendment or supplement to, the Proxy/Registration Statement or the Transaction Filings will be mutually prepared and agreed
upon by the Company and SPAC. The Company will advise SPAC, promptly after receiving notice thereof, of the time when the Proxy/Registration
Statement has become effective or any supplement or amendment has been filed, of the issuance of any stop order, of the suspension of
the qualification of Company ADSs and Company Warrants to be issued or issuable in connection with this Agreement for offering or sale
in any jurisdiction, or of any request by the SEC for amendment of the Proxy/Registration Statement or any Transaction Filings or comments
thereon and responses thereto or requests by the SEC for additional information and responses thereto, and shall provide SPAC a reasonable
opportunity to provide comments and amendments to any such filing. The Company and SPAC shall cooperate and mutually agree upon (such
agreement not to be unreasonably withheld or delayed) any response to comments of the SEC or its staff with respect to the Proxy/Registration
Statement or any Transaction Filings and any amendment to the Proxy/Registration Statement or any Transaction Filings filed in response
thereto.
(iii) If,
at any time prior to the First Effective Time, any event or circumstance relating to SPAC or the Company, or their respective officers
or directors, should be discovered by SPAC or the Company which is required to be set forth in an amendment or a supplement to the Proxy/Registration
Statement so that any of such documents would not include an untrue statement of a material fact or omit to state any material fact necessary
to make the statements therein, in light of the circumstances under which they were made, not misleading, the Party that discovers such
information shall promptly inform the other Party(ies). Thereafter, the Company and SPAC shall promptly cooperate in the preparation
and filing of an appropriate amendment or supplement to the Proxy/Registration Statement describing or correcting such information to
be promptly filed with the SEC and, to the extent required by Law, disseminate such amendment or supplement to the SPAC Shareholders.
(b) SPAC
Shareholders’ Approval.
(i) Prior
to or as promptly as practicable after the Proxy/Registration Statement is declared effective under the Securities Act, SPAC shall establish
a record date for, duly call, give notice of, convene and hold a meeting of the SPAC Shareholders (including any adjournment or postponement
thereof, the “SPAC Shareholders’ Meeting”) in accordance with the SPAC Charter and applicable Law to be held
as promptly as reasonably practicable and, unless otherwise agreed by SPAC and the Company in writing, in any event not more than forty-five
(45) days following the date that the Proxy/Registration Statement is declared effective under the Securities Act for the purpose of
voting on the Transaction Proposals and obtaining the SPAC Shareholders’ Approval (including the approval of any adjournment or
postponement of such meeting for the purpose of soliciting additional proxies in favor of the adoption of the Transaction Proposals),
providing SPAC Shareholders with the opportunity to elect to exercise their SPAC Shareholder Redemption Right and such other matters
as may be mutually agreed by SPAC and the Company. SPAC will use its reasonable best efforts (A) to solicit from its shareholders
proxies in favor of the adoption of the Transaction Proposals, including the SPAC Shareholders’ Approval, and will take all other
action necessary or advisable to obtain such proxies and SPAC Shareholders’ Approval and (B) to obtain the vote or consent
of its shareholders required by and in compliance with all applicable Law, Nasdaq rules and the SPAC Charter. SPAC (x) shall
consult with the Company regarding the record date and the date of the SPAC Shareholders’ Meeting prior to determining such dates
and (y) shall not adjourn or postpone the SPAC Shareholders’ Meeting without the prior written consent of the Company (which
consent shall not be unreasonably withheld, conditioned or delayed); provided, however, that SPAC shall adjourn or postpone
the SPAC Shareholders’ Meeting (1) to the extent necessary to ensure that any supplement or amendment to the Proxy/Registration
Statement that SPAC or the Company reasonably determines is necessary to comply with applicable Laws, is provided to the SPAC Shareholders
in advance of a vote on the adoption of the Transaction Proposals, (2) if, as of the time that the SPAC Shareholders’ Meeting
is originally scheduled, there are insufficient SPAC Shares represented at such meeting (either in person or by proxy) to constitute
a quorum necessary to conduct the business of the SPAC Shareholders’ Meeting, (3) if, as of the time that the SPAC Shareholders’
Meeting is originally scheduled, adjournment or postponement of the SPAC Shareholders’ Meeting is necessary to enable SPAC to solicit
additional proxies required to obtain SPAC Shareholders’ Approval, (4) in order to seek withdrawals from SPAC Shareholders
who have exercised their SPAC Shareholder Redemption Right if a number of SPAC Shares have been elected to be redeemed such that SPAC
reasonably expects that the condition set forth in Section 8.3(c) will not be satisfied at the Closing, or (5) to
comply with applicable Law; provided, further, however, that without the prior written consent of the Company (which
consent shall not be unreasonably conditioned, withheld or delayed), SPAC shall not adjourn or postpone on more than two (2) occasions
and so long as the date of the SPAC Shareholders’ Meeting is not adjourned or postponed more than fifteen (15) consecutive days
in connection with such adjournment or postponement.
(ii) The
Proxy/Registration Statement shall include a statement to the effect that SPAC Board has unanimously recommended that the SPAC Shareholders
vote in favor of the Transaction Proposals at the SPAC Shareholders’ Meeting (such statement, the “SPAC Board Recommendation”)
and neither the SPAC Board nor any committee thereof shall withhold, withdraw, qualify, amend or modify, or publicly propose or resolve
to withhold, withdraw, qualify, amend or modify, the SPAC Board Recommendation (a “SPAC Change in Recommendation”).
(c) Required
Shareholders’ Approval.
(i) Prior
to or as promptly as practicable after the Proxy/Registration Statement is declared effective under the Securities Act, the Company shall
establish a record date for, duly call, give notice of, convene and hold a meeting of the Company Shareholders (including any adjournment
thereof, the “Company Shareholders’ Meeting”) in accordance with the Company Charter and applicable Law to be
held as promptly as reasonably practicable following the date that the Proxy/Registration Statement is declared effective under the Securities
Act for the purpose of obtaining the Required Shareholders’ Approval (including the approval of any adjournment of such meeting
for the purpose of soliciting additional proxies in favor of the Required Shareholders’ Approval) and approval of such other matters
as may be mutually agreed by SPAC and the Company. The Company will use its reasonable best efforts to obtain the vote or consent of
its shareholders required by and in compliance with all applicable Law, the Company Charter and the Shareholders Agreement. The
Company (y) shall set the date of the Company Shareholders’ Meeting not more than thirty (30) days after the Proxy/Registration
Statement is declared effective and (z) shall not adjourn the Company Shareholders’ Meeting without the prior written consent
of SPAC (which consent shall not be unreasonably conditioned, withheld or delayed); provided, however, that the Company
may adjourn the Company Shareholders’ Meeting (1) if, as of the time that the Company Shareholders’ Meeting is originally
scheduled, there are insufficient Company Shares represented at such meeting (either in person or by proxy) to constitute a quorum necessary
to conduct the business of the Company Shareholders’ Meeting, (2) if, as of the time that the Company Shareholders’
Meeting is originally scheduled, adjournment of the Company Shareholders’ Meeting is necessary to enable the Company to solicit
additional proxies required to obtain the Required Shareholders’ Approval, or (3) to comply with applicable Law; provided,
however, that for both prior clauses (1) and (2) in the aggregate the Company may adjourn on only one occasion and so
long as the date of the Company Shareholders’ Meeting is not adjourned or postponed more than fifteen (15) consecutive days.
(ii) The
Company shall send meeting materials to the Company Shareholders which shall seek the Required Shareholders’ Approval and shall
include in all such meeting materials it sends to the Company Shareholders in connection with the Company Shareholders’ Meeting
a statement to the effect that the Company Board has unanimously recommended that the Company Shareholders vote in favor of granting
the Required Shareholders’ Approval (such statement, the “Company Board Recommendation”) and neither the Company
Board nor any committee thereof shall withhold, withdraw, qualify, amend or modify, or publicly propose or resolve to withhold, withdraw,
qualify, amend or modify, the Company Board Recommendation.
Section 7.3.
Support of Transaction.
Without limiting any covenant contained in Article V or Article VI (a) the Company shall, and shall cause
its Subsidiaries to, and (b) SPAC shall, (i) use reasonable best efforts to obtain all material consents and approvals of third
parties that the Company and any of its Subsidiaries or SPAC, as applicable, are required to obtain in order to consummate the Transactions,
(ii) use reasonable best efforts to take such other action as may be reasonably necessary or as another party hereto may reasonably
request to satisfy the conditions of Article VIII or otherwise to comply with this Agreement and to consummate the Transactions
as soon as practicable; provided, however, that, notwithstanding anything contained in this Agreement to the contrary,
nothing in this Agreement, including this Article VII, shall require the Company, any of its Subsidiaries or SPAC or any
of their respective Affiliates to (A) commence or threaten to commence, pursue or defend against any Action, whether judicial or
administrative, (B) seek to have any stay or Governmental Order vacated or reversed, (C) propose, negotiate, commit to or effect
by consent decree, hold separate order or otherwise, the sale, divestiture, licensing or disposition of any assets or businesses of the
Company or any of its Subsidiaries or SPAC, (D) take or commit to take actions that limit the freedom of action of the Company,
any of its Subsidiaries or SPAC with respect to, or the ability to retain, control or operate, or to exert full rights of ownership in
respect of, any of the businesses, product lines or assets of the Company, any of its Subsidiaries or SPAC or (E) grant any financial,
legal or other accommodation to any other Person, including agreeing to change any of the terms of the Transactions.
Section 7.4.
Tax Matters.
The Parties intend that (i) the Mergers, taken together, are to constitute an integrated transaction described in Revenue Ruling
2001-46, 2001-2 C.B. 321 that qualifies as a “reorganization” within the meaning of Section 368(a) of the Code
and the Treasury Regulations promulgated thereunder and (ii) the SPAC Class B Conversion qualifies as a “reorganization”
within the meaning of Section 368(a)(1)(E) of the Code and the Treasury Regulations promulgated thereunder (the “Intended
Tax Treatment”) and the Parties shall reasonably cooperate with each other and their respective tax counsel to document and
support the Intended Tax Treatment and take all the actions described in Section 7.4 of the Company Disclosure Letter. The
Parties agree and acknowledge that, for U.S. federal income tax purposes, it is intended that this Agreement constitutes, and is adopted
as, a separate “plan of reorganization” within the meaning of Treasury Regulations Sections 1.368-2(g) and 1.368-3(a) for
each of the Mergers and the SPAC Class B Conversion for purposes of Sections 354, 361 and 368 of the Code and the Treasury Regulations
promulgated thereunder. Except as contemplated by this Agreement, the Transaction Documents, or the Transactions, each of the Parties
shall not take any action, or knowingly fail to take any action, which action or failure to act would reasonably be expected to prevent,
impair or impede the Intended Tax Treatment. Each of the Parties shall (and shall cause their respective Affiliates to) report the Mergers
and the SPAC Class B Conversion consistently with the Intended Tax Treatment unless otherwise required pursuant to a “determination”
within the meaning of Section 1313(a) of the Code. Upon the request of either Party’s tax counsel, prior to Closing,
each of the Company and SPAC shall use reasonable best efforts to deliver to such tax counsel customary representations letters as shall
be reasonably necessary or appropriate to enable such tax counsel to render an opinion regarding the Intended Tax Treatment, provided,
however, that a Party’s failure to execute and deliver such representation letter shall not cause such Party to fail to
satisfy the condition in Sections 8.2(b) or 8.3(b) of this Agreement, as applicable.
Section 7.5.
Shareholder Litigation.
Each Party shall promptly advise the other Parties of any Action commenced (or to the Knowledge of the Company or the Knowledge of SPAC,
as applicable, threatened) on or after the date of this Agreement against such party, any of its Subsidiaries or any of its directors
or officers by any Company Shareholder or SPAC Shareholder relating to this Agreement or the Original Merger Agreement, the Mergers or
any of the other Transactions (any such Action, “Shareholder Litigation”), and such party shall keep the other party
informed regarding any such Shareholder Litigation. Other than with respect to any Shareholder Litigation where the parties identified
in this sentence are adverse to each other or in the context of any Shareholder Litigation related to or arising out of a Company Acquisition
Proposal or a SPAC Acquisition Proposal, (a) the Company shall give SPAC a reasonable opportunity to participate in the defense
or settlement of any such Shareholder Litigation (and consider in good faith the suggestions of SPAC in connection therewith) brought
against the Company, any of their respective Subsidiaries or any of their respective directors or officers and no such settlement shall
be agreed to without the SPAC’s prior consent (which consent shall not be unreasonably withheld, conditioned or delayed) and (b) SPAC
shall give the Company a reasonable opportunity to participate in the defense or settlement of any such Shareholder Litigation (and consider
in good faith the suggestions of the Company in connection therewith) brought against SPAC or any of its directors or officers, and no
such settlement shall be agreed to without the Company’s prior consent (which consent shall not be unreasonably withheld, conditioned
or delayed).
Section 7.6.
Pre-Closing Financing
and PIPE Financing.
(a) As
promptly as reasonably practicable after the date hereof, the Company shall, and shall cause its Affiliates to, use commercially reasonable
efforts to take promptly, or cause to be taken, all actions, and to do promptly, or cause to be done, all things necessary, proper or
advisable (i) with reasonable prior notice to SPAC, enter into such Contracts (the “Pre-Closing Financing Agreements”)
with investors (the “Pre-Closing Financing Investors”), in a form and with terms reasonably acceptable to SPAC and
the Company, pursuant to which the Pre-Closing Financing Investors commit to acquiring Equity Securities of the Company, with the form
of such Equity Securities to be agreed by the Company and SPAC (the “Pre-Closing Financing”); and (ii) consummate
any Pre-Closing Financing at such time as may be agreed upon between the Company and SPAC and in accordance with the terms and conditions
of the Pre-Closing Financing Agreements. The Company shall not, without the consent of SPAC (such consent not to be unreasonably withheld,
conditioned or delayed), permit any amendment or modification to be made to, or any waiver (in whole or in part) of any provision or
remedy under, or any replacements of, any of the Pre-Closing Financing Agreements. The Company shall, and shall cause its financial advisors
and legal counsel to, keep SPAC and SPAC’s financial advisors and legal counsel reasonably informed with respect to such Pre-Closing
Financing.
(b) SPAC
and the Company shall, and shall cause their respective Affiliates to, use commercially reasonable efforts to take promptly, or cause
to be taken, all actions, and to do promptly, or cause to be done, all things necessary, proper or advisable (i) to obtain executed
subscription agreements (such executed subscription agreements, the “Subscription Agreements”), which shall have terms,
and be in a form, reasonably acceptable to SPAC and the Company, from investors (the “PIPE Investors”) pursuant to
which the PIPE Investors commit to make private investments in public equity in the form of Company Ordinary Shares at the Closing (the
“PIPE Financing”), and (ii) to consummate the PIPE Financing substantially concurrently with the Closing. SPAC
and the Company shall not, without the consent of the other party (such consent not to be unreasonably conditioned, withheld or delayed),
permit any amendment or modification to be made to, or any waiver (in whole or in part) of any provision or remedy under, or any replacements
of, any of the Subscription Agreements. The Parties agree that SPAC shall be an intended third party beneficiary of any Subscription
Agreements to the extent SPAC is not a party thereto. From the date hereof until the Closing Date, SPAC and the Company shall, and shall
cause their respective financial advisors and legal counsels to, keep each other and their respective financial advisors and legal counsels
reasonably informed with respect to the PIPE Financing.
Article VIII
CONDITIONS
TO OBLIGATIONS
Section 8.1.
Conditions to Obligations
of Each Party. The respective obligations of each Party to this Agreement to effect the Mergers and the other Transactions, shall
be subject to the satisfaction at or prior to the Closing of the following conditions, any one or more of which may be waived in writing
by the party or parties whose obligations are conditioned thereupon:
(a) The
SPAC Shareholders’ Approval and the Company Shareholders’ Approval shall have been obtained and shall remain in full force
and effect;
(b) The
Proxy/Registration Statement shall have become effective under the Securities Act and no stop order suspending the effectiveness of the
Proxy/Registration Statement shall have been issued and no proceedings for that purpose shall have been initiated or threatened by the
SEC and not withdrawn.
(c) (i) the
Company’s initial listing application with the Stock Exchange in connection with the Transactions shall have been conditionally
approved and, immediately following the Closing, the Company shall satisfy any applicable initial and continuing listing requirements
of the Stock Exchange and the Company shall not have received any notice of non-compliance therewith, and (ii) the Company ADSs
representing the ADS Merger Consideration to be issued in connection with the Mergers shall have been conditionally approved for listing
on the Stock Exchange, subject to official notice of issuance;
(d) After
deducting the SPAC Shareholder Redemption Amount, SPAC shall have at least $5,000,001 of net tangible assets (as determined in accordance
with Rule 3a51-1(g)(1) of the Exchange Act); and
(e) No
Governmental Authority shall have enacted, issued, promulgated, enforced or entered any Law (whether temporary, preliminary or permanent)
or Governmental Order that is then in effect and which has the effect of making the Closing illegal or which otherwise prohibits consummation
of the Closing (any of the foregoing, a “restraint”), other than any such restraint that is immaterial.
(f) The
Capital Restructuring shall have been completed in accordance with the terms hereof and the Company’s Organizational Documents.
Section 8.2.
Additional Conditions to
Obligations of SPAC. The obligations of SPAC to consummate, or cause to be consummated, the Transactions shall be subject to the
satisfaction at or prior to the Closing Date of each of the following additional conditions, any one or more of which may be waived in
writing by SPAC:
(a) The
representations and warranties contained in the first sentence of Section 3.1 (Organization, Good Standing and Qualification),
Section 3.5 (Authorization) and Section 3.10(b) (Absence of Changes) shall be true and correct in all respects
as of the Closing Date as if made at and as of the Closing Date. The representations and warranties contained in Section 3.2
(Subsidiaries), Section 3.4 (Capitalization of Subsidiaries) and Section 3.17 (Brokers) (disregarding any
qualifications and exceptions contained therein relating to materiality, “material” or “Company Material Adverse Effect”
or any similar qualification or exception) shall be true and correct in all material respects as of the Closing Date as if made at and
as of the Closing Date (except with respect to such representations and warranties which speak as to an earlier date, which representations
and warranties (disregarding any such qualifications and exceptions) shall be true and correct in all material respects at and as of
such date). The representations and warranties contained in Section 3.3(a) and Section 3.3(b) (Capitalization
of the Company) shall be true and correct in all respects, except for inaccuracies that, individually or in the aggregate, have no more
than a de minimis effect as of the Closing Date as if made at and as of the Closing Date (except with respect to such representations
and warranties which speak as to an earlier date, which representations and warranties shall be true and correct in all material respects
at and as of such date). Each of the other representations and warranties of the Company contained in this Agreement shall be true and
correct as of the Closing Date as if made at and as of the Closing Date (except with respect to such representations and warranties which
speak as to an earlier date, which representations and warranties shall be true and correct at and as of such date) except for inaccuracies
in or the failure of such representations and warranties to be true and correct that (disregarding any qualifications or exceptions contained
therein relating to materiality, “material” or “Company Material Adverse Effect” or any similar qualification
or exception) individually or in the aggregate, has not had, and would not reasonably be expected to have, a Company Material Adverse
Effect;
(b) Each
of the covenants of the Company to be performed as of or prior to the Closing Date shall have been performed in all material respects;
and
(c) (i) the
Distribution Agreement and each of the Put Option Agreements shall continue to be in full force and effect, (ii) no Group Company
that is a party thereto shall be in material breach thereof or shall have failed to perform its obligations thereunder in any material
respect, and (iii) no party thereto shall have delivered written notice that it intends to terminate the Distribution Agreement.
Section 8.3.
Additional Conditions
to Obligations of the Company, Merger Sub 1 and Merger Sub 2. The obligations of the Company, Merger Sub 1 and Merger Sub 2 to consummate,
or cause to be consummated, the Transactions shall be subject to the satisfaction at or prior to the Closing Date of each of the following
additional conditions, any one or more of which may be waived in writing by the Company:
(a) The
representations and warranties contained in Section 4.1 (Organization, Good Standing, Corporate Power and Qualification),
Section 4.4 (Authorization) and Section 4.8(b) (Absence of Changes) shall be true and correct in all respects
as of the Closing Date as if made at and as of the Closing Date. The representations and warranties contained in Section 4.3
(Corporate Structure; Subsidiaries) and Section 4.10 (Brokers) shall be true and correct in all material respects as
of the Closing Date as if made at and as of the Closing Date (except with respect to such representations and warranties which speak
as to an earlier date, which representations and warranties shall be true and correct in all material respects at and as of such date).
The representations and warranties contained in Section 4.2 (Capitalization and Voting Rights) shall be true and correct
in all respects, except for inaccuracies that, individually or in the aggregate, have no more than a de minimis effect as of the
Closing Date as if made at and as of the Closing Date (except with respect to such representations and warranties which speak as to an
earlier date, which representations and warranties shall be true and correct in all material respects at and as of such date). Each of
the other representations and warranties of SPAC contained in this Agreement shall be true and correct as of the Closing Date (except
with respect to such representations and warranties which speak as to an earlier date, which representations and warranties shall be
true and correct at and as of such date) except for inaccuracies in or the failure of such representations and warranties to be true
and correct that (disregarding any qualifications or exceptions contained therein relating to materiality, “material” or
“SPAC Material Adverse Effect” or any similar qualification or exception) individually or in the aggregate, has not had,
and would not reasonably be expected to have, a SPAC Material Adverse Effect;
(b) Each
of the covenants of SPAC to be performed as of or prior to the Closing Date shall have been performed in all material respects; and
(c) The
Aggregate Cash Proceeds shall not be less than $100,000,000 prior to payment of any unpaid or contingent liabilities, deferred underwriting
fees of SPAC, Company Transaction Expenses, or SPAC Transaction Expenses.
Section 8.4.
Frustration of Conditions.
None of SPAC, Merger Sub 1, Merger Sub 2 or the Company may rely on the failure of any condition set forth in this Article VIII
to be satisfied if such failure was caused by such party’s failure to comply in all material respects with its obligations
under Section 7.3.
Article IX
TERMINATION/EFFECTIVENESS
Section 9.1.
Termination.
This Agreement may be terminated and the Transactions abandoned at any time prior to the First Effective Time:
(a) by
mutual written consent of the Company and SPAC;
(b) by
written notice from the Company or SPAC to the other if any Governmental Authority shall have enacted, issued, promulgated, enforced
or entered any Governmental Order which has become final and nonappealable and has the effect of making consummation of the Transactions
illegal or otherwise preventing or prohibiting consummation of the Transactions;
(c) by
written notice from the Company to SPAC if the SPAC Board or any committee thereof shall have made a SPAC Change in Recommendation;
(d) by
written notice from the Company to SPAC if SPAC fails to obtain the SPAC Shareholder Extension Approval upon vote taken thereon at a
duly convened meeting of the SPAC Shareholders (or at a meeting of SPAC Shareholders following any adjournment or postponement thereof);
(e) by
written notice from the Company or SPAC to the other if the SPAC Shareholders’ Approval shall not have been obtained by reason
of the failure to obtain the required vote at the SPAC Shareholders’ Meeting duly convened therefor or at any adjournment or postponement
thereof taken in accordance with this Agreement;
(f) by
written notice from SPAC to the Company if there is any breach of any representation, warranty, covenant or agreement on the part of
the Company set forth in this Agreement, such that the conditions specified in Section 8.2 would not be satisfied at the
relevant Closing Date (a “Terminating Company Breach”), except that, if such Terminating Company Breach is curable
by the Company then, for a period of up to 30 days after receipt by the Company of written notice from SPAC of such breach, such termination
shall not be effective, and such termination shall become effective only if the Terminating Company Breach is not cured within such 30-day
period; provided that SPAC shall not have the right to terminate this Agreement pursuant to this Section 9.1(f) if
it is then in material breach of any of its representations, warranties, covenants or agreements set forth in this Agreement;
(g) by
written notice from SPAC to the Company if the Required Shareholders’ Approval shall not have been obtained by reason of the failure
to obtain (i) the required votes at the Company Shareholders’ Meeting duly convened therefor or at any adjournment or postponement
thereof taken in accordance with this Agreement, or (ii) unanimous written resolutions of the Company Shareholders;
(h) by
written notice from the Company to SPAC if there is any breach of any representation, warranty, covenant or agreement on the part of
SPAC set forth in this Agreement, such that the conditions specified in Section 8.3 would not be satisfied at the Closing
Date (a “Terminating SPAC Breach”), except that if any such Terminating SPAC Breach is curable by SPAC then, for a
period of up to 30 days after receipt by SPAC of written notice from the Company of such breach, such termination shall not be effective,
and such termination shall become effective only if the Terminating SPAC Breach is not cured within such 30-day period; provided
that the Company shall not have the right to terminate this Agreement pursuant to this Section 9.1(h) if it is then
in material breach of any of its representations, warranties, covenants or agreements set forth in this Agreement; or
(i) by
written notice from SPAC or the Company to the other, if the transactions contemplated by this Agreement shall not have been consummated
on or prior to March 15, 2024 (the “Termination Date”); provided that the right to terminate this
Agreement pursuant to this Section 9.1(i) will not be available to any Party whose breach of any provision of this Agreement
primarily caused or resulted in the failure of the transactions contemplated by this Agreement to be consummated by the Termination Date;
provided, further, that the Termination Date may be extended to a later date by mutual written consent of the Company and
SPAC, in which case such later date shall be deemed the “Termination Date.”
Section 9.2. Effect
of Termination.
(a) In
the event of the termination of this Agreement pursuant to Section 9.1, this Agreement shall forthwith become void and have
no effect, without any liability on the part of any party hereto or its respective Affiliates, officers, directors or shareholders, other
than liability of any Party for fraud or any willful and material breach of this Agreement occurring prior to such termination, except
that the provisions of this Section 9.2, Section 7.1(c), the last sentence of Section 7.2(a)(i),
Article X and the NDA shall survive any termination of this Agreement.
(b) In
the event that this Agreement is terminated pursuant to Section 9.1 (other than a termination pursuant to Section 9.1(c) or
Section 9.1(h)), then notwithstanding anything to the contrary herein, as soon as reasonably practicable following such a
termination, SPAC shall deliver, or cause to be delivered, to the Company a written statement (the “SPAC Termination Statement”)
setting forth the amount of the Extension Expenses, which shall include the wire transfer instructions thereof. During the ten (10)-day
period following the Company’s receipt of the SPAC Termination Statement, SPAC shall consider in good faith any reasonable comments
of the Company to the SPAC Termination Statement. If the Company and SPAC agree to make any modification to the SPAC Termination Statement,
then such SPAC Termination Statement as so agreed by the Company and SPAC to be modified shall be deemed to be the SPAC Termination Statement
for purposes of determining the amounts that the Company shall pay or cause to be paid pursuant to this Section 9.2(b). Within
ten (10) days after receiving the SPAC Termination Statement, the Company shall pay, or cause to be paid, to SPAC or SPAC’s
designee an amount in cash equal to (i) one hundred percent (100%) of the Extension Expense specified on the SPAC Termination Statement,
as modified, in the event that (A) this Agreement is terminated pursuant to Section 9.1(f) or Section 9.1(g),
or (B) (x) this Agreement is terminated pursuant to Section 9.1(a) or Section 9.1(i), and (y) at
the time of such termination, the condition set forth in Section 8.3(c) is the only condition under Article VIII
that would not be capable of being satisfied at the Closing, and the Company is not willing to unconditionally waive such condition;
or (ii) fifty percent (50%) of the Extension Expense specified on the SPAC Termination Statement, as modified, in the event that
this Agreement is terminated pursuant to Section 9.1(a), Section 9.1(b), Section 9.1(d), Section 9.1(e),
or Section 9.1(i) (with respect to a termination pursuant to Section 9.1(a) or Section 9.1(i),
other than under the circumstance specified in the foregoing clause (i)(B)).
Article X
MISCELLANEOUS
Section 10.1. Trust
Account Waiver. Notwithstanding anything to the contrary set forth in this Agreement, each of the Company, Merger Sub 1 and Merger
Sub 2 acknowledges that it has read the publicly filed final prospectus of SPAC, filed with the SEC on March 12, 2021 (File No. 333-253334),
including the Trust Agreement, and understands that SPAC has established the trust account described therein (the “Trust Account”)
for the benefit of SPAC’s public shareholders and that disbursements from the Trust Account are available only in the limited circumstances
set forth therein. Each of the Company, Merger Sub 1 and Merger Sub 2 further acknowledges and agrees that SPAC’s sole assets
consist of the cash proceeds of SPAC’s initial public offering (the “IPO”) and
private placements of its securities occurring simultaneously with the IPO, and that substantially all of these proceeds have been deposited
in the Trust Account for the benefit of its public shareholders. Accordingly, each of the Company (on behalf of itself and its Affiliates,
Representatives and equityholders), Merger Sub 1 and Merger Sub 2 hereby waives any past, present or future claim of any kind arising
out of this Agreement against, and any right to access, the Trust Account, any trustee of the Trust Account to collect from the Trust
Account any monies that may be owed to them by SPAC or any of its Affiliates for any reason whatsoever, and will not seek recourse against
the Trust Account at any time for any reason whatsoever, including, without limitation, for any knowing and intentional material breach
by any of the parties to this Agreement of any of its representations or warranties as set forth in this Agreement, or such party’s
breach of any of its covenants or other agreements set forth in this Agreement. This Section 10.1 shall survive the termination
of this Agreement for any reason.
Section 10.2. Waiver.
Any party to this Agreement may, at any time prior to the Closing, by action taken by its board of directors or officers or Persons thereunto
duly authorized, (a) extend the time for the performance of the obligations or acts of the other parties hereto, (b) waive
any inaccuracies in the representations and warranties (of another party hereto) that are contained in this Agreement or (c) waive
compliance by the other parties hereto with any of the agreements or conditions contained in this Agreement, but such extension or waiver
shall be valid only if set forth in an instrument in writing signed by the party granting such extension or waiver.
Section 10.3. Notices.
All general notices, demands or other communications required or permitted to be given or made hereunder shall be in writing and delivered
personally or sent by courier or sent by registered post or sent by electronic mail to the intended recipient thereof at its address
or at its email address set out below (or to such other address or email address as a party may from time to time notify the other parties).
Any such notice, demand or communication shall be deemed to have been duly served (a) if given personally or sent by courier, upon
delivery during normal business hours at the location of delivery or, if later, then on the next Business Day after the day of delivery;
(b) if sent by electronic mail during normal business hours at the location of delivery, immediately, or, if later, then on the
next Business Day after the day of delivery; (c) the third Business Day following the day sent by reputable international overnight
courier (with written confirmation of receipt), and (d) if sent by registered post, five days after posting. The initial addresses
and email addresses of the parties for the purpose of this Agreement are:
(a) If
to SPAC, to:
L Catterton Asia Acquisition Corp
8 Marina View, Asia Square Tower 1
#41-03, Singapore 018960
Attention: James Steinthal
Email: Jim.Steinthal@lcatterton.com
with a copy (which shall not constitute
notice) to:
Kirkland & Ellis
26th Floor, Gloucester Tower, The Landmark
15 Queen’s Road Central, Hong Kong
| Attn: |
Jesse Sheley |
| |
Joseph Raymond Casey |
| E-mail: |
jesse.sheley@kirkland.com |
| |
joseph.casey@kirkland.com |
(b) If
to the Company, Merger Sub 1 or Merger Sub 2, to:
Lotus Technology Inc.
No. 800 Century Avenue
Pudong District
Shanghai 200120, People’s Republic of China
Attention: Alexious Lee, Chief Financial Officer
Email: Alexious.Lee@lotuscars.com.cn
with a copy (which shall not constitute
notice) to:
Skadden, Arps, Slate, Meagher & Flom LLP
30/F, China World Office 2
No. 1, Jian Guo Men Wai Avenue
Beijing 100004, China
Email: peter.huang@skadden.com
Attention: Peter X. Huang
Section 10.4. Assignment.
No party hereto shall assign this Agreement or any part hereof without the prior written consent of the other parties hereto and any
such transfer without prior written consent shall be void. Subject to the foregoing, this Agreement shall be binding upon and inure to
the benefit of the parties hereto and their respective permitted successors and assigns.
Section 10.5. Rights
of Third Parties. Nothing expressed or implied in this Agreement is intended or shall be construed to (a) confer upon or give
any Person (including any equityholder, any current or former director, manager, officer, employee or independent contractor of the Company
or any of its Subsidiaries, or any participant in any Benefit Plan or other employee benefit plan, agreement or other arrangement (or
any dependent or beneficiary thereof)), other than the parties hereto, any right or remedies under or by reason of this Agreement, (b) establish,
amend or modify any employee benefit plan, program, policy, agreement or arrangement or (c) limit the right of SPAC, the Company
or their respective Affiliates to amend, terminate or otherwise modify any Benefit Plan or other employee benefit plan, policy, agreement
or other arrangement following the Closing; provided, however, that (i) the SPAC D&O Indemnified Parties (and
their successors, heirs and representatives) are intended third-party beneficiaries of, and may enforce, Section 6.5, and
(ii) the Non-Recourse Parties (and their successors, heirs and representatives) are intended third-party beneficiaries of, and may
enforce, Section 10.17.
Section 10.6. Expenses.
Except as set forth in Sections 7.1(c), Section 7.2(a)(i), Section 5.5(b) and Section 9.2(b),
each party hereto shall be responsible for and pay its own expenses incurred in connection with this Agreement and the Transactions,
including all fees of its legal counsel, financial advisers and accountants; provided, however, that if the Closing shall
occur, the Company shall pay or cause to be paid, in accordance with Section 2.4(b)(iv), the SPAC Transaction Expenses and
the Company Transaction Expenses.
Section 10.7. Governing
Law. This Agreement, and any claim or cause of action hereunder based upon, arising out of or related to this Agreement (whether
based on law, in equity, in contract, in tort or any other theory) or the negotiation, execution, performance or enforcement of this
Agreement, shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to the principles
of conflicts of laws that would otherwise require the application of the law of any other state (provided that the fiduciary duties of
the Company Board and the SPAC Board, the Mergers and any exercise of appraisal and dissenters’ rights under the laws of the Cayman
Islands with respect to the Mergers, shall in each case be governed by the laws of the Cayman Islands).
Section 10.8. Consent
to Jurisdiction. THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE STATE OR FEDERAL COURTS LOCATED IN NEW
YORK COUNTY, STATE OF NEW YORK (OR ANY APPELLATE COURTS THEREFROM) SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS
OF THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE, AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT
OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE
IN SAID COURTS OR THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS AGREEMENT MAY NOT BE ENFORCED IN OR BY SUCH COURTS,
AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD AND DETERMINED
BY ANY SUCH COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND OVER THE SUBJECT
MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING IN THE MANNER
PROVIDED IN SECTION 10.3 OR IN SUCH OTHER MANNER AS MAY BE PERMITTED BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.
EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY WHICH MAY ARISE UNDER THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY
IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY
RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE,
AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION,
SEEK TO ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH
PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS,
THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 10.8.
Section 10.9. Headings;
Counterparts. The headings in this Agreement are for convenience only and shall not be considered a part of or affect the construction
or interpretation of any provision of this Agreement. This Agreement may be executed in two or more counterparts, and by different parties
in separate counterparts, with the same effect as if all parties hereto had signed the same document, but all of which together shall
constitute one and the same instrument. Copies of executed counterparts of this Agreement transmitted by electronic transmission (including
by email or in .pdf format) or facsimile as well as electronically or digitally executed counterparts (such as DocuSign) shall have the
same legal effect as original signatures and shall be considered original executed counterparts of this Agreement.
Section 10.10. Disclosure
Letters. The Disclosure Letters (including, in each case, any section thereof) referenced in this Agreement are a part of this Agreement
as if fully set forth herein. All references in this Agreement to the Disclosure Letters (including, in each case, any section thereof)
shall be deemed references to such parts of this Agreement, unless the context shall otherwise require. Any disclosure made by a party
in the applicable Disclosure Letter, or any section thereof, with reference to any section of this Agreement or section of the applicable
Disclosure Letter shall be deemed to be a disclosure with respect to such other applicable sections of this Agreement or sections of
the applicable Disclosure Letter to which it is reasonably apparent on the face of such disclosure that such disclosure is responsive
to such other section of this Agreement or section of the applicable Disclosure Letter. Certain information set forth in the Disclosure
Letters is included solely for informational purposes and may not be required to be disclosed pursuant to this Agreement. The disclosure
of any information shall not be deemed to constitute an acknowledgement that such information is required to be disclosed in connection
with the representations and warranties made in this Agreement, nor shall such information be deemed to establish a standard of materiality
or that the facts underlying such information constitute a Company Material Adverse Effect or a SPAC Material Adverse Effect, as applicable.
Section 10.11. Entire
Agreement. This Agreement (together with the Disclosure Letters), the NDA and the other Transaction Documents constitute the entire
agreement among the parties to this Agreement relating to the Transactions and supersede any other agreements, whether written or oral,
that may have been made or entered into by or among any of the parties hereto or any of their respective Subsidiaries relating to the
Transactions (including the Non-binding Letter of Intent between SPAC and the Company, dated as of October 27, 2022, and the Original
Merger Agreement). No representations, warranties, covenants, understandings, agreements, oral or otherwise, relating to the Transactions
exist between such parties except as expressly set forth in the Transaction Documents. This Agreement supersedes the Original Merger
Agreement in its entirety, and upon the effectiveness of this Agreement, the Original Merger Agreement shall no longer have any force
or effect; provided that, upon the effectiveness of this Agreement, (a) Exhibit E and Exhibit I to
the Original Merger Agreement shall be amended and restated in their entirety in the form of the amended and restated exhibits attached
hereto bearing the same alphabetical exhibit references, and (b) all other exhibits to the Original Merger Agreement shall continue
to be effective in their existing form and any Contracts or other documents executed and delivered based on such exhibits shall continue
in full force and effect as between the parties thereto. For the avoidance of doubt, each reference to the “Merger Agreement”
in each of the exhibits, Contracts or other documents set forth in the foregoing clause (b) shall be a reference to this Agreement
instead of the Original Merger Agreement.
Section 10.12. Amendments.
This Agreement may be amended or modified in whole or in part prior to the First Effective Time, only by a duly authorized agreement
in writing in the same manner as this Agreement, which makes reference to this Agreement and which shall be executed by the Company and
SPAC; provided, however, that after the Company Shareholders’ Approval or the SPAC Shareholders’ Approval has
been obtained, there shall be no amendment or waiver that by applicable Law requires further approval by the shareholders of the Company
or the shareholders of SPAC, respectively, without such approval having been obtained.
Section 10.13. Publicity.
(a) All
press releases or other public communications relating to the Transactions, and the method of the release for publication thereof, shall
prior to the Closing, be subject to the prior mutual approval of the Company and SPAC; provided that no such party shall be required
to obtain consent pursuant to this Section 10.13(a) to the extent any proposed release or statement is substantially
equivalent to the information that has previously been made public without breach of the obligation under this Section 10.13(a).
(b) The
restriction in Section 10.13(a) shall not apply to the extent the public announcement is required by applicable securities
Law, any Governmental Authority or stock exchange rule; provided, however, that in such an event, the party making the
announcement shall, to the extent practicable, use its commercially reasonable efforts to consult with the other party in advance as
to its form, content and timing.
Section 10.14. Confidentiality.
The existence and terms of this Agreement and any information provided by either party hereto in connection with this Agreement and the
Transactions are confidential and may not be disclosed by either party hereto, their respective Affiliates or any Representatives of
any of the foregoing, and shall at all times be considered and treated as “Confidential Information” as such term is defined
in the NDA. Notwithstanding anything to the contrary contained in the preceding sentence or in the NDA, each party shall be permitted
to disclose Confidential Information, including the Transaction Documents, the fact that the Transaction Documents have been signed and
the status and terms of the Transactions to its existing or potential Affiliates, joint ventures, joint venture partners, shareholders,
lenders, underwriters, financing sources and any Governmental Authority (including the Stock Exchange), and to the extent required, in
regulatory filings, and their respective Representatives; provided that such parties entered into customary confidentiality agreements
or are otherwise bound by fiduciary or other duties to keep such information confidential.
Section 10.15. Severability.
If any provision of this Agreement is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this
Agreement shall remain in full force and effect. The parties hereto further agree that if any provision contained in this Agreement is,
to any extent, held invalid or unenforceable in any respect under the Laws governing this Agreement, they shall take any actions necessary
to render the remaining provisions of this Agreement valid and enforceable to the fullest extent permitted by Law and, to the extent
necessary, shall amend or otherwise modify this Agreement to replace any provision contained in this Agreement that is held invalid or
unenforceable with a valid and enforceable provision giving effect to the intent of the parties hereto.
Section 10.16. Enforcement.
The parties hereto agree that irreparable damage would occur in the event that any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties hereto shall be entitled
to an injunction or injunctions to prevent breaches of this Agreement and to specific enforcement of the terms and provisions of this
Agreement, in addition to any other remedy to which any party is entitled at law or in equity. In the event that any Action shall be
brought in equity to enforce the provisions of this Agreement, no party shall allege, and each party hereby waives the defense, that
there is an adequate remedy at law, and each party agrees to waiver any requirement for the securing or posting of any bond in connection
therewith.
Section 10.17. Non-Recourse.
This Agreement may only be enforced against, and any claim or cause of action based upon, arising out of, or related to this Agreement
or the Transactions may only be brought against, the Company, SPAC, Merger Sub 1 and Merger Sub 2 as named parties hereto and then only
with respect to the specific obligations set forth herein with respect to such Party. Except to the extent a Party (and then only to
the extent of the specific obligations undertaken by such Party), (a) no past, present or future director, officer, employee, incorporator,
member, partner, shareholder, Affiliate, agent, attorney, advisor or other Representative of the Company, SPAC, Merger Sub 1 or Merger
Sub 2 and (b) no past, present or future director, officer, employee, incorporator, member, partner, shareholder, Affiliate, agent,
attorney, advisor or other Representative of any of the foregoing shall have any liability (whether in contract, tort, equity or otherwise)
for any one or more of the representations, warranties, covenants, agreements or other obligations or liabilities of any one or more
of the Company, SPAC, Merger Sub 1 or Merger Sub 2 under this Agreement for any claim based on, arising out of, or related to this Agreement
or the Transactions (each of the Persons identified in the foregoing sub-clauses (a) or (b), a “Non-Recourse Party,”
and collectively, the “Non-Recourse Parties”).
Section 10.18. Non-Survival
of Representations, Warranties and Covenants. Except as otherwise contemplated by Section 9.2, the representations, warranties,
covenants, obligations or other agreements in this Agreement or in any certificate (including confirmations therein), statement or instrument
delivered pursuant to this Agreement, including any rights arising out of any breach of such representations, warranties, covenants,
obligations, agreements and other provisions, shall not survive the Closing and shall terminate and expire upon the occurrence of the
Closing (and there shall be no liability after the Closing in respect thereof), except for (a) those covenants and agreements contained
in this Agreement that by their terms expressly apply in whole or in part after the Closing, and then only with respect to any breaches
occurring after the Closing and (b) this Article X.
Section 10.19. Conflicts
and Privilege. The Company, on behalf of its successors and assigns, hereby agrees that, in the event a dispute with respect to this
Agreement or the transactions contemplated hereby arises after the Closing involving the Sponsor, the shareholders or holders of other
equity interests of SPAC or the Sponsor or any of their respective directors, members, partners, officers, employees or Affiliates (other
than the Company or Surviving Entity 2) (collectively, the “Sponsor Group”), any legal counsel, including Kirkland &
Ellis LLP (“K&E”), that represented SPAC or the Sponsor prior to the Closing may represent the Sponsor or any
other member of the Sponsor Group, in such dispute even though the interests of such Persons may be directly adverse to the Company or
Surviving Entity 2, and even though such counsel may have represented SPAC in a matter substantially related to such dispute, or may
be handling ongoing matters for the Company, Surviving Entity 2 or the Sponsor. The Company, on behalf of its successors and assigns
(including, after the Closing, Surviving Entity 2), further agree that, as to all legally privileged communications prior to the Closing
(made in connection with the negotiation, preparation, execution, delivery and performance under, or any dispute or Action arising out
of or relating to, this Agreement, any Transaction Documents or the transactions contemplated hereby or thereby) between or among SPAC,
the Sponsor or any other member of the Sponsor Group, on the one hand, and K&E, on the other hand, the attorney/client privilege
and the expectation of client confidence shall survive the Mergers and belong to the Sponsor Group after the Closing, and shall not pass
to or be claimed or controlled by the Company or Surviving Entity 2. Notwithstanding the foregoing, any privileged communications or
information shared by the Company prior to the Closing with SPAC or the Sponsor under a common interest agreement shall remain the privileged
communications or information of the Company and Surviving Entity 2.
[Remainder of page intentionally left
blank]
IN WITNESS WHEREOF the Parties have hereunto caused this Agreement
to be duly executed as of the date first above written.
| |
COMPANY: |
| |
|
| |
Lotus Technology
Inc. |
| |
By: |
/s/ Alexious Kuen Long Lee |
| |
|
Name: |
Alexious Kuen Long Lee |
| |
|
Title: |
Director |
| |
MERGER SUB 1: |
| |
|
| |
Lotus
Temp Limited |
| |
|
| |
By: |
/s/
Alexious Kuen Long Lee |
| |
|
Name: |
Alexious Kuen Long Lee |
| |
|
Title: |
Director |
| |
MERGER SUB 2: |
| |
|
| |
Lotus
EV Limited |
| |
|
| |
By: |
/s/
Alexious Kuen Long Lee |
| |
|
Name: |
Alexious Kuen Long Lee |
| |
|
Title: |
Director |
| |
SPAC: |
| |
|
| |
L
Catterton Asia Acquisition Corp |
| |
|
| |
By: |
/s/
Chinta Bhagat |
| |
|
Name: |
Chinta Bhagat |
| |
|
Title: |
Co-Chief Executive Officer and Chairman |
[Signature Page to First Amended and Restated
Agreement and Plan of Merger]
Exhibit A
Sponsor Support Agreement
[attached]
Exhibit B
Company Support Agreement
[attached]
Exhibit C
Distribution Agreement
[attached]
Exhibit D-1
Put Option Agreement
[attached]
Exhibit D-2
Put Option Agreement
[attached]
Exhibit E
Form of Registration Rights Agreement
[attached]
Exhibit F
Form of First Plan of Merger
[attached]
Exhibit G
Form of Second Plan of Merger
[attached]
Exhibit H
Form of A&R Company Charter
[attached]
Exhibit I
Form of Assignment, Assumption and Amendment Agreement
[attached]
Exhibit J
Form of Lock-Up Agreement
[attached]
SPAC Disclosure Letter
[attached]
Company Disclosure Letter
[attached]
Exhibit 10.1
REGISTRATION RIGHTS AGREEMENT
This
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of _______, 2023, is made and entered into by and among
(i) Lotus Technology Inc., an exempted company limited by shares incorporated under the laws of the Cayman Islands (the “Company”),
(ii) L Catterton Asia Acquisition Corp, an exempted company limited by shares incorporated under the laws of the Cayman Islands
(“SPAC”), (iii) LCA Acquisition Sponsor, LP, a Cayman Islands exempted limited partnership (the “Sponsor”),
and (iv) the other undersigned parties listed on the signature page hereto (each such party, together with the Sponsor and
any person or entity who hereafter becomes a party to this Agreement pursuant to Section 5.2 of this Agreement,
a “Holder” and collectively the “Holders”). Capitalized terms used herein but not defined
herein shall have the meaning ascribed to such terms in the Merger Agreement (as defined below).
WHEREAS,
SPAC and the Sponsor entered into that certain Registration and Shareholder Rights Agreement dated as of March 10, 2021 (the “Prior
SPAC Agreement”), and the parties to the Prior SPAC Agreement desire to terminate, effective as of the Closing (as defined
below), the same to provide for the terms and conditions set forth in this Agreement;
WHEREAS, on January 31,
2023, the Company, SPAC, Lotus Temp Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands
and a direct wholly owned subsidiary of the Company (“Merger Sub 1”) and Lotus EV Limited, an exempted company limited
by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub
2”) entered into that certain Agreement and Plan of Merger (the “Original Merger Agreement”), pursuant to
which, among other matters, (i) Merger Sub 1 will merge with and into SPAC with SPAC continuing as the surviving entity and a wholly
owned subsidiary of the Company (the “First Merger,” and the closing of the First Merger, the “First Merger
Closing”), (ii) immediately following the consummation of the First Merger, SPAC will merge with and into Merger
Sub 2 with Merger Sub 2 continuing as the surviving entity and a wholly owned subsidiary of the Company (the “Second Merger”
and together with the First Merger, collectively, the “Mergers,” and the closing of the Mergers, the “Closing”);
WHEREAS,
on October 11, 2023, the parties to the Original Merger Agreement entered into the First Amended and Restated Agreement and Plan of Merger
(as may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Merger Agreement”),
pursuant to which the Original Merger Agreement was amended and restated in its entirety to provide, among other things, (i) that
each applicable security holder of SPAC immediately prior to the First Merger Closing shall receive the equivalent number of Company
ADSs in lieu of the Company Ordinary Shares such security holder would otherwise receive in the First Merger, and (ii) that the
Company shall establish a sponsored ADS Facility for the purpose of issuing the Company ADSs;
WHEREAS, following the Closing,
the Holders will hold certain number of Company Ordinary Shares (including Company Ordinary Shares represented by Company ADSs);
WHEREAS, at the First Merger
Closing and subject to the terms and conditions of the Merger Agreement, (i) all of the outstanding shares of SPAC will automatically
be cancelled and cease to exist in exchange for the right to receive newly issued Company Ordinary Shares in the form of Company ADSs,
and (ii) all of the outstanding warrants of SPAC will automatically be assumed by the Company and become Company Warrants.
NOW,
THEREFORE, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable consideration,
the receipt and sufficiency of which are hereby
acknowledged, the parties hereto, intending to
be legally bound, hereby agree as follows:
ARTICLE 1
DEFINITIONS
The terms defined in this
Article 1 shall, for all purposes of this Agreement, have the respective meanings set forth below:
“Adverse Disclosure”
shall mean any public disclosure of material non-public information, (a) which disclosure, in the good faith judgment
of the Chief Executive Officer or Chief Financial Officer of the Company, after consultation with counsel to the Company, (i) would
be required to be made in any Registration Statement or Prospectus in order for the applicable Registration Statement or Prospectus not
to contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements contained therein
(in the case of any prospectus and any preliminary prospectus, in the light of the circumstances under which they were made) not misleading,
and (ii) would not be required to be made at such time if the Registration Statement were not being filed, declared effective or
used, as the case may be, and (b) as to which the Company has a bona fide business purpose for not making such information public.
“Agreement”
shall have the meaning given in the Preamble.
“Board”
shall mean the board of directors of the Company.
“Business Day”
shall mean a day on which commercial banks are open for business in New York, U.S., the Cayman Islands or the PRC, except a Saturday,
Sunday or public holiday (gazetted or ungazetted and whether scheduled or unscheduled).
“Closing”
shall have the meaning given in the Recitals.
“Commission”
shall mean the United States Securities and Exchange Commission.
“Company”
shall have the meaning given in the Preamble.
“Demanding Holder”
shall have the meaning given in Section 2.4.
“Exchange Act”
shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.
“First Merger Closing”
shall have the meaning given in the Recitals.
“Form F-1”
shall mean such form under the Securities Act as in effect on the date hereof or any successor registration form under the Securities
Act subsequently adopted by the Commission.
“Form F-1 Shelf”
shall have the meaning given in subsection 2.1.1.
“Form F-3”
shall mean such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently
adopted by the Commission that permits forward incorporation of substantial information by reference to other documents filed by the
Company with the Commission.
“Form F-3 Shelf”
shall have the meaning given in subsection 2.1.3.
“Holders” shall
have the meaning given in the Preamble.
“Lock-Up Agreement”
shall mean, as applicable, the agreements and undertakings of the Holders set forth in (i) Section 4.11 of that certain Shareholder
Support Agreement dated as of the date hereof, by and among the Company, SPAC and certain shareholders of the Company identified therein,
and (ii) Section 4.12 of that certain Sponsor Support Agreement dated as of the date hereof by and among the Company, SPAC,
the Sponsor and certain other persons identified therein, in each case pursuant to which a Holder has agreed not to transfer the Registrable
Securities held by such Holder for a certain period of time after the Closing.
“Maximum Number
of Securities” shall mean, as to a given Underwritten Offering, the maximum dollar amount or maximum number of equity securities
that can be sold in such Underwritten Offering, in the reasonable determination of the managing Underwriter(s), without adversely affecting
the proposed offering price, the timing, the distribution method, or the probability of success of such offering.
“Merger Agreement”
shall have the meaning given in the Recitals.
“Misstatement”
shall mean an untrue statement of a material fact or an omission to state a material fact required to be stated in a Registration Statement
or Prospectus, or necessary to make the statements in a Registration Statement or Prospectus (in the case of a Prospectus, in the light
of the circumstances under which they were made) not misleading.
“New Registration
Statement” shall have the meaning given in subsection 2.2.1.
“Permitted Transferees”
shall mean a person or entity to whom a Holder of Registrable Securities is permitted to transfer such Registrable Securities prior to
the expiration of the lock-up period under the applicable Lock-Up Agreement, and to any transferee thereafter.
“Piggyback Registration”
shall have the meaning given in subsection 2.7.1.
“PIPE/CB Securities”
shall mean those securities issued pursuant to the PIPE Subscription Agreements or those securities issued or, issued upon conversion,
exchange or exercise of the securities issued, pursuant to the Pre-Closing Financing Agreements.
“PIPE Subscription
Agreements” shall mean the subscription agreement(s) or similar agreement(s) entered or to be entered into by and
among any investor, the Company, and, where applicable, other parties thereto, pursuant to which such investor will subscribe for Company
Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) on the date of the Closing.
“Pre-Closing Financing
Agreements” shall mean such agreements entered or to be entered into by and among any investor, the Company, and, where applicable,
other parties thereto, pursuant to which the investors will acquire equity securities of the Company prior to the date of the Closing.
“Prior SPAC Agreement”
shall have the meaning given in the Recitals.
“Pro Rata”
shall mean, with respect to a given Registration, offering or Transfer of Registrable Securities pursuant to this Agreement, pro rata
based on (A) the number of Registrable Securities that each Holder, as applicable, has requested or proposed to be included in such
Registration, offering or Transfer and (B) the aggregate number of Registrable Securities that all Holders have requested or proposed
to be included in such Registration, offering or Transfer.
“Prospectus”
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.
“Registrable Securities”
shall mean:
(A) any
outstanding Company Ordinary Shares or Company Warrants that are held by a Holder as of immediately following the Closing;
(B) any
Company Ordinary Shares that may be acquired by a Holder upon the exercise of any of the Company Warrants (or any other option or right
to acquire Company Ordinary Shares) that are held by a Holder as of immediately following the Closing; and
(C) any
other equity security of the Company issued or issuable with respect to any securities referenced in clauses (A) or (B) above
by way of a stock dividend or stock split or in connection with a recapitalization, merger, consolidation, spin-off, reorganization or
similar transaction,
provided,
however, as to any particular Registrable Securities, such securities shall cease to be Registrable Securities when: (i) a
Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities
shall have been sold, transferred, disposed of or exchanged in accordance with such Registration Statement; (ii) such securities
shall have been otherwise transferred, new certificates for such securities not bearing (or book-entry positions not subject to) a legend
restricting further transfer shall have been delivered by the Company and subsequent public distribution of such securities shall not
require registration under the Securities Act; (iii) such securities shall have ceased to be outstanding; (iv) such securities
have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction. For the
purpose of clarification, any reference to “Company Ordinary Shares” in this definition shall include Company Ordinary Shares
represented by Company ADSs.
“Registration”
shall mean a registration, including any related Underwritten Takedown, effected by preparing and filing a registration statement or
similar document in compliance with the requirements of the Securities Act, and the applicable rules and regulations promulgated
thereunder, and such registration statement becoming effective.
“Registration Expenses”
shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:
(A) all
registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority, Inc.)
and any securities exchange on which the Company ADSs are then listed;
(B) fees
and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters
in connection with blue sky qualifications of Registrable Securities);
(C) printing,
messenger, telephone and delivery expenses of the Company;
(D) reasonable
fees and disbursements of counsel for the Company;
(E) reasonable
fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection with such
Registration;
(F) the
Company’s roadshow and travel expenses, if any; and
(G) reasonable
fees and expenses of one (1) legal counsel selected by the majority-in-interest of the Demanding Holders initiating an
Underwritten Takedown.
“Registration Statement”
shall mean any registration statement that covers the Registrable Securities pursuant to the provisions of this Agreement, including
the Prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to such registration
statement, and all exhibits to and all material incorporated by reference in such registration statement.
“Requesting Holder”
shall have the meaning given in Section 2.5.
“SEC Guidance”
shall have the meaning given in subsection 2.2.1.
“Securities Act”
shall mean the Securities Act of 1933, as amended from time to time.
“Shelf”
shall mean the Form F-1 Shelf, the Form F-3 Shelf or any Subsequent Shelf, as the case may be.
“Shelf Registration”
shall mean a Registration of securities pursuant to a Registration Statement filed with the Commission in accordance with and pursuant
to Rule 415 promulgated under the Securities Act (or any successor rule then in effect).
“SPAC”
shall have the meaning given in the Preamble.
“Sponsor”
shall have the meaning given in the Recitals.
“Subsequent Shelf”
shall have the meaning given in subsection 2.3.2.
“Takedown Demand”
shall have the meaning given in subsection 2.4.1.
“Takedown Threshold”
shall have the meaning given in Section 2.4.
“Transfer”
shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or
otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or
liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act with
respect to, any security, (b) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in
cash or otherwise, or (c) public announcement of any intention to effect any transaction specified in clause (a) or (b).
“Underwriter”
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer’s market-making activities.
“Underwritten Registration”
or “Underwritten Offering” shall mean a Registration in which securities of the Company are sold to an Underwriter
in a firm commitment underwriting for distribution to the public.
“Underwritten Takedown”
shall mean an Underwritten Offering of Registrable Securities pursuant to the Shelf, as amended or supplemented.
ARTICLE 2
registrations
2.1 Resale
Shelf Registration.
2.1.1 The
Company shall (a) use its reasonable efforts to file within forty five (45) days following the Closing, and use commercially reasonable
efforts to cause to be declared effective as soon as reasonably practicable thereafter, a Registration Statement for a Shelf Registration
on Form F-1 (the “Form F-1 Shelf”) covering the resale of all the Registrable Securities (determined as
of two (2) Business Days prior to such filing) on a delayed or continuous basis pursuant to Rule 415 under the Securities Act
(or any successor or similar provision adopted by the Commission then in effect), and (b) subject to the other provisions of this
Agreement, keep such Form F-1 Shelf effective and available for use in compliance with the provisions of the Securities Act until
such time as a Form F-3 Shelf is declared effective pursuant to subsection 2.1.3.
2.1.2 Such
Shelf shall provide for the resale of the Registrable Securities included therein pursuant to any method or combination of methods legally
available to, and requested by, any Holders named therein.
2.1.3 Following
the filing of a Form F-1 Shelf, the Company shall use commercially reasonable efforts to convert the Form F-1 Shelf (and any
Subsequent Shelf in relation thereto) to, and/or to file, and to cause to become effective, a Registration Statement for a Shelf Registration
on Form F-3 (the “Form F-3 Shelf”) as soon as reasonably practicable after the Company is eligible to use
Form F-3.
2.2 Rule 415
Cutback.
2.2.1 Notwithstanding
the registration obligations set forth in Section 2.1, in the event the Commission informs the Company that all of the Registrable
Securities cannot, as a result of the application of Rule 415 of the Securities Act, be registered for resale as a secondary offering
on a single registration statement, the Company agrees to promptly (a) inform each of the Holders and use its commercially reasonable
efforts to file amendments to the Shelf Registration as required by the Commission and/or (b) withdraw the Shelf Registration and
file a new Registration Statement (a “New Registration Statement”), on Form F-3, or if Form F-3 is not then
available to the Company for such Registration Statement, on such other form available to register for resale the Registrable Securities
as a secondary offering; provided, however, that prior to filing such amendment or New Registration Statement, the Company
shall use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Registrable Securities
in accordance with any publicly-available written or oral guidance, comments, requirements or requests of the Commission staff (the “SEC
Guidance”).
2.2.2 Notwithstanding
any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted
to be registered on a particular Registration Statement as a secondary offering (and notwithstanding that the Company used commercially
reasonable efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), unless
otherwise directed in writing by a Holder as to its Registrable Securities and subject to a determination by the Commission that certain
Holders must be reduced first based on the number of Registrable Securities held by such Holders, the number of Registrable Securities
to be registered on such Registration Statement will be reduced (a) firstly, on a Pro Rata basis among the Holders; and (b) secondly,
only if the number of Registrable Securities of Holders permitted to be registered has been reduced to zero, on a Pro Rata basis among
holders of PIPE/CB Securities.
2.2.3 If
the Company amends the Shelf Registration or files a New Registration Statement, as the case may be, under this Section 2.2,
the Company shall use its commercially reasonable efforts to file with the Commission, as promptly as allowed by the Commission or SEC
Guidance, one or more registration statements on Form F-3 or such other form available to register for resale those Registrable
Securities (a) that were not registered for resale on the Shelf Registration, as amended, or the New Registration Statement and
(b) are no longer restricted by any Lock-Up Agreement.
2.3 Amendment,
Supplement and Subsequent Shelf.
2.3.1 The
Company shall use commercially reasonable efforts to maintain a Shelf in accordance with the terms of this Agreement, and shall prepare
and file with the Commission from time to time such amendments and supplements to the Shelf as may be necessary to keep the Shelf continuously
effective, available for use and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable
Securities.
2.3.2 If
a Shelf ceases to be effective under the Securities Act for any reason at any time while Registrable Securities are still outstanding,
the Company shall, subject to Section 3.4, use commercially reasonable efforts to as promptly as is reasonably practicable
(a) cause such Shelf to again become effective under the Securities Act (including using commercially reasonable efforts to obtain
the prompt withdrawal of any order suspending the effectiveness of such Shelf), (b) amend such Shelf in a manner reasonably expected
to result in the withdrawal of any order suspending the effectiveness of such Shelf, or (c) prepare and file an additional Registration
Statement for a Shelf Registration (a “Subsequent Shelf”) registering the resale of all Registrable Securities (determined
as of two (2) Business Days prior to such filing), and pursuant to any method or combination of methods legally available to, and
requested by, any Holders named therein.
2.3.3 If
a Subsequent Shelf is filed pursuant to Section 2.3.2, the Company shall use commercially reasonable efforts to (a) cause
such Subsequent Shelf to become effective under the Securities Act as promptly as is reasonably practicable after the filing thereof,
and (b) keep such Subsequent Shelf continuously effective, available for use and in compliance with the provisions of the Securities
Act until such time as there are no longer any Registrable Securities. Any such Subsequent Shelf shall be on Form F-3 to the extent
that the Company is eligible to use such form, and shall be an automatic shelf registration statement as defined in Rule 405 promulgated
under the Securities Act if the Company is a well-known seasoned issuer as defined in Rule 405 promulgated under the Securities
Act at the most recent applicable eligibility determination date.
2.4 Demand
for Underwritten Takedown. Subject to the Lock-Up Agreements and to the provisions of this Section 2.4 and Sections
2.5 and 3.4, at any time and from time to time when an effective Shelf is on file with the Commission, either (x) the
Holders of at least 50% of the then-outstanding number of Registrable Securities or (y) the Sponsor (in each case, the “Demanding
Holder(s)”) may, subject to the maximum number of Underwritten Takedowns pursuant to subsection 2.4.3, request to sell
all or a portion of their Registrable Securities in an Underwritten Takedown in accordance with this Section 2.4; provided
that the Company shall only be obligated to effect an Underwritten Takedown if such Underwritten Offering shall include Registrable
Securities proposed to be sold by the Demanding Holder with a total offering price reasonably expected to exceed, in the aggregate, US$10,000,000
(the “Takedown Threshold”).
2.4.1 Takedown
Demand Notice. All requests for an Underwritten Takedown shall be made by giving written notice to the Company, which shall specify
the number of Registrable Securities proposed to be sold in the Underwritten Takedown (such written notice, a “Takedown Demand”).
2.4.2 Underwriters.
The majority-in-interest of the Demanding Holders initiating an Underwritten Takedown shall have the right to select the Underwriter(s) for
such Underwritten Offering (which shall consist of one or more internationally recognized investment banks), subject to the approval
of the Company (which shall not be unreasonably withheld). The Company shall not be required to include any Holder’s Registrable
Securities in such Underwritten Takedown unless such Holder accepts the terms of the underwriting as agreed between the Company
and its Underwriter(s) and enters into and complies with an underwriting agreement with such Underwriter(s) in customary form
(after having considered in good faith the comments from a single U.S. counsel for the Holders which are selling in the Underwritten
Takedown). Notwithstanding anything to the contrary in this Agreement, the Company may effect any Underwritten Takedown pursuant to any
then effective Registration Statement, including a Form F-3, that is then available for such offering.
2.4.3 Number
and Frequency of Underwritten Takedowns. Notwithstanding anything to the contrary in this Section 2.4, under no circumstances
shall the Company be obligated to effect (a) more than one (1) Underwritten Takedowns within the first year following the Closing,
(b) for the period commencing one year after the Closing, more than two (2) Underwritten Takedown within any twelve-month period;
(c) more than two (2) Underwritten Takedowns where the Sponsor is a Demanding Holder, provided that the Company shall be obligated
to effect an aggregate of no more than two (2) Underwritten Takedowns. For the avoidance of doubt, a Registration will not count
as an Underwritten Takedown until the Registration Statement filed with the Commission with respect to such Underwritten Takedown has
been declared effective and the Company has complied with all of its obligations under this Agreement in all material respects with respect
to such Underwritten Takedown; provided, however, that if, after such Registration Statement has been declared effective, the offering
of Registrable Securities pursuant to such Underwritten Takedown is interfered with by any stop order or injunction of the Commission
or any other governmental agency or court, the Registration Statement with respect to such Underwritten Takedown will be deemed not to
have been declared effective, unless and until (i) such stop order or injunction is removed, rescinded or otherwise terminated,
and (ii) the majority-in-interest of the Demanding Holders, thereafter elects to continue the offering, provided, further, that
the Company shall not be obligated to file a second Registration Statement until the Registration Statement that has been previously
filed with respect to such Registration becomes effective or is subsequently terminated.
2.5 Reduction
of Underwritten Takedown. If the managing Underwriter(s) in an Underwritten Offering pursuant to a Takedown Demand advises the
Company and the Demanding Holders and the Holders requesting piggy-back rights pursuant to this Agreement with respect to such Underwritten
Offering (the “Requesting Holders”) (if any) in writing that the dollar amount or number of Registrable Securities
that the Demanding Holders and the Requesting Holders (if any) desire to sell, taken together with all other Company Ordinary Shares
(including Company Ordinary Shares represented by Company ADSs) or other equity securities that the Company desires to sell and the Company
Ordinary Shares (including Company Ordinary Shares represented by Company ADSs), if any, as to which a Registration has been requested
pursuant to separate written contractual piggy-back registration rights held by any other shareholders who desire to sell, exceeds the
Maximum Number of Securities, then the Company shall include in such Underwritten Offering:
2.5.1 first,
the Registrable Securities of the Demanding Holders and the Requesting Holders (if any) that can be sold without exceeding the Maximum
Number of Securities (to be allocated Pro Rata among the Demanding Holders and Requesting Holders if the Registrable Securities desired
to be sold by such Holders in the aggregate would exceed the Maximum Number of Securities);
2.5.2 second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing subsection 2.5.1, the Company Ordinary
Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities that the Company desires to sell, which
can be sold without exceeding the Maximum Number of Securities; and
2.5.3 third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing subsections 2.5.1 and 2.5.2,
any Company Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities as to which a
Registration has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders of
the Company that can be sold without exceeding the Maximum Number of Securities.
2.6 Withdrawal
of Underwritten Takedown.
2.6.1 Prior
to the filing of the applicable preliminary or “red herring” Prospectus used for marketing an Underwritten Takedown, if the
majority-in-interest of the Demanding Holders disapprove of the terms of any underwriting or are not entitled to include all of their
Registrable Securities in the relevant offering, such majority-in-interest of the Demanding Holders shall have the right to withdraw
from such Underwritten Takedown upon written notification to the Company, each other Demanding Holder and Requesting Holder, and the
applicable Underwriter(s).
2.6.2 Following
the receipt of any notice of withdrawal pursuant to subsection 2.6.1, the other Demanding Holders and Requesting Holders, provided
they collectively qualify as Demanding Holders pursuant to clauses (x) or (y) of Section 2.4 and the Takedown Threshold
would still be satisfied, may elect to continue with the Underwritten Offering and such continued Takedown Demand shall count as a Takedown
Demand of the continuing Demanding Holders for purposes of subsection 2.4.3 and not of the withdrawing Demanding Holders.
2.6.3 If
an Underwritten Takedown is withdrawn and not continued pursuant to subsection 2.6.2, the withdrawn Takedown Demand shall not
count as an Underwritten Takedown for purposes of subsection 2.4.3 if and only if one or more of the Demanding Holders reimburse
the Company for all Registration Expenses with respect to such Underwritten Takedown. For the avoidance of doubt, the withdrawn Takedown
Demand shall count as an Underwritten Takedown if the Company is responsible for the Registration Expenses with respect to such Underwritten
Takedown.
2.7 Piggyback
Registration.
2.7.1 Piggyback
Rights. If the Company or any Holder proposes to conduct a registered offering of, or if the Company proposes to file a Registration
Statement under the Securities Act with respect to the Registration of, equity securities, or securities or other obligations exercisable
or exchangeable for, or convertible into equity securities, for its own account or for the account of shareholders of the Company (or
by the Company and by the shareholders of the Company, including an Underwritten Takedown pursuant to Section 2.4),
other than a Registration Statement (a) filed in connection with any employee share option or other benefit plan, (b) for an
exchange offer or offering of securities solely to the Company’s existing shareholders, (c) for an offering of debt that is
convertible into equity securities of the Company, (d) for a dividend reinvestment plan or (e) for a rights offering, then
the Company shall give written notice of such proposed filing or offering to all of the Holders of Registrable Securities as soon as
practicable but not less than fifteen (15) days before the anticipated filing date of such Registration Statement, or, in the case of
an Underwritten Offering pursuant to a Shelf Registration, the applicable preliminary “red herring” Prospectus or prospectus
supplement used for marketing such offering, which notice shall (x) describe the amount and type of securities to be included in
such offering, the intended method(s) of distribution, and the name of the proposed managing Underwriter(s), if any, in such offering,
and (y) offer to all of the Holders of Registrable Securities the opportunity to register the sale of such number of Registrable
Securities as such Holders may request in writing within ten (10) days after receipt of such written notice (such Registration,
a “Piggyback Registration”). Subject to subsection 2.7.2, the Company shall, in good faith, cause such Registrable
Securities to be included in such Piggyback Registration and shall use commercially reasonable efforts to cause the managing Underwriter(s) of
a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant to this subsection 2.7.1
to be included in such Piggyback Registration on the same terms and conditions as any similar securities of the Company included in such
Registration and to permit the sale or other disposition of such Registrable Securities in accordance with the intended method(s) of
distribution thereof. In the event of any Underwritten Offering, the inclusion of any Holder’s Registrable Securities in
a Piggyback Registration shall be subject to such Holder’s agreement to enter into and comply with an underwriting agreement in
customary form with the Underwriter(s) duly selected for such Underwritten Offering.
2.7.2 Reduction
of Piggyback Registration. If the managing Underwriter(s) in an Underwritten Registration that is to be a Piggyback Registration
advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration in writing that the dollar
amount or number of the Company Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities
that Company desires to sell, taken together with (x) the Company Ordinary Shares (including Company Ordinary Shares represented
by Company ADSs) or other equity securities, if any, as to which Registration or a registered offering has been demanded pursuant to
separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (y) the
Registrable Securities as to which registration has been requested pursuant to Section 2.7 hereof, and (z) the Company
Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities, if any, as to which Registration
or a registered offering has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders
of the Company, exceeds the Maximum Number of Securities, then:
(a) If
the Registration or registered offering is undertaken for the Company’s account, the Company shall include in any such Registration
or registered offering:
(i) first,
the Company Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities that the Company
desires to sell, which can be sold without exceeding the Maximum Number of Securities;
(ii) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of
Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.7.1, Pro Rata among such Holders,
which can be sold without exceeding the Maximum Number of Securities; and
(iii) third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Company Ordinary
Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities, if any, as to which Registration or
a registered offering has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders
of the Company, which can be sold without exceeding the Maximum Number of Securities; and
(b) If
the Registration or registered offering is pursuant to a request by persons or entities other than the Holders of Registrable Securities,
then the Company shall include in any such Registration or registered offering:
(i) first,
the Company Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities, if any, of such
requesting persons or entities, other than the Holders of Registrable Securities, which can be sold without exceeding the Maximum Number
of Securities;
(ii) second,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clause (i), the Registrable Securities of
Holders exercising their rights to register their Registrable Securities pursuant to subsection 2.7.1, Pro Rata among such Holders,
which can be sold without exceeding the Maximum Number of Securities;
(iii) third,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i) and (ii), the Company Ordinary
Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities that the Company desires to sell, which
can be sold without exceeding the Maximum Number of Securities; and
(iv) fourth,
to the extent that the Maximum Number of Securities has not been reached under the foregoing clauses (i), (ii) and (iii), the Company
Ordinary Shares (including Company Ordinary Shares represented by Company ADSs) or other equity securities, if any, as to which Registration
or a registered offering has been requested pursuant to separate written contractual piggy-back registration rights of other shareholders
of the Company, which can be sold without exceeding the Maximum Number of Securities.
(c) Notwithstanding
anything to the contrary in the foregoing clauses (a) and (b), if the Registration or registered offering is pursuant to a request
by Holder(s) of Registrable Securities pursuant to Section 2.4, then the Company shall include in any such Registration
or registered offering securities pursuant to Section 2.5.
2.7.3 Piggyback
Registration Withdrawal. Any Holder of Registrable Securities shall have the right to withdraw from a Piggyback Registration for
any or no reason whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) prior to the effectiveness
of the Registration Statement filed with the Commission with respect to such Piggyback Registration. The Company (whether on its own
good faith determination or as the result of a request for withdrawal by persons pursuant to separate written contractual obligations)
may withdraw a Registration Statement filed with the Commission in connection with a Piggyback Registration at any time prior to the
effectiveness of such Registration Statement. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible
for the Registration Expenses incurred in connection with the Piggyback Registration prior to its withdrawal under this subsection
2.7.3.
2.8 Restrictions
on Registration Rights. Notwithstanding any provision of this Agreement to the contrary, if
Holders have requested an Underwritten Takedown and the Company and such Holders are unable to obtain the commitment of underwriters
to firmly underwrite such offering, the Company shall have the right to defer the filing of the Registration Statement or conduct
of an Underwritten Offering for a period of not more than sixty (60) days, if the Company determines, in the good faith judgment of the
Board, that it would be materially detrimental to the Company to do otherwise than defer such filing or conduct.
2.9 Market
Stand-Off Agreement. Each Holder given an opportunity to participate in an Underwritten Offering of the Company (other than a Block
Trade) pursuant to the terms of this Agreement agrees that it shall not Transfer any Company Ordinary Shares (including Company Ordinary
Shares represented by Company ADSs) or other equity securities of the Company (other than those included in such offering pursuant to
this Agreement), without the prior written consent of the Company, during the ninety (90)-day period beginning on the date of pricing
of such offering, except in the event the managing Underwriter(s) otherwise agree by written consent. Each Holder agrees to execute
a customary lock-up agreement in favor of the relevant Underwriter(s) to such effect (in each case on substantially the same terms
and conditions as all such Holders).
2.10 Block
Trade; Other Coordinated Offerings.
2.10.1 Notwithstanding
the forgoing, at any time and from time to time when an effective Shelf is on file with the Commission, if a Demanding Holder wishes
to engage in (a) an underwritten or other coordinated registered offering not involving a “roadshow,” an offer
commonly known as a “block trade” (a “Block Trade”), (b) an “at the market” or similar registered
offering through a broker, sales agent or distribution
agent, whether as agent or principal (an “Other Coordinated Offering”), in each case with a total offering price reasonably
expected to exceed, in the aggregate, either (x) US$10,000,000 or (y) all remaining Registrable Securities held by the Demanding
Holder, then such Demanding Holder shall use commercially reasonable efforts to notify the Company of the Block Trade or Other Coordinated
Offering at least five (5) Business Days prior to the day such offering is to commence and the Company shall as expeditiously as
possible use commercially reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding
Holders representing a majority of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall
use commercially reasonable efforts to work with the Company and any Underwriters prior to making such request in order to facilitate
preparation of the registration statement, prospectus and other offering documentation related to the Block Trade or Other Coordinated
Offering.
2.10.2 Prior
to the filing of the applicable “red herring” prospectus or prospectus supplement used in connection with a Block
Trade or Other Coordinated Offering, the majority-in-interest of the Demanding Holders initiating such Block Trade or Other Coordinated
Offering shall have the right to withdraw upon written notification to the Company and the Underwriter or Underwriters (if any). Notwithstanding
anything to the contrary in this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with
a Block Trade or Other Coordinated Offering prior to its withdrawal under this section.
2.10.3 The
Demanding Holder in a Block Trade or Other Coordinated Offering shall have the right to select the Underwriters, sales agents or placement
agents for such Block Trade or Other Coordinated Offering (which shall consist of one or more reputable nationally recognized investment
banks), provided that the Company shall have the right to consent to the Underwriters and any sale agents or placement agents (if any)
for such Block Trade or Other Coordinated Offering, which consent will not be unreasonably withheld, conditioned or delayed.
2.10.4 Any
Registration effected pursuant to this Section 2.10 shall be deemed an Underwritten Takedown and within the cap on Underwritten
Takedowns provided in subsection 2.4.3.
2.10.5 Notwithstanding
anything to the contrary in this Agreement, Section 2.7 hereof shall not apply to a Block Trade or Other Coordinated Offering
initiated by a Demanding Holder pursuant to this Agreement.
ARTICLE 3
COMPANY PROCEDURES
3.1 General
Procedures. In connection with any Shelf and/or Underwritten Takedown, the Company shall use commercially reasonable efforts to effect
such Registration to permit the sale of such Registrable Securities in accordance with the intended plan of distribution thereof, and
pursuant thereto the Company shall, as expeditiously as reasonably possible:
3.1.1 prepare
and file with the Commission a Registration Statement with respect to such Registrable Securities and use commercially reasonable efforts
to cause such Registration Statement to become effective and remain effective until all Registrable Securities covered by such Registration
Statement are disposed of in accordance with the intended plan of distribution set forth in such Registration Statement or supplement
to the Prospectus;
3.1.2 prepare
and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements to the
Prospectus as may be reasonably requested by the Holders or any Underwriter of Registrable Securities or as may be required by the rules,
regulations or instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations
thereunder to keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are disposed
of in accordance with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus or such
securities have been withdrawn;
3.1.3 prior
to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriter(s),
if any, and the Holders of Registrable Securities included in such Registration, and such Holders’ legal counsel, copies of such
Registration Statement as proposed to be filed, each amendment and supplement to such Registration Statement (in each case including
all exhibits thereto and documents incorporated by reference therein), the Prospectus included in such Registration Statement (including
each preliminary Prospectus), and such other documents as the Underwriter(s) and the Holders of Registrable Securities included
in such Registration or the legal counsel for any such Holders may reasonably request in order to facilitate the disposition of the Registrable
Securities owned by such Holders;
3.1.4 prior
to any public offering of Registrable Securities, use commercially reasonable efforts to (a) register or qualify the Registrable
Securities covered by the Registration Statement under such securities or “blue sky” laws of such jurisdictions in the United
States as the Holders of Registrable Securities included in such Registration Statement (in light of their intended plan of distribution)
may reasonably request and (b) take such action necessary to cause such Registrable Securities covered by the Registration Statement
to be registered with or approved by such other governmental authorities as may be reasonably necessary by virtue of the business and
operations of the Company and do any and all other acts and things that may be reasonably necessary to enable the Holders of Registrable
Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such jurisdictions; provided, however,
that the Company shall not be required to qualify generally to do business in any jurisdiction where it would not otherwise be required
to qualify or take any action to which it would be subject to general service of process or taxation in any such jurisdiction where it
is not then otherwise so subject;
3.1.5 cause
all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities issued
by the Company are then listed;
3.1.6 provide
a transfer agent, as applicable, and registrar for all such Registrable Securities no later than the effective date of such Registration
Statement;
3.1.7 advise
each seller of such Registrable Securities, promptly, and in no event later than two (2) Business Day, after it shall receive notice
or obtain knowledge thereof, of the issuance of any stop order by the Commission suspending the effectiveness of such Registration Statement
or the initiation or threatening of any proceeding for such purpose and promptly use commercially reasonable efforts to prevent the issuance
of any stop order or to obtain its withdrawal if such stop order should be issued;
3.1.8 notify
the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities Act,
of the occurrence of any event as a result of which the Prospectus included in such Registration Statement, as then in effect, includes
a Misstatement, and then to correct such Misstatement as set forth in Section 3.4 hereof;
3.1.9 permit
a representative of the Holders (such representative to be selected by a majority-in-interest of the participating Holders), the Underwriters,
if any, and any attorney or accountant retained by such Holders or Underwriter to participate, at each such person’s own expense,
in the preparation of the Registration Statement, and cause the Company’s officers, directors and employees to supply all information
reasonably requested by any such representative, Underwriter, attorney or accountant in connection with the Registration; provided, however,
that such representative, or Underwriters enter into a confidentiality agreement, in form and substance reasonably satisfactory
to Company, prior to the release or disclosure of any such information;
3.1.10 obtain
a “comfort” letter from the Company’s independent registered public accountants in the event of an Underwritten Registration,
Block Trade or Other Coordinated Offering that is registered pursuant to a Registration Statement, in customary form and covering such
matters of the type customarily covered by “comfort” letters as the managing Underwriter(s) or other similar type of
sales agent(s) or placement agent(s) may reasonably request and reasonably satisfactory to the participating Holders ;
3.1.11 in
the event of an Underwritten Registration, on the date the Registrable Securities are delivered for sale pursuant to such Registration,
obtain an opinion and a negative assurance letter, each dated such date, of counsel representing the Company for the purposes of such
Registration, addressed to the participating Holders, the placement agent or sales agent, if any, and the Underwriter(s), if any, as
the case may be, covering such legal matters with respect to the Registration in respect of which such opinion or negative assurance
letter is being given as the participating Holders, placement agent, sales agent, or Underwriter, as the case may be, may reasonably
request and as are customarily included in such opinions and negative assurance letters and reasonably satisfactory to a majority-in-interest
of the participating Holders;
3.1.12 in
the event of any Underwritten Offering or Other Coordinated Offering that is registered pursuant to a Registration Statement, enter into
and perform its obligations under an underwriting agreement, sales agreement or placement agreement, in usual and customary form, with
the managing Underwriter(s), sales agent(s) or placement agent(s) of such offering;
3.1.13 make
available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve (12) months
beginning with the first day of the Company’s first full calendar quarter after the effective date of the Registration Statement
which satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder (or any successor rule then
in effect);
3.1.14 with
respect to an Underwritten Offering pursuant to Section 2.4, use commercially reasonable efforts to make available senior
executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the Underwriter(s) in
such Underwritten Offering;
3.1.15 otherwise
cooperate reasonably with, and take such customary actions as may reasonably be requested by the participating Holders, consistent with
the terms of this Agreement, in connection with such Registration;
3.1.16 assist
the Depository Bank to maintain an effective registration of the Company ADSs on Form F-6 in accordance with the Deposit Agreement
and cooperate with the Depositary Bank in filing amendments to such Form F-6 sufficient to allow the Holders to exercise their rights
hereunder and under the Deposit Agreement to cover the Registrable Securities then outstanding.
3.2 Registration
Expenses. The Registration Expenses of all Registrations shall be borne by the Company. It is acknowledged by the Holders that the
Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters’ commissions
and discounts, brokerage fees and Underwriter marketing costs and, other than as set forth in the definition of “Registration Expenses,”
all reasonable fees and expenses of any legal counsel representing the Holders.
3.3 Requirements
for Participation in Underwritten Offerings. Each Holder shall provide such information as may reasonably be requested by the Company,
or the managing Underwriter(s) or placement agent or sales agent, if any, in connection with the preparation of any Registration
Statement or Prospectus, including amendments and supplements thereto, in order to effect the Registration of any Registrable Securities
under the Securities Act pursuant to ARTICLE 2 and in connection with the Company’s obligation to comply with federal
and applicable state securities laws. No person may participate in any Underwritten Offering for equity securities of the Company pursuant
to a Registration initiated by the Company hereunder unless such person:
3.3.1 agrees
to sell such person’s securities on the basis provided in any customary underwriting arrangements approved by the Company (after
having considered and given good faith consideration to the comments from U.S. counsel(s) for the Holders that are selling in the
Underwritten offering); and
3.3.2 completes
and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements and
other customary documents as may be reasonably required under the terms of such underwriting arrangements.
The exclusion of a Holder’s Registrable
Securities as a result of this Section 3.3 shall not affect the Registration of the other Registrable Securities to be included
in such Registration.
3.4 Suspension
of Sales; Adverse Disclosure. Upon receipt of written notice from the Company that a Registration Statement or Prospectus contains
a Misstatement (including pursuant to subsection 3.1.8), each of the Holders shall forthwith discontinue disposition of Registrable
Securities until it has received copies of a supplemented or amended Prospectus correcting the Misstatement (it being understood that
the Company hereby covenants to prepare and file such supplement or amendment as soon as practicable after the time of such notice),
or until it is advised in writing by the Company that the use of the Prospectus may be resumed. In addition, if the filing, initial effectiveness
or continued use of a Registration Statement in respect of any Registration at any time would (a) require the inclusion in such
Registration Statement of financial statements that are unavailable to the Company for reasons beyond the Company’s control, (b) in
the good faith view of the Company, require the Company to make an Adverse Disclosure, or (c) in the good faith judgment of the
Company, be materially detrimental to the Company as a result that it is essential to defer such filing, initial effectiveness or continued
use at such time, the Company may, upon giving prompt written notice of such action to the Holders, delay the filing or initial effectiveness
of, or suspend use of, such Registration Statement for the period of time determined in good faith by the Company to be necessary for
such purpose; provided, however, that the Company shall not have the right to exercise the rights set forth this Section 3.4 for
more than 90 consecutive days or more than 120 days, in any such case, in any 12-month period. In the event the Company exercises its
rights under the preceding sentence, the Holders agree to suspend, immediately upon their receipt of the notice referred to above, their
use of the Prospectus relating to any Registration in connection with any sale or offer to sell Registrable Securities.
3.5 Reporting
Obligations. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be a reporting company
under the Exchange Act, covenants to use commercially reasonable efforts to file timely (or obtain extensions in respect thereof and
file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to Sections
13(a) or 15(d) of the Exchange Act and to promptly furnish the Holders with true and complete copies of all such filings;
provided that any documents publicly filed or furnished with the Commission pursuant to the Electronic Data Gathering, Analysis
and Retrieval system shall be deemed to have been furnished or delivered to the Holders pursuant to this Section 3.5. The
Company further covenants that it shall use commercially reasonable efforts to take such further action as any Holder may reasonably
request, all to the extent required from time to time to enable such Holder to sell Company Ordinary Shares (including Company Ordinary
Shares represented by Company ADSs) held by such Holder without registration under the Securities Act within the limitation of the exemptions
provided by Rule 144 promulgated under the Securities Act (or any successor rule then in effect). Upon the request of any Holder,
the Company shall deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such
requirements.
ARTICLE 4
INDEMNIFICATION AND CONTRIBUTION
4.1 Indemnification
by the Company. The Company agrees to indemnify and hold harmless, to the extent permitted by law, each Holder of Registrable Securities,
its officers, directors, agents and each person who controls such Holder (within the meaning of the Securities Act) (each, a “Holder
Indemnified Party”) against all losses, judgements, claims, damages, liabilities and out-of-pocket expenses (including reasonable
attorneys’ fees) resulting from, arising out of or that are based on (a) any untrue or alleged untrue statement of a material
fact contained in any Registration Statement, Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or
any omission or alleged omission of a material fact required to be stated therein or necessary to make the statements therein not misleading,
or any violation by the Company of the Securities Act or any rule or regulation promulgated thereunder applicable to the Company
and relating to action or inaction required of the Company in connection with any such registration, except insofar as the same are caused
by or contained in any information or affidavit furnished in writing to the Company by such Holder expressly for use therein, or (b) if
such losses, judgments, claims, damages, liabilities or out-of-pocket expenses are based on any such Holder’s violation of the
federal securities laws or failure to sell the Registrable Securities in accordance with the intended plan of distribution contained
in the Prospectus. The Company shall promptly reimburse a Holder Indemnified Party for any reasonable expenses incurred by
such Holder Indemnified Party in connection with investigating and defending any proceeding or action to which this Section 4.1
applies (including the reasonable fees and disbursements of legal counsel) except insofar as such proceeding or action arise out
of or are based on any information or affidavit furnished in writing to the Company by such Holder, or if such proceeding or action are
based on any such Holder’s violation of the federal securities laws or failure to sell the Registrable Securities in accordance
with the intended plan of distribution contained in the Prospectus.
4.2 Information
Provided by and Indemnification by Holders. In connection with any Registration Statement in which a Holder of Registrable Securities
is participating, such Holder shall furnish to the Company in writing such information and affidavits as the Company reasonably requests
for use in connection with any such Registration Statement or Prospectus and, to the extent permitted by law, shall indemnify and hold
harmless the Company, its directors, officers and agents and each person who controls the Company (within the meaning of the Securities
Act) against any losses, claims, damages, liabilities and out-of-pocket expenses (including reasonable attorneys’ fees) resulting
from, arising out of or that are based on any untrue or alleged untrue statement of a material fact contained in the Registration Statement,
Prospectus or preliminary Prospectus or any amendment thereof or supplement thereto or any omission or alleged omission of a material
fact required to be stated therein or necessary to make the statements therein not misleading, but only to the extent that such untrue
or alleged untrue statement or omission or alleged omission are caused by or contained in any information or affidavit so furnished in
writing by such Holder expressly for use therein, or if such losses, judgments, claims, damages, liabilities or out-of-pocket expenses
are based on any such Holder’s violation of the federal securities laws or failure to sell the Registrable Securities in accordance
with the intended plan of distribution contained in the Prospectus; provided, however, that the obligation to
indemnify shall be several, not joint and several, among such Holders of Registrable Securities, and the liability of each such Holder
of Registrable Securities shall be in proportion to and limited to the net proceeds received by such Holder from the sale of Registrable
Securities pursuant to such Registration Statement. The Holders of Registrable Securities shall indemnify the Underwriter(s), their officers,
directors and each person who controls such Underwriter(s) (within the meaning of the Securities Act) to the same extent as provided
in the foregoing with respect to indemnification of the Company.
4.3 Indemnification
Process.
4.3.1 Any
person entitled to indemnification pursuant to Sections 4.1 or 4.2 (each, an “Indemnified Party”) shall:
(a) if
a claim is to be made against any person (the “Indemnifying Party”) for indemnification hereunder, give prompt written
notice to the Indemnifying Party of the losses, claims, damages, liabilities or out-of-pocket expenses (provided that the failure to
give prompt notice shall not impair any person’s right to indemnification hereunder to the extent such failure has not prejudiced
the Indemnifying Party); and
(b) unless
in the Indemnified Party’s reasonable judgment a conflict of interest between such Indemnified Party and Indemnifying Party may
exist with respect to such claim, permit such Indemnifying Party to assume control of the defense of such claim with counsel reasonably
satisfactory to the Indemnified Party. If such defense is assumed, the Indemnifying Party shall not, without its consent (such consent
shall not be unreasonably withheld), be subject to any liability for any settlement made by the Indemnified Party.
4.3.2 If
such control of defense is assumed, the Indemnifying Party shall not be subject to any liability to the Indemnified Party for any legal
or other expenses subsequently incurred by the Indemnified Party in connection with the defense thereof.
4.3.3 An
Indemnifying Party who is not entitled to, or elects not to, assume the control of defense of a claim shall not be obligated to pay the
fees and expenses of more than one (1) counsel for all parties indemnified by such Indemnifying Party with respect to such claim,
unless in the reasonable judgment of any Indemnified Party a conflict of interest may exist between such Indemnified Party and any other
of such Indemnified Parties with respect to such claim.
4.3.4 No
Indemnifying party shall, without the prior written consent of the Indemnified party, consent to the entry of any judgment or enter into
any settlement which cannot be settled in all respects by the payment of money (and such money is so paid by the Indemnifying Party pursuant
to the terms of such settlement) or which settlement includes a statement or admission of fault and culpability on the part of such Indemnified
Party or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified
Party of a release from all liability in respect to such claim or litigation.
4.3.5 The
indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on
behalf of the Indemnified Party or any officer, director or controlling person of such Indemnified Party and shall survive the transfer
of securities.
4.4 Contribution.
If the indemnification provided under Sections 4.1, 4.2, and 4.3 from the Indemnifying Party is judicially determined to
be unavailable or insufficient to hold harmless an Indemnified Party in respect of any losses, claims, damages, liabilities and out-of-pocket
expenses referred to herein, then the Indemnifying Party, in lieu of indemnifying the Indemnified Party, shall contribute to the amount
paid or payable by the Indemnified Party as a result of such losses, claims, damages, liabilities and out-of-pocket expenses in such
proportion as is appropriate to reflect the relative fault of the Indemnifying Party and the Indemnified Party, as well as any other
relevant equitable considerations. The relative fault of the Indemnifying Party and the Indemnified Party shall be determined by reference
to, among other things, whether any action in question, including any untrue or alleged untrue statement of a material fact or omission
or alleged omission to state a material fact, was made by (or omitted to be made by, in the case of an omission), or relates to any information
or affidavit supplied by (or not supplied by, in the case of an omission), such Indemnifying Party and the Indemnified Party, and the
Indemnifying Party’s and the Indemnified Party’s relative intent, knowledge, access to information and opportunity
to correct or prevent such action; provided, however, that the liability of any Holder under this subsection 4.4 shall
be limited to the amount of the net proceeds received by such Holder in such offering giving rise to such liability. The amount paid
or payable by a party as a result of the losses or other liabilities referred to above shall be deemed to include, subject to the limitations
set forth in subsections 4.1, 4.2 and 4.3 above, any legal or other fees, charges or out-of-pocket
expenses reasonably incurred by such party in connection with any investigation or proceeding. The parties hereto agree that it would
not be just and equitable if contribution pursuant to this subsection 4.4 were determined by pro rata allocation or
by any other method of allocation, which does not take account of the equitable considerations referred to in this subsection
4.4. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution pursuant to this subsection 4.4 from any person who was not guilty of such fraudulent
misrepresentation.
ARTICLE 5
MISCELLANEOUS
5.1 Notices.
All general notices, demands or other communications required or permitted to be given or made hereunder (“Notices”)
shall be in writing and delivered personally or sent by courier or sent by electronic mail to the intended recipient thereof. Any such
Notice shall be deemed to have been duly served (a) if given personally or sent by local courier, upon delivery during normal business
hours at the location of delivery or, if later, then on the next Business Day after the day of delivery; (b) if sent by electronic
mail during normal business hours at the location of delivery, immediately, or, if later, then on the next Business Day after the day
of delivery; or (c) the third Business Day following the day sent by reputable international overnight courier (with written confirmation
of receipt). Any notice or communication under this Agreement must be addressed:
If to the Company:
Lotus
Technology Inc.
800
Century Avenue
Lujiazui CBD
Pudong District
Shanghai 200120
China
Attention:
Chief Financial Officer
E-mail: Alexious.Lee@lotuscars.com.cn
With
a copy (which shall not constitute notice) to:
Skadden,
Arps, Slate, Meagher & Flom LLP
30/F, China World Office 2
No. 1, Jian Guo Men Wai Avenue
Beijing 100004, China
Attention: Peter X. Huang
Email: peter.huang@skadden.com
and
Skadden, Arps, Slate, Meagher & Flom LLP
c/o 42/F, Edinburgh Tower, The Landmark
15 Queen’s Road Central, Hong Kong
Attention: Shu Du
Email: shu.du@skadden.com
If to SPAC or the Sponsor:
L Catterton Asia Acquisition Corp
8 Marina View, Asia Square Tower 1
#41-03, Singapore 018960
Attention: James Steinthal
Email: Jim.Steinthal@lcatterton.com
With
a copy (which shall not constitute notice) to:
Kirkland & Ellis
26th Floor, Gloucester Tower, The Landmark
15 Queen’s Road Central, Hong Kong
Attn: Jesse Sheley
Joseph Raymond Casey
E-mail: jesse.sheley@kirkland.com
joseph.casey@kirkland.com
29th Floor, China World Office 2
No.1 Jian Guo Men Wai Avenue
Beijing 100004, P.R. China
Attn: Steve Lin
Email: steve.lin@kirkland.com
If
to any Holder, at such Holder’s address or contact information as set forth under such Holder’s signature to this
Agreement or to such Holder’s address as found in Company’s books and records.
Any party may change its address for notice at
any time and from time to time by written notice to the other parties hereto, and such change of address shall become effective thirty
(30) days after delivery of such notice as provided in this Section 5.1. Any Holder not desiring to receive Notices
at any time and from time to time may so notify the other parties, who shall thereafter not make, give or deliver any Notice to such
Holder until duly notified otherwise (or until the expiry of any period specified in such Holder’s notice).
5.2 Assignment;
No Third Party Beneficiaries.
5.2.1 This
Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole or
in part.
5.2.2 Prior
to the expiration of the lock-up period applicable to such Holder pursuant to any Lock-Up Agreement, no Holder may assign or delegate
such Holder’s rights, duties or obligations under this Agreement, in whole or in part, except in connection with a transfer of
Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees to become bound by the terms
and conditions of this Agreement. After the expiration of the lock-up period applicable to such Holder pursuant to any Lock-Up Agreement,
the Holder may assign or delegate such Holder’s rights, duties or obligations under this Agreement, in whole or in part, to any
person to whom it transfers Registrable Securities; provided that such Registrable Securities remain Registrable Securities following
such transfer, and such person agrees to be bound by the terms and conditions of this Agreement.
5.2.3 This
Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors and
the permitted assigns of the Holders, which shall include Permitted Transferees.
5.2.4 This
Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth in this
Agreement and Section 5.2 hereof.
5.2.5 No
assignment by any party hereto of such party’s rights, duties and obligations hereunder shall be binding upon or obligate the Company
unless and until the Company shall have received (i) written notice of such assignment as provided in Section 5.1 hereof
and (ii) the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms and conditions
of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer or assignment
made other than as provided in this Section 5.2 shall be null and void.
5.3 Counterparts.
This Agreement may be executed in multiple counterparts (including by electronic means), each of which shall be deemed an original, and
all of which together shall constitute the same instrument, but only one of which need be produced.
5.4 Governing
Law; Venue. Each party expressly agrees that this Agreement, and all claims or causes of action based upon, arising out of, or related
to this Agreement or the transactions contemplated hereby, shall be governed by, and construed in accordance with, the laws of the State
of New York, without giving effect to principles or rules of conflict of laws to the extent such principles or rules would
require or permit the applicable of laws of another jurisdiction. Any claim or cause of action based upon, arising out of or related
to this Agreement or the transactions contemplated hereby may be brought in federal and state courts in New York county in the State
of New York, and each of the parties irrevocably submits to the exclusive jurisdiction of each such court, waives any obligation it may
now or hereafter have to personal jurisdiction, venue or to convenience of forum, agrees that all claims in respect of any cause of action
may be heard and determined only in any such court, and agrees not to bring any cause of action arising out of or relating to this Agreement
or the transactions contemplated hereby in any other court. Nothing herein contained shall be deemed to affect the right of any party
to serve process in any manner permitted by law or to commence legal proceedings or otherwise proceed against any other party in any
other jurisdiction, in each case, to enforce judgments obtained in any action brought pursuant to this Section 5.4. EACH
OF THE PARTIES HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY ACTION BASED UPON, ARISING OUT OF OR RELATED TO THIS
AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
5.5 Severability.
The invalidity or unenforceability of any specific provision of this Agreement shall not invalidate or render unenforceable any of its
other provisions. The parties hereto further agree that if any provision contained in this Agreement is, to any extent, held invalid
or unenforceable in any respect under the laws governing this Agreement, they shall take any actions necessary to render the remaining
provisions of this Agreement valid and enforceable to the fullest extent permitted by law and, to the extent necessary, shall amend or
otherwise modify this Agreement to replace any provision contained in this Agreement that is held invalid or unenforceable with a valid
and enforceable provision giving effect to the intent of the parties hereto.
5.6 Entire
Agreement. This Agreement (together with the Merger Agreement, and any applicable Lock-Up Agreement to the extent incorporated
herein, and including all agreements entered into pursuant hereto or thereto or referenced herein or therein and all certificates and
instruments delivered pursuant hereto and thereto) set forth the entire understanding of the parties with respect to the subject matter
hereof and supersede all other prior and contemporaneous agreements and understandings between the parties, whether oral or written,
with respect to such subject matter.
5.7 Construction.
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rule of
strict construction will be applied against any party. Unless the context otherwise requires: (a) “or” is disjunctive
but not exclusive; (b) words in the singular include the plural, and in the plural include the singular; (c) the words “hereof,”
“herein,” “hereunder” and words of similar import when used in this Agreement refer to this Agreement as a whole
and not to any particular provision of this Agreement, and section and subsection references are to this Agreement unless otherwise specified;
(d) the term “including” is not limiting and means “including without limitation”; (e) whenever the
context requires, any pronouns used herein shall include the corresponding masculine, feminine or neuter forms; (f) references to
agreements and other documents shall be deemed to include all subsequent amendments and other modifications or supplements thereto; and
(g) references to statutes shall include all regulations promulgated thereunder and references to statutes or regulations shall
be construed as including all statutory and regulatory provisions consolidating, amending or replacing the statute or regulation. Where
any Company Ordinary Shares are held by the Depository Trust Company or any person who operates a clearing system or issues depositary
receipts (or their nominees) and/or a nominee, custodian or trustee for any person, that person shall (unless the context requires otherwise)
be treated for the purposes of this Agreement as the holder of those shares and references to shares being “held by” a person,
to a person “holding” shares or to a person who “holds” any such shares, or equivalent formulations, shall be
construed accordingly. The headings, subheadings and captions contained in this Agreement are included for convenience of reference only,
and in no way define, limit or describe the scope of this Agreement or the intent of any provision hereof.
5.8 Amendments
and Modifications. Upon the prior written consent of the Company and the Holders of at least a majority of the Registrable Securities
at the time in question, compliance with any of the provisions, covenants and conditions set forth in this Agreement may be waived, or
any of such provisions, covenants or conditions may be amended or modified; provided, however, that notwithstanding
the foregoing, any amendment or modification to this Agreement that would have a disproportionately adverse effect on any party’s
rights hereunder in any material respect shall require the prior written consent of such party.
5.9 Termination
of Prior SPAC Agreement and Termination and Effectiveness of this Agreement.
5.9.1 Each
of SPAC, the Sponsor and the “Holders” (as defined in the Prior SPAC Agreement) hereby agrees that the Prior SPAC
Agreement shall terminate as of the First Merger Closing, and thereafter shall be of no further force and effect.
5.9.2 The
registration rights granted under this Agreement shall supersede any registration, qualification or similar rights of the Holders with
respect to the securities of SPAC or the Company granted under any other agreement, and any of such preexisting registration, qualification
or similar rights and such agreements shall be terminated and of no further force and effect. With effect from the First Merger Closing,
each party to this Agreement hereby irrevocably waives and agrees not to exercise or enforce any rights it may have (a) in respect
of the registration of Registrable Securities pursuant to any other agreement.
5.9.3 This
Agreement shall take effect as of and from the First Merger Closing; provided, that if the Merger Agreement is terminated prior
to the First Merger Closing, this Agreement shall not become effective and shall be deemed void.
5.10 Term.
This Agreement shall terminate upon the earlier of (a) the tenth (10th) anniversary of the date of this Agreement and (b) with
respect to any Holder, on the date that such Holder no longer holds any Registrable Securities. The provisions of Section 3.5 shall
survive any termination of this Agreement.
[Signature Pages Follow]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
Company: |
| |
|
| |
Lotus Technology Inc. |
| |
|
| |
By: |
|
| |
|
Name: |
|
| |
|
Title: |
|
[Signature Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
SPAC: |
| |
|
| |
L Catterton Asia Acquisition Corp. |
| |
|
| |
By: |
|
| |
|
Name: |
|
| |
|
Title: |
|
[Signature Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
Sponsor: |
| |
|
| |
LCA Acquisition Sponsor, LP |
| |
|
| |
By: |
|
| |
|
Name: |
|
| |
|
Title: |
|
[Signature Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
Holder: |
| |
|
| |
Sanford Litvack |
| |
|
| |
By: |
|
| |
|
Name: |
Sanford
Litvack |
| |
|
|
|
| |
|
|
|
| |
Address
for Notices: |
[Signature Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
Holder: |
| |
|
| |
Frank N. Newman |
| |
|
| |
By: |
|
| |
|
Name: |
Frank N.
Newman |
| |
|
|
|
| |
|
|
|
| |
Address
for Notices: |
[Signature Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
Holder: |
| |
|
| |
Anish Melwani |
| |
|
| |
By: |
|
| |
|
Name: |
Anish Melwani |
| |
|
|
|
| |
|
|
|
| |
Address
for Notices: |
[Signature Page to Registration Rights Agreement]
IN
WITNESS WHEREOF, the undersigned have caused this Agreement to be executed as of the date first written above.
| |
Holder: |
| |
|
| |
[●] |
| |
|
| |
By: |
|
| |
|
Name: |
|
| |
|
Title: |
|
| |
|
|
|
| |
|
|
|
| |
Address
for Notices: |
[Signature Page to Registration Rights Agreement]
Exhibit 10.2
ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT
This
ASSIGNMENT, ASSUMPTION AND AMENDMENT AGREEMENT (this “Agreement”), is made and entered into as of _________, 2023,
by and among L Catterton Asia Acquisition Corp, a Cayman Islands exempted company (“SPAC”), Lotus Technology Inc.,
a Cayman Islands exempted company (the “Company”), Continental Stock Transfer & Trust Company, a New York
corporation (the “Predecessor Warrant Agent”), and Equiniti Trust Company, LLC, a New York limited liability trust
company (the “Successor Warrant Agent”). Capitalized terms used but not otherwise defined herein shall have
the respective meanings assigned to such terms in the Warrant Agreement (as defined below) (and if such term is not defined in the Warrant
Agreement, then the Merger Agreement (as defined below)).
WHEREAS,
SPAC and the Predecessor Warrant Agent are parties to that certain Warrant Agreement, dated March 10, 2021 (as amended, including
without limitation by this Agreement, the “Warrant Agreement”), pursuant to which the Predecessor Warrant Agent agreed
to act as SPAC’s warrant agent with respect to the issuance, registration, transfer, exchange, redemption and exercise of (i) warrants
to purchase ordinary shares of SPAC issued in SPAC’s initial public offering (“IPO”) (the “Public Warrants”),
(ii) warrants to purchase ordinary shares of SPAC acquired by LCA Acquisition Sponsor, LP (the “Sponsor”), in
a private placement concurrent with IPO (the “Private Placement Warrants”), and (iii) warrants to purchase ordinary
shares issuable to the Sponsor or an affiliate of the Sponsor or certain officers and directors of SPAC upon conversion of up to $1,500,000
of working capital loans (the “Working Capital Warrants”, and together with the Public Warrants and the Private Placement
Warrants, in each case, as amended, including without limitation by this Agreement, the “Warrants”);
WHEREAS,
on January 31, 2023, (i) SPAC, (ii) the Company, (iii) Lotus Temp Limited, an exempted company limited by
shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company (“Merger Sub 1”),
and (iv) Lotus EV Limited, an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct
wholly owned subsidiary of the Company (“Merger Sub 2”), entered into an agreement and plan of merger (the “Original
Merger Agreement”);
WHEREAS,
on October 11, 2023, the parties to the Original Merger Agreement entered into the First Amended and Restated Agreement and Plan
of Merger (as may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Merger
Agreement”), pursuant to which the Original Merger Agreement was amended and restated in its entirety to provide, among other
things, (i) that each applicable SPAC Shareholder (other than the Founder Shareholders) immediately prior to the First Effective
Time shall receive Company ADSs (as defined below) in lieu of Company Ordinary Shares (as defined below) in the Mergers, and (ii) that
the Company shall establish a sponsored ADS Facility for the purpose of issuing the Company ADSs;
WHEREAS,
pursuant to the Merger Agreement, upon the consummation of the transactions contemplated thereby (the “Closing”), among
other matters and subject to the terms and conditions thereof, (a) Merger Sub 1 will merge with and into SPAC (the “First
Merger”), with SPAC being the surviving entity, and (b) immediately following the First Merger and as part of the same
overall transaction as the First Merger, SPAC, in its capacity as the surviving entity of the First Merger, will merge with and into Merger
Sub 2 (the “Second Merger” and together with the First Merger, collectively, the “Mergers”), with
Merger Sub 2 being the surviving entity, and as a result of which, among other matters, (i) Merger Sub 2, in its capacity as the
surviving entity of the Second Merger, shall remain a wholly-owned Subsidiary of the Company, (ii) each SPAC Class A Ordinary
Share (which includes each SPAC Class A Ordinary Share (A) issued in connection with the SPAC Class B Conversion and (B) held
as a result of the Unit Separation) immediately prior to the effective time of the First Merger (the “First Effective Time”)
(other than any SPAC Shares owned by SPAC as treasury shares or owned by any direct or indirect Subsidiary of SPAC immediately prior to
the First Effective Time, Redeeming SPAC Shares, Dissenting SPAC Shares or any SPAC Shares held by the Founder Shareholders) shall automatically
be cancelled and cease to exist in exchange for the right to receive one American depositary share of the Company duly and validly
issued against the deposit of one underlying ordinary share of the Company, par value $0.00001 per share (together with any other securities
of the Company or any successor entity issued in consideration of (including as a stock split, dividend or distribution) or in exchange
for any of such securities, the “Company Ordinary Shares”) deposited with the Depositary Bank in accordance with the
Deposit Agreement (the “Company ADSs”), and (iii) each SPAC Class A Ordinary Share issued and outstanding
immediately prior to the First Effective Time held by the Founder Shareholders shall automatically be cancelled and cease to exist in
exchange for the right to receive one Company Ordinary Share, in each case, upon the terms and subject to the conditions set forth in
the Merger Agreement and in accordance with the provisions of applicable law;
WHEREAS, upon
consummation of the Mergers, as provided in the Merger Agreement and Section 4.5 of the Warrant Agreement, each of the issued
and outstanding Warrants will no longer be exercisable for SPAC Ordinary Shares (as defined in the Merger Agreement) but instead
will be exercisable (subject to the terms and conditions of the Warrant Agreement as amended hereby) for the same number of Company
Ordinary Shares in the form of Company ADSs at the same exercise price per share;
WHEREAS, the Company Ordinary
Shares in the form of Company ADSs constitute an Alternative Issuance as defined in said Section 4.5 of the Warrant Agreement;
WHEREAS, all references to
“Ordinary Shares” in the Warrant Agreement (including all Exhibits thereto) shall mean the Company Ordinary Shares in the
form of Company ADSs;
WHEREAS, the board of directors
of SPAC has determined that the consummation of the transactions contemplated by the Merger Agreement will constitute a Business Combination
(as defined in the Warrant Agreement);
WHEREAS, in connection with
the Mergers, SPAC desires to assign all of its right, title and interest in the Warrant Agreement to the Company, and the Company wishes
to accept such assignment and assume all the liabilities and obligations of SPAC under the Warrant Agreement with the same force and effect
as if the Company were initially a party to the Warrant Agreement;
WHEREAS, SPAC, the Company
and the Predecessor Warrant Agent also desire to amend the Warrant Agreement to appoint the Successor Warrant Agent as the Warrant Agent
under the Warrant Agreement and the Successor Warrant Agent wishes to accept such appointment; and
WHEREAS, Section 9.8
of the Warrant Agreement provides that SPAC and the Warrant Agent may amend the Warrant Agreement without the consent of any Registered
Holders as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interests of the Registered
Holders under the Warrant Agreement.
NOW, THEREFORE, in consideration
of the premises and the mutual promises herein made, and in consideration of the representations, warranties and covenants herein contained,
and intending to be legally bound hereby, the parties hereto agree as follows:
| 1. | Assignment
and Assumption; Consent. |
| 1.1 | Assignment
and Assumption. |
| (a). | SPAC hereby assigns to the Company all
of SPAC’s right, title and interest in and to the Warrant Agreement and the Warrants
(each as amended hereby) as of the Effective Time. The Company hereby assumes, and agrees
to pay, perform, satisfy and discharge in full, as the same become due, all of SPAC’s
liabilities and obligations under the Warrant Agreement and the Warrants (each as amended
hereby) arising from and after the Effective Time with the same force and effect as if the
Company were initially a party to the Warrant Agreement. |
| (b). | The Predecessor Warrant Agent hereby assigns
to the Successor Warrant Agent all of the Predecessor Warrant Agent’s right, title
and interest in and to the Warrant Agreement and the Warrants (each as amended hereby) as
of the Effective Time. The Successor Warrant Agent hereby assumes, and agrees to pay, perform,
satisfy and discharge in full, as the same become due, all of the Predecessor Warrant Agent’s
liabilities and obligations under the Warrant Agreement and the Warrants (each as amended
hereby) arising from and after the Effective Time with the same force and effect as if the
Successor Warrant Agent were initially a party to the Warrant Agreement. |
| (a). | The
Successor Warrant Agent hereby consents to (i) the assignment of the Warrant Agreement
and the Warrants (each as amended hereby) by SPAC to the Company pursuant to Section 1.1(a) and
the assumption of the Warrant Agreement and the Warrants (each as amended hereby) by the
Company from SPAC pursuant to Section 1.1(a), in each case effective as of the Effective
Time, and (ii) the continuation of the Warrant Agreement and Warrants, in full force
and effect from and after the Effective Time, subject at all times to the Warrant Agreement
and Warrants (each as amended hereby) and to all of the provisions, covenants, agreements,
terms and conditions of the Warrant Agreement and this Agreement. |
| (b). | The Company hereby consents to (i) the
assignment of the Warrant Agreement and the Warrants (each as amended hereby) by the Predecessor
Warrant Agent to the Successor Warrant Agent pursuant to Section 1.1(b) and the
assumption of the Warrant Agreement and the Warrants (each as amended hereby)
by the Successor Warrant Agent from the Predecessor Warrant Agent pursuant to Section 1.1(b), in each case effective as of the Effective
Time, and (ii) the continuation of the Warrant Agreement and Warrants, in full force and effect from the Effective Time, subject
at all times to the Warrant Agreement and Warrants (each as amended hereby) and to all of the provisions, covenants, agreements, terms
and conditions of the Warrant Agreement and this Agreement. |
| 2. | Amendment
of Warrant Agreement. The parties hereto hereby agree to the following amendments
to the Warrant Agreement as provided in this Section 2 effective from the Effective
Time, and acknowledge and agree that the amendments to the Warrant Agreement set forth in
this Section 2 (i) are necessary and desirable and do not adversely affect
the rights of the Registered Holders under the Warrant Agreement and (ii) are to provide
for the delivery of Alternative Issuance pursuant to Section 4.5 of the Warrant Agreement
(in connection with the Mergers and the transactions contemplated by the Merger Agreement). |
| 2.1 | Preamble
and References to the “Company”. The preamble of the Warrant Agreement is
hereby amended by deleting “L Catterton Asia Acquisition Corp” and replacing
it with “Lotus Technology Inc.”. As a result thereof, all references to the “Company”
in the Warrant Agreement (including all exhibits thereto) shall be amended such that they
refer to the Company rather than SPAC. |
| 2.2 | Recitals.
The recitals on pages one and two of the Warrant Agreement are hereby deleted and replaced
in their entirety as follows: |
“WHEREAS, on March 10, 2021,
L Catterton Asia Acquisition Corp. (“LCAA”) entered into that certain Private Placement Warrants Purchase Agreement
with LCA Acquisition Sponsor, LP, a Cayman Islands exempted limited partnership (the “Sponsor”), pursuant to
which the Sponsor agreed to purchase an aggregate of 5,000,000 warrants (or up to 5,500,000 warrants if the Over-allotment Option (as
defined below) in connection with the Offering (as defined below) is exercised in full) simultaneously with the closing of the Offering
(and the closing of the Over-allotment Option, if applicable) bearing the legend set forth in Exhibit B hereto (the “Private
Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant; and
WHEREAS, in order to finance LCAA’s
transaction costs in connection with an intended initial merger, share exchange, asset acquisition, share purchase, reorganization or
similar business combination, involving the Company and one or more businesses, the Sponsor or an affiliate of the Sponsor or certain
of LCAA’s officers and directors could, but were not obligated to, loan LCAA funds as LCAA required, of which up to $1,500,000
of such loans may be convertible into up to an additional 1,000,000 Private Placement Warrants at a price of $1.50 per Private Placement
Warrant (the “Working Capital Warrants”); and
WHEREAS, LCAA consummated an initial
public offering (the “Offering”) of units of LCAA’s equity securities, each such unit comprised of one
Class A ordinary share and one-third of one Public Warrant (as defined below) (the “Units”) and, in connection
therewith, issued and delivered up to 9,583,333 warrants (including up to 1,250,000 warrants subject to the Over-allotment Option) to
public investors in the Public Offering (the “Public Warrants” and together with the Private Placement Warrants
and Working Capital Warrants, the “LCAA Warrants”). Each whole LCAA Warrant entitles the holder thereof to
purchase one Class A ordinary share of LCAA for $11.50 per share, subject to adjustment. Only whole warrants are exercisable; and
WHEREAS, LCAA has filed with the Securities
and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-253334
and a prospectus (the “Prospectus”), for the registration, under the Securities Act of 1933, as amended (the
“Securities Act”), of the Units, and the Public Warrants and the Class A ordinary shares included in the
Units; and
WHEREAS, on January 31, 2023, (i) LCAA,
(ii) the Company, (iii) Lotus Temp Limited, an exempted company limited by shares incorporated under the laws of the Cayman
Islands and a direct wholly owned subsidiary of the Company (“Merger Sub 1”), and (iv) Lotus EV Limited,
an exempted company limited by shares incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of the Company
(“Merger Sub 2”), entered into that certain Agreement and Plan of Merger (the “Original Merger
Agreement”);
WHEREAS,
on October 11, 2023, the parties to the Original Merger Agreement entered into the First Amended and Restated Agreement and
Plan of Merger (as may be amended, supplemented or otherwise modified from time to time in accordance with its terms, the
“Merger Agreement”), pursuant to which the Original Merger Agreement was amended and restated in its
entirety to provide, among other things, that all Class A ordinary shares of LCAA (other than the Class A ordinary shares
of LCAA held by the Founder Shareholders (as defined in the Merger Agreement)) shall be exchanged for the right to receive American
depositary shares of the Company duly and validly issued against the deposit of the underlying ordinary shares, par value $0.00001
per share, of the Company (“Company Ordinary Shares”) deposited with the Depositary Bank (as defined in
the Merger Agreement) in accordance with the Deposit Agreement (as defined in the Merger Agreement) (“Company
ADSs”);
WHEREAS, pursuant to the Merger Agreement
and Section 4.5 of this Agreement, immediately after the First Effective Time (as defined in the Merger Agreement), each of the
issued and outstanding LCAA Warrants will no longer be exercisable for Class A ordinary share of LCAA but instead will become exercisable
(subject to the terms and conditions of this Agreement) for Company Ordinary Shares in the form of Company ADSs (each a “Warrant”
and collectively, the “Warrants”); and
WHEREAS, the Company desires the Warrant
Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer,
exchange, redemption and exercise of the Warrants; and
WHEREAS, the Company desires to provide
for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation
of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and
WHEREAS, all acts and things have been
done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf
of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and
delivery of this Agreement.
NOW, THEREFORE, in consideration of the
mutual agreements herein contained, the parties hereto agree as follows:”
| 2.3 | Detachability
of Warrants. Section 2.4 of the Warrant Agreement is hereby deleted and replaced
with the following: “[INTENTIONALLY OMITTED]” |
| 2.4 | References
to “Ordinary Shares”. All references to “Ordinary Shares” in
the Warrant Agreement (including all Exhibits thereto) shall be amended such that they refer
to Company Ordinary Shares in the form of Company ADSs after the Company Ordinary Shares
have been deposited into the ADS Facility in connection with the Mergers or, if at the time
of exercise the Company no longer uses the ADS Facility, Company Ordinary Shares. |
| 2.5 | References
to Business Combination. All references to “Business Combination” in the
Warrant Agreement (including all Exhibits thereto) shall be references to the transactions
contemplated by the Merger Agreement, and references to “the completion of the Business
Combination” and all variations thereof in the Warrant Agreement (including all Exhibits
thereto) shall be references to the closing of the transactions contemplated by the Merger
Agreement. |
| 2.6 | Warrant
Agent. All references to “Warrant Agent” and “Transfer Agent”
in the Warrant Agreement (including all Exhibits thereto) shall be references to the Successor
Warrant Agent hereunder. |
| 2.7 | Notices.
Section 9.2 of the Warrant Agreement is hereby deleted and replaced with the following: |
“Notices. Any notice, statement
or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company
shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service
within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the
Company with the Warrant Agent), as follows:
Lotus Technology Inc.
No. 800 Century Avenue
Pudong District
Shanghai 200120, People’s Republic
of China
Attention: Chief Financial Officer
E-mail: Alexious.Lee@lotuscars.com.cn
with a copy (which shall not constitute
notice) to:
Skadden, Arps, Slate, Meagher &
Flom LLP
30/F, China World Office 2
No. 1, Jian Guo Men Wai Avenue
Beijing 100004, China
Attn: Peter X. Huang
Email: peter.huang@skadden.com
Any notice, statement or demand authorized
by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently
given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days
after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
as follows:
Equiniti Trust Company, LLC
48 Wall Street, 22nd Floor
New York, NY 10005
Attention: Reorg Department
Email: ReorgWarrants@equiniti.com
| 3. | Miscellaneous
Provisions. |
| 3.1 | Effectiveness.
Notwithstanding anything to the contrary contained herein, this Agreement shall be expressly
subject to the occurrence of and only become effective upon the Closing. In the event that
the Merger Agreement is terminated for any reason in accordance with its terms prior to the
Closing, this Agreement and all rights and obligations of the parties hereunder shall automatically
terminate and be of no further force or effect. |
| 3.2 | Miscellaneous.
Except as expressly provided in this Agreement, all of the terms and provisions in the Warrant
Agreement are and shall remain in full force and effect, on the terms and subject to the
conditions set forth therein. This Agreement does not constitute, directly or by implication,
an amendment or waiver of any provision of the Warrant Agreement, or any other right, remedy,
power or privilege of any party thereto, except as expressly set forth herein. Any reference
to the Warrant Agreement in the Warrant Agreement or any other agreement, document, instrument
or certificate entered into or issued in connection therewith, shall hereinafter mean the
Warrant Agreement as the case may be, as amended by this Agreement (or as such agreement
may be further amended or modified in accordance with the terms thereof). The terms of this
Agreement shall be governed by, enforced and construed and interpreted in a manner consistent
with the provisions of the Warrant Agreement, as it applies to the amendments to the Warrant
Agreement herein, including without limitation Section 9 of the Warrant Agreement. |
[Signature Pages Follow]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.
| |
L CATTERTON ASIA ACQUISITION CORP,
as SPAC |
| |
|
| |
By: |
|
| |
Name: |
| |
Title: |
[Signature
Page to Assignment, Assumption and Amendment Agreement]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.
| |
LOTUS TECHNOLOGY INC., as the
Company |
| |
|
| |
By: |
|
| |
Name: |
| |
Title: |
[Signature
Page to Assignment, Assumption and Amendment Agreement]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.
| |
CONTINENTAL STOCK TRANSFER &
TRUST COMPANY, as Predecessor Warrant Agent |
| |
|
| |
By: |
|
| |
Name: |
| |
Title: |
[Signature
Page to Assignment, Assumption and Amendment Agreement]
IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed as of the date first above written.
| |
EQUINITI TRUST COMPANY, LLC,
as Successor Warrant Agent |
| |
|
| |
By: |
|
| |
Name: |
| |
Title: |
[Signature
Page to Assignment, Assumption and Amendment Agreement]
L Catterton Asia Acquisi... (NASDAQ:LCAAU)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
L Catterton Asia Acquisi... (NASDAQ:LCAAU)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
